Processing 00000000.tx.1: Tetracyclines inhibit activated B cell function Igor I. 

Phrase: "Tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "activated B cell function Igor I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0021966:I- [Inorganic Chemical]
   799   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: Kuzin1, Jennifer E. 

Phrase: "Kuzin1,"

Phrase: "Jennifer E."
Processing 00000000.tx.3: Snyder2,4, Gregory D. 

Phrase: "Snyder2,"

Phrase: "4,"

Phrase: "Gregory D."
Processing 00000000.tx.4: Ugine1, Dongming Wu1, Sang Lee3,4, Timothy Bushnell, Jr1, Richard A. 

Phrase: "Ugine1,"

Phrase: "Dongming Wu1,"

Phrase: "Sang"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1864650:SANG [Gene or Genome]
   966 E C0037173:SING [Geographic Area]
   966 E C0234857:sing [Individual Behavior]

Phrase: "Lee3,"

Phrase: "4,"

Phrase: "Timothy Bushnell,"

Phrase: "Jr1,"

Phrase: "Richard A."
Processing 00000000.tx.5: Insel3, Faith M. 

Phrase: "Insel3,"

Phrase: "Faith M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: Young1,2,3 and Andrea Bottaro1,2 1 Departments of Medicine, 2 Microbiology and Immunology, and 3 Pediatrics, and the 4 Graduate Program in Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA Correspondence to: A. 

Phrase: "Young1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Andrea Bottaro1,"

Phrase: "2 1 Departments of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704729:Department [Organization]

Phrase: "2 Microbiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025952:Microbiology [Biomedical Occupation or Discipline]
   861   C0025953:microbiology [Intellectual Product]
   861   C0085672:Microbiology [Laboratory Procedure]

Phrase: "and"

Phrase: "Immunology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0152036:Immunology [Biomedical Occupation or Discipline]
  1000   C1522005:immunology [Qualitative Concept]
   928 E C0205470:Immunological [Functional Concept]

Phrase: "and"

Phrase: "3 Pediatrics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030755:Paediatrics [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "the 4 Graduate Program in Microbiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1709697:Program [Conceptual Entity]
   753   C2728259:Program [Pharmacologic Substance]
   753   C3484370:Program [Functional Concept]

Phrase: "and"

Phrase: "Immunology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0152036:Immunology [Biomedical Occupation or Discipline]
  1000   C1522005:immunology [Qualitative Concept]
   928 E C0205470:Immunological [Functional Concept]

Phrase: "University of Rochester School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Dentistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011438:Dentistry [Biomedical Occupation or Discipline]

Phrase: "Rochester,"

Phrase: "NY 14642,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: "USA Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "A."
Processing 00000000.tx.7: Bottaro, Immunology Unit, University of Rochester School of Medicine, URMC Box 695, 601 Elmwood Avenue, Rochester, NY 14642, USA  Abstract Top Abstract Introduction Methods Results Discussion References  Tetracyclines have recently been shown to exert a number of pleiotropic anti-inflammatory and immunomodulatory activities, independent of their antibiotic properties. 

Phrase: "Bottaro,"

Phrase: "Immunology Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "University of Rochester School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "URMC Box 695,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0179400:Box [Manufactured Object]
   827   C1533124:Box [Medical Device]

Phrase: "601 Elmwood Avenue,"

Phrase: "Rochester,"

Phrase: "NY 14642,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027976:NY [Geographic Area]
   861   C1879958:NY [Intellectual Product]

Phrase: "USA  Abstract Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "a number of pleiotropic anti-inflammatory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "immunomodulatory activities,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "independent of their antibiotic properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]
Processing 00000000.tx.8: These include the ability to inhibit metalloproteinases (MP), a class of enzymes involved in crucial cellular functions such as the shedding of soluble mediators and their receptors from the cell surface, as well as interaction with, and remodeling of, the extracellular matrix. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "metalloproteinases (MP),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a class of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456387:Class [Intellectual Product]
   770   C1705943:Class [Classification]

Phrase: "involved in crucial cellular functions"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0007613:Cellular Function [Cell Function]
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0542341:Functions [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "such as the shedding"

Phrase: "of soluble mediators"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   827 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their receptors from the cell surface,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0034800:Receptors, Cell Surface [Amino Acid, Peptide, or Protein,Receptor]
   767   C1514760:Receptor Cell [Cell]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "as well as"

Phrase: "interaction with,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "remodeling of,"

Phrase: "the extracellular matrix."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015350:Extracellular Matrix [Tissue]
   861   C0521119:Extracellular [Cell Component]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.9: Here we report that doxycycline at therapeutic concentrations (15 g/ml) significantly suppresses Ig secretion and class switching by in vitro activated murine B cells. 

Phrase: "Here"

Phrase: "we"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that doxycycline at therapeutic concentrations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   704 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "(15 g/ml) significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439267:g% [Quantitative Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "Ig secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching by in vitro activated murine B cells."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   770   C0004561:B-Cells [Cell]
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]
   744   C0007634:Cells [Cell]
   744   C0026809:Murine [Mammal]
   744   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   744   C1879547:Activated [Activity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1515877:Activate [Functional Concept]
   711 E C1704653:Cell [Medical Device]
   711   C1707719:Switch [Manufactured Object]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.10: Suppression of Ig secretion correlates with a decrease in levels of mRNA for the terminal B cell differentiation-associated genes Blimp-1 and mad-4, as well as to a reduction in expression of the plasma cell markers Syndecan-1 and J chain. 

Phrase: "Suppression of Ig secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "correlates with a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for the terminal B cell differentiation-associated genes Blimp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0254341:BLIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mad-4,"

Phrase: "as well as to a reduction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205170:Well [Qualitative Concept]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]
   753   C3146287:Well [Manufactured Object]

Phrase: "in expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of the plasma cell markers Syndecan-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1419891:SYNDECAN 1 [Gene or Genome]
           SYNDECAN
   840   C1609943:Syndecan-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0075691:syndecan [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "J chain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416161:J CHAIN [Gene or Genome]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.11: Inhibition of class switching occurs at the recombination stage and is also induced by other MP inhibitors, including tetracycline analogs lacking antibiotic activity and the chemically unrelated hydroxamate KB8301. 

Phrase: "Inhibition of class"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "occurs at the recombination stage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0034865:Recombination [Genetic Function]
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "also"

Phrase: "induced by other MP inhibitors,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205263:Induced [Functional Concept]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "tetracycline analogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:analogs [Chemical Viewed Structurally]
   755 E C0679213:analogies [Idea or Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "antibiotic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "the chemically unrelated hydroxamate KB8301."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1175466:KB8301 [Organic Chemical]
Processing 00000000.tx.12: These novel, direct effects of MP inhibitors on B lymphocytes suggest an intrinsic role for MP in B cell activation and likely explain some of the observed in vivo immunomodulatory properties of tetracyclines. 

Phrase: "These novel, direct effects of MP inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on B lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004561:B-Lymphocytes [Cell]
   861   C0024264:Lymphocytes [Cell]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "an intrinsic role for MP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in B cell activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155003:B-Cell Activation [Cell Function]
  1000   C1332420:B-cell activation [Gene or Genome]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "explain"

Phrase: "some of the observed in vivo immunomodulatory properties of tetracyclines."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C1515655:In Vivo [Spatial Concept]
           vivo
   739   C0039651:Tetracyclines [Organic Chemical]
   739   C0205392:Some [Quantitative Concept]
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   739   C1441672:Observed [Functional Concept]
   739   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   739   C3540770:Some [Intellectual Product]
   706 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]
Processing 00000000.tx.13: Moreover, these findings have significant implications for tetracycline therapy in Ig-mediated autoimmune or allergic diseases and raise questions about the use of doxycycline-inducible transgenic systems for the study of B cell function. 

Phrase: "Moreover,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "have"

Phrase: "significant implications for tetracycline therapy"

Phrase: "in Ig-mediated autoimmune"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443146:Autoimmune [Pathologic Function]

Phrase: "or"

Phrase: "allergic diseases"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "raise"

Phrase: "questions about the use of doxycycline-inducible transgenic systems"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1522634:Question [Intellectual Product]

Phrase: "for the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of B cell function."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007613:Cell Function [Cell Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0004561:B-cell [Cell]
Processing 00000000.tx.14: Keywords: B lymphocyte, Ig, isotype switching, metalloproteinase, tetracycline  Introduction Top Abstract Introduction Methods Results Discussion References  Tetracyclines, among the most commonly prescribed antibiotics, also display a number of independent, pleiotropic activities on inflammatory and immune processes. 

Phrase: "Keywords"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708608:Keyword [Intellectual Product]

Phrase: ":"

Phrase: "B lymphocyte,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004561:B lymphocyte [Cell]
   861   C0024264:Lymphocyte [Cell]

Phrase: "Ig,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3541296:IG [Idea or Concept]

Phrase: "isotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: ","

Phrase: "metalloproteinase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "tetracycline  Introduction Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Tetracyclines,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "among the most commonly prescribed antibiotics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003232:Antibiotics [Antibiotic]

Phrase: "also"

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a number of independent, pleiotropic activities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "on inflammatory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333348:Inflammatory [Functional Concept]

Phrase: "and"

Phrase: "immune processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.15: They have been shown to specifically decrease levels of inducible NO synthase in activated macrophages by regulating the stability of its mRNA (1,2) and to inhibit phospholipase A2 (3). 

Phrase: "They"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "levels of inducible NO synthase"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "in activated macrophages"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0001280:Activated macrophage [Cell]
   861   C0024432:Macrophages [Cell]
   861   C1546706:Macrophages [Intellectual Product]
   861   C1550652:Macrophages [Body Substance]

Phrase: "by"

Phrase: "regulating"

Phrase: "the stability of its mRNA (1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1257757:mRNA Stability [Qualitative Concept]
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "phospholipase A2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031667:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1744635:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539768:Phospholipase A2 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.16: Cyclo-oxygenase-2-mediated prostaglandin synthesis is also differentially affected by various tetracyclines (4,5). 

Phrase: "Cyclo-oxygenase-2-mediated prostaglandin synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1157324:prostaglandin synthesis [Molecular Function]
   799   C0220781:synthesis [Biologic Function]
   799   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "also differentially"

Phrase: "affected by various tetracyclines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0039651:Tetracyclines [Organic Chemical]
   770   C0392760:Affected [Functional Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1314939:Affected [Functional Concept]
   770   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   737 E C0001721:Affect [Mental Process]
   737 E C0039644:Tetracycline [Antibiotic,Organic Chemical]

Phrase: "(4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: Finally, tetracyclines can specifically inhibit the expression, activation from pro-enzyme precursor, as well as the enzymatic activity of metalloproteinases (MP) (68, reviewed in 9,10). 

Phrase: "Finally,"

Phrase: "tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "can"

Phrase: "specifically"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "activation from pro-enzyme precursor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0014429:Enzyme Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "as well as"

Phrase: "the enzymatic activity of metalloproteinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C2267219:Enzymatic Activity [Molecular Function]
   781   C1150224:metalloproteinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(MP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "(68,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: "reviewed in 9,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.18: MP inhibition is in part responsible for the tetracyclines' ability to modulate secretion of soluble factors released by proteolytic ectodomain shedding, such as tumor necrosis factor (TNF)- (11) and Fas ligand (12), and to reduce the destruction of connective tissue during severe inflammation (reviewed in 9,10). 

Phrase: "MP inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "is in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "responsible for the tetracyclines' ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1273518:Responsible to [Finding]
           Responsible

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "secretion of soluble factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "released by proteolytic ectodomain shedding,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0391871:Released [Functional Concept]
   760   C0597304:Proteolytic [Molecular Function]
   760   C1283071:Released [Functional Concept]
   760   C1947941:proteolytic [Enzyme]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "such as tumor necrosis factor (TNF)-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "Fas ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "the destruction of connective tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C1446300:Destruction of tissue [Therapeutic or Preventive Procedure]
   760   C1261381:Destruction [Therapeutic or Preventive Procedure]
   760   C1948029:Destruction [Activity]

Phrase: "during severe inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522569:Severe inflammation [Finding]
   861   C0021368:Inflammation [Pathologic Function]

Phrase: "("

Phrase: "reviewed in 9,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.19: This wide array of biological activities has resulted in the widespread application of tetracycline-based therapy in inflammatory disorders such as periodontitis and rheumatoid arthritis (7,13,14). 

Phrase: "This wide array of biological activities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510941:Array [Spatial Concept]

Phrase: "has"

Phrase: "resulted in the widespread application of tetracycline-based therapy"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   742   C0039644:Tetracycline [Antibiotic,Organic Chemical]
   742   C0039651:tetracycline [Organic Chemical]
   742   C0039798:therapy [Functional Concept]
   742   C0087111:Therapy [Therapeutic or Preventive Procedure]
   742   C0185125:Application [Health Care Activity]
   742   C0205391:Widespread [Spatial Concept]
   742   C1363945:Therapy [Finding]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C1744619:tetracycline [Antibiotic,Organic Chemical]
   742   C1947919:Application [Intellectual Product]
   742   C2347934:Application [Intellectual Product]
   742   C3539080:APPLICATION [Quantitative Concept]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708 E C1880279:Base [Biomedical or Dental Material]
   708   C2825142:Result [Finding]

Phrase: "in inflammatory disorders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1290884:Inflammatory disorder [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "such as periodontitis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0031099:Periodontitis [Disease or Syndrome]
   944 E C0031051:Pericementitides [Disease or Syndrome]

Phrase: "and"

Phrase: "rheumatoid arthritis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "(7,"

Phrase: "13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.20: In a number of studies, tetracyclines have also been shown to decrease humoral immune responses in mice (1517). 

Phrase: "In a number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "humoral immune responses in mice"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   862   C1155229:Immune Responses, Humoral [Cell Function]
   845 E C0020967:Humoral Immune Response [Organism Function]
   806   C0301872:immune responses [Organ or Tissue Function]
   760   C0439662:Immune [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "(1517"

Phrase: ")."
Processing 00000000.tx.21: Moreover, minocycline treatment reduced serum levels of rheumatoid factor and total Ig in rheumatoid arthritis patients (13,14). 

Phrase: "Moreover,"

Phrase: "minocycline treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "serum levels of rheumatoid factor"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0427389:Rheumatoid factor level [Laboratory or Test Result]
   760   C0229671:Serum [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "total Ig in rheumatoid arthritis patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C3541296:IG [Idea or Concept]

Phrase: "(13,"

Phrase: "14"

Phrase: ")."
Processing 00000000.tx.22: Tetracyclines have also been reported to suppress lymphocyte proliferation to mitogens and cytokine secretion in vitro, although the effect was variable and observed in only some systems (1824). 

Phrase: "Tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "lymphocyte proliferation to mitogens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0596873:lymphocyte proliferation [Cell Function]
   770   C0024264:Lymphocyte [Cell]
   770   C0334094:Proliferation [Pathologic Function]
   770   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "cytokine secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1327414:cytokine secretion [Cell Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "although"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "observed in only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Only [Quantitative Concept]
   790   C1441672:Observed [Functional Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "some systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0449913:System [Functional Concept]
   966   C1553451:System [Manufactured Object]
   966   C1704459:System [Medical Device]
   916 E C0205373:Systemic [Functional Concept]

Phrase: "(1824"

Phrase: ")."
Processing 00000000.tx.23: The complexity of the tetracyclines' pleiotropic effects has hampered the study of the actual mechanisms responsible for their immunosuppressive activity, which have remained elusive. 

Phrase: "The complexity of the tetracyclines' pleiotropic effects"

Phrase: "has"

Phrase: "hampered"

Phrase: "the study of the actual mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "responsible for their immunosuppressive activity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "which"

Phrase: "have"

Phrase: "remained"

Phrase: "elusive."
Processing 00000000.tx.24: Tetracyclines, in particular doxycycline, are commonly used experimentally in cell lines and transgenic mice as regulators of artificial inducible/repressible transcription systems (2527). 

Phrase: "Tetracyclines,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "in particular doxycycline,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   805 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "are"

Phrase: "commonly"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "experimentally in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0007600:Cell lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "transgenic mice as regulators of artificial inducible/repressible transcription systems"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025936:Mice, Transgenic [Mammal]
   739   C0003069:Transgenic [Animal]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]

Phrase: "(2527"

Phrase: ")."
Processing 00000000.tx.25: Despite the considerable amount of evidence pointing to specific activities of tetracyclines in eukaryotic organisms, the doxycycline-regulatable systems have become widely utilized because of their purported lack of significant pleiotropic effects. 

Phrase: "Despite the considerable amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of evidence pointing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]

Phrase: "to specific activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0205369:Specific [Qualitative Concept]
   861   C0441655:Activities [Activity]
   861   C1552740:specific [Intellectual Product]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "of tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "in eukaryotic organisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029235:Organisms [Organism]

Phrase: "the doxycycline-regulatable systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "have"

Phrase: "become"

Phrase: "widely"

Phrase: "utilized because of their purported lack of significant pleiotropic effects."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   739   C0237881:significant [Quantitative Concept]
   739   C0332268:lack [Qualitative Concept]
   739   C0750502:Significant [Idea or Concept]
   739   C1280500:effects [Qualitative Concept]
   739   C1546944:Significant [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.26: We have conducted a series of control experiments to establish the effect of doxycycline treatment on our model system, i.e. in vitro activated primary mouse B lymphocytes, as a preliminary step to establishing such inducible systems for the study of B cell activation. 

Phrase: "We"

Phrase: "have"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "a series of control experiments to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the effect of doxycycline treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on our model system,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0026339:Model System [Intellectual Product,Research Device]
  1000   C3161035:Model System [Intellectual Product]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "i.e. in vitro activated primary mouse B lymphocytes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   829   C1515878:Activated B-Lymphocyte [Cell]
   825   C1515879:Activated Lymphocyte [Cell]
   810   C1522109:Mouse B-Lymphocyte [Cell]
   807   C0004561:B-Lymphocytes [Cell]
   800   C1522703:Mouse Lymphocyte [Cell]
   791   C0024264:Lymphocytes [Cell]

Phrase: "as"

Phrase: "a preliminary step to establishing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1261552:Step [Conceptual Entity]
   760   C1704379:Step [Functional Concept]
   760   C1705117:Step [Quantitative Concept]
   760   C2825408:Step [Manufactured Object]

Phrase: "such inducible systems for the study of B cell activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0449913:System [Functional Concept]
   706   C1553451:System [Manufactured Object]
   706   C1704459:System [Medical Device]
Processing 00000000.tx.27: The results we present here demonstrate that tetracyclines display several specific and dramatic inhibitory effects on B cell function in vitro at concentrations commonly achieved during antibiotic therapy and comparable to those used in inducible transgenic systems.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "we"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "here"

Phrase: "demonstrate"

Phrase: "that tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "several specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "dramatic inhibitory effects on B cell"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "in vitro at concentrations commonly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]

Phrase: "achieved during antibiotic therapy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0338237:Antibiotic therapy [Therapeutic or Preventive Procedure]
   770   C0003232:Antibiotic [Antibiotic]
   770   C0039798:therapy [Functional Concept]
   770   C0087111:Therapy [Therapeutic or Preventive Procedure]
   770   C1363945:Therapy [Finding]

Phrase: "and"

Phrase: "comparable to those"

Phrase: "used in inducible transgenic systems."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0003069:Transgenic [Animal]
   760   C0205263:Inducible [Functional Concept]
   760   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726   C0449913:System [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.28: Methods Top Abstract Introduction Methods Results Discussion References  Reagents and cell lines Doxycycline (1 mg/ml in water; Sigma, St Louis, MO), chemically modified tetracyclines (CMT; 1 mg/ml in 90% ethanol, 10% DMSO; kindly provided by Collagenex Pharmaceuticals, Newton, PA), the hydroxamate KB8301 (10 mM in DMSO; PharMingen, San Diego, CA) were all stored aliquoted at 20C. 

Phrase: "Methods Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "cell lines Doxycycline"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   771 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
   734   C0007600:Cell lines [Cell]

Phrase: "(1 mg/ml in water"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0439294:mg ml [Quantitative Concept]
   760   C0439526:/mL [Quantitative Concept]

Phrase: "; Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "chemically modified tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0039651:Tetracyclines [Organic Chemical]
   827   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   793 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   755 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   755 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "(CMT"

Phrase: "; 1 mg/ml in 90% ethanol,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439294:mg ml [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "10% DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "; kindly"

Phrase: "provided by Collagenex Pharmaceuticals,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1135440:Pharmaceuticals [Therapeutic or Preventive Procedure]
   770   C1254351:Pharmaceuticals [Pharmacologic Substance]
   770   C1999230:Provided [Activity]
   737 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "the hydroxamate KB8301"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1175466:KB8301 [Organic Chemical]

Phrase: "(10 mM in DMSO"

Phrase: "; PharMingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "were"

Phrase: "all"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "aliquoted at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1510844:Aliquot [Quantitative Concept]
Processing 00000000.tx.29: Human tissue inhibitor of metalloproteinases (TIMP)-1 and -2 (0.5 mg/ml in PBS; Chemicon International, Temecula, CA) were stored at 80C. 

Phrase: "Human tissue inhibitor of metalloproteinases (TIMP)-1"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   938   C1522552:Tissue Inhibitor of Metalloproteinases 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Tissue Inhibitor of Metalloproteinases
           Metalloproteinase Inhibitor 1
   929 E C0145947:Tissue-Inhibitor of Metalloproteinase-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-1 Tissue Inhibitor
   882   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   783   C1418824:INHIBITOR 1 [Gene or Genome]
   767   C1152589:metalloproteinase inhibitor [Molecular Function]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(0.5 mg/ml in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C2984062:mg/5 ml [Quantitative Concept]
   790   C0439294:mg ml [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "; Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555271:Temecula [Population Group]

Phrase: "CA)"

Phrase: "were"

Phrase: "stored at 80C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.30: In vitro activation assays Splenocytes were derived from 4- to 16-week-old C57Bl/6 or BALB/c mice housed in specific pathogen-free conditions in the URMC Vivarium. 

Phrase: "In vitro activation assays Splenocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1519477:Splenocyte [Cell]
   705   C1515653:In Vitro Assay [Research Activity]

Phrase: "were"

Phrase: "derived from 4-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "to 16-week-old C57Bl/6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1521751:C57BL/6 [Mammal]
   804   C0025921:C57BL [Mammal]
   804   C0332174:/week [Temporal Concept]
   804   C0439230:week [Temporal Concept]
   804   C0580836:Old [Temporal Concept]

Phrase: "or"

Phrase: "BALB/c mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025919:Mice, BALB C [Mammal]
           BALB/C
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "housed in specific pathogen-free conditions"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0162470:Specific Pathogen Free [Organism]
   753   C0020056:Housed [Manufactured Object]
   753   C0205369:Specific [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C0450254:Pathogen [Organism]
   753   C1552740:specific [Intellectual Product]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719 E C0442519:house [Conceptual Entity]
   719   C1705253:Condition [Conceptual Entity]
   719 E C2003847:House [Manufactured Object]

Phrase: "in the URMC Vivarium."
Processing 00000000.tx.31: CD19+ B cells were purified in some experiments using a Miltenyi Biotec (Bergisch-Gladbach, Germany) Midi-MACS magnetic sorting apparatus and columns with either directly conjugated anti-CD19 beads or FITC-conjugated anti-CD19 antibody and anti-FITC beads, according to the manufacturer's protocols. 

Phrase: "CD19+ B cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0004561:B-Cells [Cell]
   896   C0882808:CD19+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "purified in some experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1998793:Purified [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Miltenyi Biotec"

Phrase: "(Bergisch-Gladbach,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "Midi-MACS magnetic sorting apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0243111:apparatus [Manufactured Object]
   804   C1947951:Apparatus [Anatomical Structure]

Phrase: "and"

Phrase: "columns with either directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1185738:Column [Body Part, Organ, or Organ Component]
   737   C1706132:Column [Idea or Concept]

Phrase: "conjugated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522529:Conjugated [Spatial Concept]
   966 E C0301869:Conjugate [Immunologic Factor]

Phrase: "anti-CD19 beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "or"

Phrase: "FITC-conjugated anti-CD19 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C3540683:CD19 [Laboratory Procedure]

Phrase: "and"

Phrase: "anti-FITC beads,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]

Phrase: "according to the manufacturer's protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.32: A single purification step consistently yielded 9598% B220+, IgM+ cells. 

Phrase: "A single purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243114:purification [Functional Concept]
   861   C1998793:Purification [Functional Concept]

Phrase: "step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1261552:Step [Conceptual Entity]
  1000   C1704379:Step [Functional Concept]
  1000   C1705117:Step [Quantitative Concept]
  1000   C2825408:Step [Manufactured Object]

Phrase: "consistently"

Phrase: "yielded"

Phrase: "9598% B220+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1335285:B220 [Gene or Genome]
   861   C1706240:B220 [Gene or Genome]

Phrase: "IgM+ cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.33: In some experiments, the cells were loaded prior to culture with the vital fluorescent dye 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR), which allows estimation of division cycles of proliferating cells, as described (28,29). 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "loaded prior to culture"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C1708715:Loaded [Activity]
   770   C2242979:Culture [Laboratory Procedure]
   770   C2826257:PRIOR [Event]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "with the vital fluorescent dye 5-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   812   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   812   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0442732:Vital [Qualitative Concept]
   812   C1875856:VITAL [Food]

Phrase: "("

Phrase: "and"

Phrase: "6-"

Phrase: ")"

Phrase: "carboxyfluorescein diacetate succinimidyl ester"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0254579:carboxyfluorescein diacetate succinimidyl ester [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0054736:carboxyfluoresceindiacetate [Organic Chemical]
   812   C0014898:Ester [Organic Chemical]
   812   C0108453:carboxyfluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0369114:Diacetate [Organic Chemical]

Phrase: "(CFSE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0254579:CFSE [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "; Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "estimation of division"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0680844:estimation [Mental Process]
   790   C0681916:Estimation [Quantitative Concept]
   790   C0750572:Estimation [Quantitative Concept]

Phrase: "cycles of proliferating cells,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   819   C0007586:cells cycle [Cell Function]
   802 E C1155839:Cell Cycle [Cell Function]
   770   C0007634:Cells [Cell]
   770   C1511572:Cycle [Temporal Concept]
   770   C1514485:Proliferating [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.34: Splenocytes or CD19+ B cells were cultured for 5 days in complete RPMI medium, 10% FCS plus activatorseither 20 g/ml bacterial lipopolysaccharide (LPS; Sigma)/10 g/ml dextran sulfate or 2 g/ml anti-CD40 antibody (clone HM40-3; PharMingen)with or without 25 ng/ml recombinant mouse IL-4 (R & D Systems, Minneapolis, MN). 

Phrase: "Splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "or"

Phrase: "CD19+ B cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0004561:B-Cells [Cell]
   896   C0882808:CD19+ cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 5 days"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in complete RPMI medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "10% FCS plus activatorseither 20 g/ml bacterial lipopolysaccharide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0023810:Lipopolysaccharide [Lipid]

Phrase: "(LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023810:LPS [Lipid]
  1000   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
  1000   C2697656:LPS [Gene or Genome]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "/10 g/ml dextran sulfate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0079224:Dextran Sulfate [Carbohydrate,Pharmacologic Substance]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "2 g/ml anti-CD40 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   839   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone HM40-3"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "; PharMingen"

Phrase: ")"

Phrase: "with"

Phrase: "or without 25 ng/ml recombinant mouse IL-4"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0439275:ng/mL [Quantitative Concept]
   742   C0020898:IL [Geographic Area]
   742   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0022271:IL [Geographic Area]
   742   C0025914:Mouse [Mammal]
   742   C0025929:mouse [Mammal]
   742   C0026809:Mouse [Mammal]
   742   C0439526:/mL [Quantitative Concept]
   742   C1514798:recombinant [Organism]

Phrase: "(R & D Systems,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "Minneapolis,"

Phrase: "MN"

Phrase: ")."
Processing 00000000.tx.35: The cell concentration was adjusted daily to ~106/ml. 

Phrase: "The cell concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "adjusted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456081:Adjusted [Functional Concept]

Phrase: "daily to ~106/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.36: All additional reagents were added from day 0 of culture at the concentrations indicated in the text. 

Phrase: "All additional reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "added from day 0 of culture"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0332173:/day [Temporal Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C1524062:Added [Functional Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C1883712:Add [Functional Concept]

Phrase: "at the concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "indicated in the text."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1444656:Indicated [Finding]
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]
Processing 00000000.tx.37: At day 5, the B cell blasts were stained for expression of surface markers and Ig heavy chain isotypes using fluorochrome-conjugated mAb (PharMingen and Southern Biotechnology Associates, Birmingham, AL) (see legends for antibody description). 

Phrase: "At day 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the B cell blasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0337026:blasts [Natural Phenomenon or Process]
   827   C0368761:Blasts [Cell]
   827   C0523113:Blasts [Laboratory Procedure]
   734   C0004561:B-cell [Cell]

Phrase: "were"

Phrase: "stained for expression of surface markers"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205148:Surface [Spatial Concept]
   753   C2986582:Stained [Qualitative Concept]
   719   C0005516:Marker [Clinical Attribute]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Ig heavy chain isotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0021034:IG HEAVY CHAIN [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorochrome-conjugated mAb (PharMingen"

Phrase: "and"

Phrase: "Southern Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ","

Phrase: "Birmingham,"

Phrase: "AL) ("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "legends for antibody description"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2729544:Legend [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.38: Stained cells were analyzed by flow cytometry on a Becton Dickinson (Mountain View, CA) FACSCalibur instrument using CellQuest software. 

Phrase: "Stained cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed by flow cytometry"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "on a Becton Dickinson"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "(Mountain View,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]

Phrase: "CA) FACSCalibur instrument"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0348000:Instrument [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CellQuest software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.39: The fraction of switched cells was quantified using CellQuest software in eight to 16 independent LPS culture experiments, depending on the isotype, and three independent experiments for anti-CD40/IL-4 cultures; 

Phrase: "The fraction of switched cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   781   C0805525:Cell Fraction [Cell Component]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CellQuest software in eight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "to 16 independent LPS culture experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "depending on the isotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "three independent experiments for anti-CD40/IL-4 cultures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0681814:Experiments [Research Activity]
   708 E C1706386:Experiment [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.40: specific gates were drawn according to the distribution of isotype-positive cells in inducing versus non-inducing conditions (e.g. LPS versus LPS/IL-4 for IgG3). 

Phrase: "specific gates"

Phrase: "were"

Phrase: "drawn according to the distribution of isotype-positive cells"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   764   C0439178:% positive cells [Quantitative Concept]
           % Positive
   742   C0007634:Cells [Cell]
   742   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0520511:distribution [Idea or Concept]
   742   C0680240:according [Social Behavior]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C1704711:Distribution [Functional Concept]
   742   C2825490:Positive [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708   C0013113:Draw [Intellectual Product]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "in inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "versus"

Phrase: "non-inducing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "("

Phrase: "e.g. LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023810:LPS [Lipid]
  1000   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
  1000   C2697656:LPS [Gene or Genome]

Phrase: "versus"

Phrase: "LPS/IL-4 for IgG3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020898:IL [Geographic Area]
   760   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.41: [3H]Thymidine incorporation was measured at 48 h of culture, using flat-bottom 96-well plates (starting concentration, 105 cells/well) with 1 Ci/well [3H]thymidine for 1216 h. 

Phrase: "[3H]Thymidine incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "measured at 48 h of culture,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   753   C0010453:Culture [Idea or Concept]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0220814:culture [Functional Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0441932:H+ [Classification]
   753   C0444706:Measured [Qualitative Concept]
   753   C0564385:/h [Quantitative Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "flat-bottom 96-well"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0205170:Well [Qualitative Concept]
   812   C0205324:Flat [Spatial Concept]
   812   C0457933:Flat [Manufactured Object]
   812   C1511276:Bottom [Spatial Concept]
   812   C1552825:bottom [Idea or Concept]
   812   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "(starting concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "105 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "with 1 Ci/well"

Phrase: "[3H]thymidine for 1216 h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1442460:3H [Temporal Concept]
Processing 00000000.tx.42: Analysis of Ig secretion C57Bl/6 lymphoblasts (from day 5 LPS cultures with or without doxycycline) were washed in PBS and resuspended at 106 live cells/ml in fresh culture medium with or without doxycycline. 

Phrase: "Analysis of Ig secretion C57Bl/6 lymphoblasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "("

Phrase: "from day 5 LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0023810:LPS [Lipid]
   827   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   827   C2697656:LPS [Gene or Genome]

Phrase: "cultures with"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0010453:Culture [Idea or Concept]
   833   C0220814:culture [Functional Concept]
   833   C0430400:Culture [Laboratory Procedure]
   833   C2242979:Culture [Laboratory Procedure]

Phrase: "or without doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   734 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "were"

Phrase: "washed in PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "resuspended at 106 live cells/ml"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C2699156:Cells/mL [Quantitative Concept]
   753   C0007634:Cells [Cell]
   753   C0439526:/mL [Quantitative Concept]
   753   C1548795:Live [Qualitative Concept]
   753   C1634625:% live [Qualitative Concept]
   753   C2982691:Live [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "in fresh culture medium"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C2242979:Culture [Laboratory Procedure]
   827   C3244283:medium [Intellectual Product]

Phrase: "with"

Phrase: "or without doxycycline."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   734 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.43: These secondary cultures were incubated for another 24 h, after which supernatants were collected and analyzed by ELISA using polyclonal anti-IgM antibodies (Southern Biotechnology Associates) on Dynatech Immulon I plates. 

Phrase: "These secondary cultures"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0010453:Cultures [Idea or Concept]
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated for another 24 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "after"

Phrase: "which supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "analyzed by ELISA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014441:ELISA [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal anti-IgM antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   886   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0051980:anti-IgM [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2754997:IgM antibody [Cell Component]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Southern Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Associates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750490:Associate [Idea or Concept]
  1000   C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "on Dynatech Immulon I plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1139930:plates [Medical Device]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.44: RNA analysis Total RNA was extracted using the Trizol reagent (Gibco/BRL, Carlsbad, CA). 

Phrase: "RNA analysis Total RNA"

Phrase: "was"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Trizol reagent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Gibco/BRL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: "Carlsbad,"

Phrase: "CA)."
Processing 00000000.tx.45: Northern blot analysis was performed by electrophoresis of 10 g of total RNA on 2% formaldehyde, 1% agarose gels, transfer onto ZetaProbe nylon membranes (BioRad, Hercules, CA) and hybridization to random-primed 32P-labeled probes (see legends for probe description). 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "was"

Phrase: "performed by electrophoresis of 10 g of total RNA"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   764   C1550369:Performed By [Qualitative Concept]
   742   C0013855:Electrophoresis [Laboratory Procedure]
   742   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0439175:% total [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0439810:Total [Qualitative Concept]
   742   C0884358:Performed [Functional Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on 2% formaldehyde,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1% agarose gels,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1706746:Agarose Gel [Research Device]
   827   C0017243:Gels [Biomedical or Dental Material]
   793 E C1382104:Gel [Substance]

Phrase: "transfer onto ZetaProbe nylon membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040671:Transfer [Mental Process]
   760   C1705822:Transfer [Activity]

Phrase: "(BioRad,"

Phrase: "Hercules,"

Phrase: "CA)"

Phrase: "and"

Phrase: "hybridization to random-primed 32P-labeled probes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020202:Hybridisation [Genetic Function]
   748   C1300517:Hybridization [Laboratory Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "legends for probe description"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2729544:Legend [Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.46: Multiprobe RNase protection assays (RPA) were performed using the mMyc probe template set with the Riboquant in vitro transcription and RPA kits (PharMingen) on RNAs from two independent experiments, with reproducible results. 

Phrase: "Multiprobe RNase protection assays (RPA)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   890   C0597416:RNase protection assay [Molecular Biology Research Technique]
   812   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1545588:Protection [Finding]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mMyc probe template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0728990:TEMPLATE [Medical Device]
   827   C1514575:Template [Conceptual Entity]
   827   C1705542:Template [Idea or Concept]

Phrase: "set with the Riboquant in vitro transcription"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C0036849:Set [Mental Process]
   748   C0040649:Transcription [Genetic Function]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "RPA kits"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   858   C2949108:Protection KIT [Drug Delivery Device]
   812   C1690540:Kits [Qualitative Concept]
   779 E C0812225:KIT [Medical Device]
   779 E C1150635:KIT [Molecular Function]
   779 E C1705212:Kit [Medical Device]
   779 E C1705213:KIT [Medical Device]
   779 E C3273202:Kit [Manufactured Object]
   723   C0597416:RNase protection assay [Molecular Biology Research Technique]

Phrase: "(PharMingen"

Phrase: ")"

Phrase: "on RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "from two independent experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "with reproducible results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.47: Amounts of 15 g of total RNA/sample were used in each assay. 

Phrase: "Amounts of 15 g of total RNA/sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "used in each assay."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1510438:Assay [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.48: The RPA products were separated by 6 M ureaPAGE and detected by autoradiography for 216 h. 

Phrase: "The RPA products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]
   723   C0597416:RNase protection assay [Molecular Biology Research Technique]

Phrase: "were"

Phrase: "separated by 6 M ureaPAGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086972:Separated [Finding]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]

Phrase: "and"

Phrase: "detected by autoradiography"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0004400:Autoradiography [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "for 216 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.49: For RT-PCR, 5 g of total RNA from the indicated sources were reverse transcribed using random hexamer primers and Superscript reverse transcriptase (Gibco/BRL). 

Phrase: "For RT-PCR,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599161:RT-PCR [Molecular Biology Research Technique]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]

Phrase: "5 g of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "from the indicated sources"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449416:sources [Finding]
   827 E C1705919:Source [Idea or Concept]

Phrase: "were"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "random hexamer primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "Superscript reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1555029:Reverse [Idea or Concept]
   827   C2257077:transcriptase [Genetic Function]

Phrase: "(Gibco/BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.50: After digestion with RNase H, the cDNA was subject to PCR using the following primers: secretory C tail: 5'-CACACTGTACAATGTCTCCCT-3' and 5'-AAAATGCAACATCTCACTCTG-3'; 

Phrase: "After digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "with RNase H,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0085431:RNAase H [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was subject to PCR"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0677874:pCR [Finding]
   770   C0681850:Subject [Group]
   770   C1421478:WAS [Gene or Genome]
   770   C1550501:{Subject} [Idea or Concept]
   770   C1706203:Subject [Idea or Concept]
   770   C2349001:Subject [Human]
   770   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the following primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "secretory C tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "5'-CACACTGTACAATGTCTCCCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-AAAATGCAACATCTCACTCTG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.51: membrane C tail: 5'-TCCTCCTGAGCCTCTTCTAC-3' and 5'-CCAGACATTGCTTCAGATTG-3'. 

Phrase: "membrane C tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "5'-TCCTCCTGAGCCTCTTCTAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CCAGACATTGCTTCAGATTG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.52: Co-amplification reactions were set up with both sets of primers, and PCR aliquots were withdrawn at 23, 25, 27, 29 and 31 cycles (1 min denaturation at 94C, 30 s annealing at 55C and 1 min extension at 72C each) to control for linear amplification of both products. 

Phrase: "Co-amplification reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "set up with both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036849:Set [Mental Process]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]

Phrase: "sets of primers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PCR aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "withdrawn at 23,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0424092:Withdrawn [Finding]
   790   C0450348:23 [Quantitative Concept]
   790   C2349954:Withdrawn [Activity]
   790   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "25,"

Phrase: "27,"

Phrase: "29"

Phrase: "and"

Phrase: "31 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "(1 min denaturation at 94C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0301642:Denaturation [Molecular Function]

Phrase: "30 s annealing at 55C"

Phrase: "and"

Phrase: "1 min extension at 72C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0231448:Extension [Functional Concept]
   760   C1880641:Extension [Conceptual Entity]

Phrase: "each"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for linear amplification of both products."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0205132:Linear [Spatial Concept]
   748   C0243148:control [Qualitative Concept]
   748   C1514468:Products [Entity]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1550141:Control [Substance]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.53: Amplified fragments were run on a 1.5% agarose gel and visualized by ethidium bromide staining. 

Phrase: "Amplified fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "run on a 1.5% agarose gel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C1706746:Agarose Gel [Research Device]
   795   C0017243:Gel [Biomedical or Dental Material]
   795   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by ethidium bromide staining."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   760   C0006222:Bromide [Inorganic Chemical]
   760   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   760   C0234621:Visualized [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.54: Digestioncircularization PCR (DC-PCR) Genomic DNAs were extracted from day 4 LPS B cell blasts using the Qiagen (Valencia, CA) DNeasy kit and digested to completion with the indicated restriction enzymes. 

Phrase: "Digestioncircularization PCR (DC-PCR) Genomic DNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017428:Genomic [Gene or Genome]
   812   C0887950:genomic [Biomedical Occupation or Discipline]
   779   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "extracted from day 4 LPS B cell blasts"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   770   C0004561:B-cell [Cell]
   750   C0038250:blast cell [Cell]
   750   C0368761:Blast Cell [Cell]
           Blasts
   744   C0007634:Cell [Cell]
   744   C0023810:LPS [Lipid]
   744   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C0332173:/day [Temporal Concept]
   744   C0337026:blasts [Natural Phenomenon or Process]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]
   744   C0523113:Blasts [Laboratory Procedure]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2697656:LPS [Gene or Genome]
   744   C3541890:EXTRACTED [Finding]
   711 E C2828366:Extract [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Qiagen"

Phrase: "(Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA) DNeasy kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0812225:KIT [Medical Device]
   827   C1150635:KIT [Molecular Function]
   827   C1705212:Kit [Medical Device]
   827   C1705213:KIT [Medical Device]
   827   C3273202:Kit [Manufactured Object]

Phrase: "and"

Phrase: "digested to completion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205197:Completion [Qualitative Concept]
   790   C0868946:digested [Physiologic Function]
   790   C1554962:completion [Qualitative Concept]

Phrase: "with the indicated restriction enzymes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   867   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0443288:Restriction [Functional Concept]
Processing 00000000.tx.55: The digested samples were then re-ligated in diluted conditions (360 ng/200 l reaction) which favor re-circularization of the products, precipitated and resuspended, and 100 ng aliquots were subject to DC-PCR amplification. 

Phrase: "The digested samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "re-ligated in diluted conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C2986904:RE [Idea or Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "(360 ng/200 l reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]

Phrase: ")"

Phrase: "which"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "re-circularization of the products,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986904:RE [Idea or Concept]

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "and"

Phrase: "resuspended,"

Phrase: "and"

Phrase: "100 ng aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510844:Aliquot [Quantitative Concept]

Phrase: "were subject to DC-PCR amplification."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C0681850:Subject [Group]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]
Processing 00000000.tx.56: Published primers and conditions were used for nested PCR of EcoRI-cut and re-circularized SS rearranged fragments (30) and for PCR of the non-rearranging acetylcholine receptor (AchR) gene, as an internal control (31). 

Phrase: "Published primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "used for nested PCR of EcoRI-cut"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0242574:Nested PCR [Molecular Biology Research Technique]
   757   C1524063:Use of [Functional Concept]
   748   C0000925:Cut [Injury or Poisoning]
   748   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]
   748   C1273517:used [Finding]
   748   C1883724:CUT [Phenomenon or Process]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "re-circularized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "SS rearranged fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "(30"

Phrase: ")"

Phrase: "and for PCR of the non-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C1515981:And [Idea or Concept]
   753   C1518422:Non [Functional Concept]

Phrase: "rearranging"

Phrase: "acetylcholine receptor (AchR) gene,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   734   C0034792:Acetylcholine receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "as"

Phrase: "an internal control"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0597937:internal control [Mental Process]
   861   C0205102:Internal [Spatial Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.57: For SS3 rearrangements, genomic DNAs were digested with XbaI, and the religated product subjected to a nested PCR reaction using first the primer pair 5'-GGTCAAACTTGTTACAGCCGTT-3' and 5'-ACTGAGTGTCCTCTCAACCACC-3' (30 cycles, 1 min at 94C, 90 s at 55C, 2 min at 72C), followed by the primer pair 5'-ATGCACAGAGGGAAGGAAGAAG-3' and 5'-CCAGCATGTTCAACCGAAATAA-3' (30 cycles, 1 min at 94C, 1 min at 58C, 90 s at 72C). 

Phrase: "For SS3 rearrangements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangements [Genetic Function]

Phrase: "genomic DNAs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0017428:Genomic [Gene or Genome]
   861   C0887950:genomic [Biomedical Occupation or Discipline]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "digested with XbaI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "the religated product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "subjected to a nested PCR reaction"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0242574:Nested PCR [Molecular Biology Research Technique]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0443286:Reaction [Functional Concept]
   753   C0677874:pCR [Finding]
   753   C1114821:Reaction [Clinical Attribute]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "the primer pair 5'-GGTCAAACTTGTTACAGCCGTT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C1709450:Pair [Qualitative Concept]

Phrase: "and"

Phrase: "5'-ACTGAGTGTCCTCTCAACCACC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(30 cycles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "1 min at 94C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "90 s at 55C,"

Phrase: "2 min at 72C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "followed by the primer pair 5'-ATGCACAGAGGGAAGGAAGAAG-3'"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1709450:Pair [Qualitative Concept]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "5'-CCAGCATGTTCAACCGAAATAA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(30 cycles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "1 min at 94C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "1 min at 58C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "90 s at 72C"

Phrase: ")."
Processing 00000000.tx.58: Internal control for this reaction was a DC-PCR assay for the Delta-like 3 Notch ligand gene (GenBank accession no. AF068865), using the primers 5'-ATAACGTGTTTGTGGAAGTTAGAGGA-3' and 5'-CGATGATAGAGAAGGGACAAGATAGA-3'. 

Phrase: "Internal control for this reaction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0597937:internal control [Mental Process]
   760   C0205102:Internal [Spatial Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "a DC-PCR assay for the Delta-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0243073:assay [Qualitative Concept]
   748   C0677874:pCR [Finding]
   748   C1510438:Assay [Laboratory Procedure]

Phrase: "like 3 Notch ligand gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "(GenBank accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1510755:Accession [Intellectual Product]
   861   C1706078:Accession [Activity]

Phrase: "no. AF068865"

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primers 5'-ATAACGTGTTTGTGGAAGTTAGAGGA-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-CGATGATAGAGAAGGGACAAGATAGA-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.59: All products were separated on a 1.5% agarose gel and visualized by ethidium bromide.  

Phrase: "All products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated on a 1.5% agarose gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1706746:Agarose Gel [Research Device]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by ethidium bromide."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   770   C0006222:Bromide [Inorganic Chemical]
   770   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   770   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.60: Results Top Abstract Introduction Methods Results Discussion References  Doxycycline significantly inhibits Ig secretion and class switching in vitro Primary mouse splenocytes were cultured in medium containing LPS/dextran, with or without the addition of IL-4, in the presence of increasing concentrations of doxycycline (in the therapeutically effective range of 1.255 g/ml). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Doxycycline significantly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   805 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Ig secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "in vitro Primary mouse splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1519477:Splenocyte [Cell]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "in medium containing LPS/dextran,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0086140:Dextran [Carbohydrate,Pharmacologic Substance]

Phrase: "with"

Phrase: "or without the addition of IL-4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0020898:IL [Geographic Area]
   748   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0022271:IL [Geographic Area]
   748   C1883712:Addition [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of increasing concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "("

Phrase: "in the therapeutically effective range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]

Phrase: "of 1.255 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.61: At day 5, the activated B cell blasts were harvested and analyzed for expression of Ig isotypes by flow cytometry. 

Phrase: "At day 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the activated B cell blasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337026:blasts [Natural Phenomenon or Process]
   812   C0368761:Blasts [Cell]
   812   C0523113:Blasts [Laboratory Procedure]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "analyzed for expression of Ig isotypes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0936012:Analyzed [Research Activity]
   753   C3541296:IG [Idea or Concept]

Phrase: "by flow cytometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]
Processing 00000000.tx.62: Treatment with 5 g/ml doxycycline resulted in a significant decrease in the fraction of lymphoblasts positive for secondary isotypes (Fig. 1). 

Phrase: "Treatment with 5 g/ml doxycycline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in a significant decrease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0237881:significant [Quantitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "of lymphoblasts positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "for secondary isotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.63: On average, a 10-fold decrease was observed for IgG3 expression, 2-fold for IgG1 and 4-fold for IgG2b. 

Phrase: "On average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "a 10-fold decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0392756:Decrease [Qualitative Concept]
   812   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed for IgG3 expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020859:IgG3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1441672:Observed [Functional Concept]
   770   C2828356:IgG3 [Cell Component]

Phrase: "2-fold for IgG1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "4-fold for IgG2b."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.64: Similarly, surface staining for IgE in LPS/IL-4-treated B cells was also significantly diminished (14% of normal MFI). 

Phrase: "Similarly,"

Phrase: "surface staining for IgE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "in LPS/IL-4-treated B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0004561:B-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also significantly"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "(14% of normal MFI"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1881923:MFI [Intellectual Product]
   770   C2347086:% Normal [Quantitative Concept]
   770   C3272964:MFI [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.65: Note, however, that this decrease, unlike that in IgG isotype-positive cells, indicates a lower level of IgE in the supernatant, rather than lower numbers of IgE-switched cells, because of passive IgE binding to the low-affinity FcRI, CD23. 

Phrase: "Note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "however,"

Phrase: "that"

Phrase: "this decrease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "unlike that"

Phrase: "in IgG isotype-positive cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "indicates"

Phrase: "a lower level of IgE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the supernatant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "rather than"

Phrase: "lower numbers of IgE-switched cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "because of passive IgE binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1149309:IgE binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "to the low-affinity FcRI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541895:FCRI [Gene or Genome]

Phrase: "CD23."
Processing 00000000.tx.66: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.67: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.68: Doxycycline inhibits Ig class switching in LPS-activated B cells. 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Ig class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "switching in LPS-activated B cells."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   790   C0004561:B-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0023810:LPS [Lipid]
   753   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   753   C1879547:Activated [Activity]
   753   C2697656:LPS [Gene or Genome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1515877:Activate [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719   C1707719:Switch [Manufactured Object]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.69: Day 5 lymphoblasts from LPS/dextran cultures, with (right) or without (left) addition of IL-4, were stained with antibodies to B220 (vertical axis) and Ig isotypes (horizontal axis, as indicated) and analyzed by flow cytometry. 

Phrase: "Day 5 lymphoblasts from LPS/dextran cultures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0229613:Lymphoblasts [Cell]
   748   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "with"

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "or without"

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "addition of IL-4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "were"

Phrase: "stained with antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to B220"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335285:B220 [Gene or Genome]
  1000   C1706240:B220 [Gene or Genome]

Phrase: "(vertical axis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1704553:Vertical Axis [Spatial Concept]
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Ig isotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(horizontal axis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by flow cytometry."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.70: The following rat-anti-mouse mAb were used: CyChromeanti-B220 (clone RA3-6B2), PEanti-IgM (1B4B1), FITCanti-IgG1 (A85-1), FITCanti-IgG3 (R40-82), PEanti-IgE (23G3) and PEanti-IgG2b (LO-MG2b). 

Phrase: "The following rat-anti-mouse mAb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003250:MAb [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "CyChromeanti-B220"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1335285:B220 [Gene or Genome]
   861   C1706240:B220 [Gene or Genome]

Phrase: "(clone RA3-6B2"

Phrase: ")"

Phrase: ","

Phrase: "PEanti-IgM (1B4B1"

Phrase: ")"

Phrase: ","

Phrase: "FITCanti-IgG1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020855:IgG1 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(A85-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445540:A85 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "FITCanti-IgG3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020859:IgG3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2828356:IgG3 [Cell Component]

Phrase: "(R40-82"

Phrase: ")"

Phrase: ","

Phrase: "PEanti-IgE (23G3"

Phrase: ")"

Phrase: "and"

Phrase: "PEanti-IgG2b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020858:IgG2B [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(LO-MG2b"

Phrase: ")."
Processing 00000000.tx.71: Plots show the profile of 104 live lymphoblasts gated on forward/side scatter. 

Phrase: "Plots"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the profile of 104 live lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]

Phrase: "gated on forward/side scatter."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439742:scatter [Spatial Concept]
   760   C0439780:Forward [Spatial Concept]
   760   C0441987:Side [Spatial Concept]
Processing 00000000.tx.72: The top row of panels shows the class switch profile of normal cultures and the bottom row shows the profile of cultures supplemented with 5 g/ml doxycycline. 

Phrase: "The top row of panels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552846:Row [Idea or Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the class switch profile of normal cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "the bottom row"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552846:Row [Idea or Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the profile of cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1979963:Profile [Laboratory Procedure]
   770   C2003903:Profile [Functional Concept]

Phrase: "supplemented with 5 g/ml doxycycline."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.73: The percentage of cells in the indicated gates versus total live lymphoblasts is shown. 

Phrase: "The percentage of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "in the indicated gates"

Phrase: "versus"

Phrase: "total live lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0229613:Lymphoblasts [Cell]
   827   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.74: Note the marked decrease in the number of IgG3, IgG2b, IgG1 and IgMlow cells in doxycycline-treated cultures. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the marked decrease in the number of IgG3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "IgG2b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020858:IgG2B [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "IgG1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020855:IgG1 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IgMlow cells in doxycycline-treated cultures."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   783   C0007585:cells cultures [Laboratory Procedure]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.75: As discussed in the text, IgE staining corresponds to the amount of passively absorbed, CD23-bound IgE. 

Phrase: "As"

Phrase: "discussed in the text,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1527021:Text [Intellectual Product]
   770   C1554111:Text [Idea or Concept]
   770   C1705606:Text [Intellectual Product]
   770   C3541382:Text [Intellectual Product]

Phrase: "IgE staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "corresponds to the amount of passively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "absorbed"

Phrase: ","

Phrase: "CD23-bound IgE."
Processing 00000000.tx.76: Therefore, a generalized decrease in stain intensity (measured as MFI), as opposed to lower numbers of positive cells, is observed in these samples.  

Phrase: "Therefore,"

Phrase: "a generalized decrease in stain intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "("

Phrase: "measured as MFI"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0444706:Measured [Qualitative Concept]
   790   C1881923:MFI [Intellectual Product]
   790   C3272964:MFI [Quantitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "opposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "numbers of positive cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "observed in these samples."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1441672:Observed [Functional Concept]
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.77: In agreement with a block of class switching in doxycycline-treated cells, lower numbers of surface IgMdull lymphoblasts (which include isotype-switched cells) were observed (40% of normal), while IgMbright cells were correspondingly increased (Fig. 1). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with a block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "of class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching in doxycycline-treated cells,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726   C1707719:Switch [Manufactured Object]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "lower numbers of surface IgMdull lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "("

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "isotype-switched cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(40% of normal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C0439509:/40 [Temporal Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "IgMbright cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "correspondingly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.78: Furthermore, splenocytes activated with anti-CD40 and IL-4 displayed a similar block in expression of IgG1 (4-fold) and IgE (6.3% of normal MFI) in the presence of doxycycline (Fig. 2); 

Phrase: "Furthermore,"

Phrase: "splenocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1519477:Splenocyte [Cell]

Phrase: "activated with anti-CD40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a similar block in expression of IgG1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0028778:Block [Pathologic Function]
   748   C0332206:Block [Functional Concept]
   748   C1533157:Block [Substance]
   748   C1706084:Block [Geographic Area]
   748   C2828370:Block [Quantitative Concept]

Phrase: "(4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: ")"

Phrase: "and"

Phrase: "IgE (6.3% of normal MFI"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C1881923:MFI [Intellectual Product]
   753   C2347086:% Normal [Quantitative Concept]
   753   C3272964:MFI [Quantitative Concept]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.79: thus, the inhibitory mechanism is not LPS specific. 

Phrase: "thus,"

Phrase: "the inhibitory mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "not LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023810:LPS [Lipid]
   861   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   861   C2697656:LPS [Gene or Genome]

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.80: Class switch inhibition by doxycycline was found to be dose dependent, with a small but detectable effect observed in most cases at concentrations as low as 1.25 g/ml doxycycline (Fig. 2). 

Phrase: "Class switch inhibition by doxycycline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "dose dependent,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1512045:Dose-dependent [Quantitative Concept]
   861   C0178602:Dose [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C0869039:Dose [Quantitative Concept]
   861   C1114758:Dose # [Clinical Attribute]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "with a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "detectable effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "observed in most cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0868928:Cases [Functional Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "as low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "as 1.25 g/ml doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   748 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.81: View larger version (43K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.82: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.83: Doxycycline inhibits Ig class switching in CD40-activated B cells. 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Ig class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "switching in CD40-activated B cells."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C0004561:B-Cells [Cell]
   783   C1440306:Cells.CD40 [Cell]
   753   C0007634:Cells [Cell]
   753   C1879547:Activated [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1515877:Activate [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719   C1707719:Switch [Manufactured Object]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.84: Day 5 lymphoblasts from anti-CD40/IL-4 cultures were stained with antibodies to B220 (vertical axis) and Ig isotypes (horizontal axis, as indicated), and analyzed by flow cytometry as described in Fig. 

Phrase: "Day 5 lymphoblasts from anti-CD40/IL-4 cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0229613:Lymphoblasts [Cell]
   742   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "were"

Phrase: "stained with antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to B220"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335285:B220 [Gene or Genome]
  1000   C1706240:B220 [Gene or Genome]

Phrase: "(vertical axis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1704553:Vertical Axis [Spatial Concept]
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Ig isotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(horizontal axis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "analyzed by flow cytometry"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.85: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.86: Top, IgG1 and IgE switch profile of control cultures. 

Phrase: "Top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "IgG1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020855:IgG1 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IgE switch profile of control cultures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1979963:Profile [Laboratory Procedure]
   753   C2003903:Profile [Functional Concept]
Processing 00000000.tx.87: Underneath, class switch profiles of cultures treated with progressively higher concentrations of doxycycline (indicated on the right). 

Phrase: "Underneath,"

Phrase: "class switch profiles of cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "treated with progressively higher concentrations of doxycycline"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   748   C0086045:Concentrations [Mental Process]
   748   C1522326:Treated [Functional Concept]
   714   C0205250:High [Qualitative Concept]
   714 E C1292734:TREAT [Functional Concept]
   714   C1299351:High [Qualitative Concept]
   714 E C1446561:Concentration [Quantitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "("

Phrase: "indicated on the right"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]

Phrase: ")."
Processing 00000000.tx.88: Note the dose-dependent decrease in both the fraction of IgG1+ cells and the stain intensity for IgE. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the dose-dependent decrease in both"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "the fraction of IgG1+ cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   781   C0805525:Cell Fraction [Cell Component]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "the stain intensity for IgE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.89: A similar dose dependence was observed also in LPS cultures (not shown).  

Phrase: "A similar dose dependence"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   865   C1512045:Dose-dependent [Quantitative Concept]
   827   C0011546:Dependence [Mental Process]
   827   C0439857:Dependence [Mental or Behavioral Dysfunction]
   827   C2698668:DEPENDENCE [Regulation or Law]
   755 E C0851827:Dependent [Qualitative Concept]
   755 E C1701901:Dependent [Qualitative Concept]
   755 E C3244310:dependent [Functional Concept]
   727 E C1546937:Dependency [Idea or Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "also in LPS cultures"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0010453:Cultures [Idea or Concept]
   770   C0023810:LPS [Lipid]
   770   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   770   C2697656:LPS [Gene or Genome]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.90: Secondary isotype expression was also affected in doxycycline-treated magnetically sorted CD19+ B lymphocytes (>95% B220+, IgM+ cells) and in splenic B cells from TCR / T cell-deficient mice, strongly suggesting a B cell-intrinsic mechanism for the inhibition (not shown). 

Phrase: "Secondary isotype expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "affected in doxycycline-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   734 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "magnetically sorted CD19+ B lymphocytes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   867   C1267837:CD19+ B Lymphocyte [Cell]
   853   C3641613:CD19/Lymphocytes [Laboratory Procedure]
   840   C0004561:B-Lymphocytes [Cell]
   836 E C1267886:CD19+ Lymphocyte [Cell]
   804   C0024264:Lymphocytes [Cell]

Phrase: "("

Phrase: ">95% B220+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1335285:B220 [Gene or Genome]
   861   C1706240:B220 [Gene or Genome]

Phrase: "IgM+ cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "and in splenic B cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0004561:B-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0037993:Splenic [Body Part, Organ, or Organ Component]
   760   C1515981:And [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "from TCR / T cell-deficient mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "strongly"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a B cell-intrinsic mechanism for the inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: As a second parameter in B cell activation, we analyzed the ability of LPS-activated lymphoblasts to secrete Ig. 

Phrase: "As a second parameter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0549193:Parameter [Spatial Concept]
   861   C1704769:Parameter [Conceptual Entity]
   861   C2350001:Parameter [Quantitative Concept]

Phrase: "in B cell activation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155003:B-Cell Activation [Cell Function]
  1000   C1332420:B-cell activation [Gene or Genome]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0004561:B-cell [Cell]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the ability of LPS-activated lymphoblasts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "Ig."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3541296:IG [Idea or Concept]
Processing 00000000.tx.92: Day 5-activated B cells from control and doxycycline-treated cultures were washed and cultured at 106 cells/ml for a further 24 h in fresh medium. 

Phrase: "Day 5-activated B cells from control"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   778   C0004561:B-Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "doxycycline-treated cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "cultured at 106 cells/ml"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   806   C2699156:Cells/mL [Quantitative Concept]
   797   C0007600:cultured cells [Cell]
   797   C0007635:Cultured Cells [Cell]
   797   C3282338:Cells, Cultured [Cell]
   781 E C0007585:cells culture [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0439526:/mL [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "for a further 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "in fresh medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.93: ELISA on the supernatants showed that doxycycline-treated cells secreted ~10-fold less IgM than control cells (Fig. 3A). 

Phrase: "ELISA on the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014441:ELISA [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that doxycycline-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "~10-fold less IgM than control cells"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.94: Since surface IgM+ cells are actually more abundant in doxycycline cultures because of the block in class switching, the difference on a cell basis is likely even more pronounced. 

Phrase: "Since"

Phrase: "surface IgM+ cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C2754998:surface IgM [Cell Component]

Phrase: "are"

Phrase: "actually more abundant in doxycycline cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346714:Abundant [Qualitative Concept]

Phrase: "because of the block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "in class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: ","

Phrase: "the difference on a cell basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "is"

Phrase: "likely even more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "pronounced."
Processing 00000000.tx.95: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.96: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.97: Doxycycline inhibits IgM secretion by activated B cell blasts. 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IgM secretion by activated B cell blasts."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1327616:secretion by cell [Cell Function]
           Cell secretion
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
Processing 00000000.tx.98: Doxycycline-treated and control day 5 LPS lymphoblasts were plated at 106 cells/ml in fresh medium (supplemented with 5 g/ml doxycycline when appropriate), and IgM secretion was measured 24 h later by ELISA on the culture supernatants. 

Phrase: "Doxycycline-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "control day 5 LPS lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0229613:Lymphoblasts [Cell]
   804   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "were"

Phrase: "plated at 106 cells/ml"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C2699156:Cells/mL [Quantitative Concept]
   781   C1166718:cells plate [Cell Component]
   760   C0007634:Cells [Cell]
   760   C0439526:/mL [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726   C0005971:Plate [Medical Device]
   726   C1139930:plate [Medical Device]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C3537155:Plate [Manufactured Object]

Phrase: "in fresh medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "("

Phrase: "supplemented with 5 g/ml doxycycline"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "when"

Phrase: "appropriate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548787:Appropriate [Qualitative Concept]
   928 E C0814634:appropriateness [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IgM secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "24 h"

Phrase: "later by ELISA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0205087:Late [Temporal Concept]

Phrase: "on the culture supernatants."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]
   827   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.99: In three independent experiments with activated B cell blasts a 5- to 10-fold suppression in IgM production is observed in doxycycline-treated cells. 

Phrase: "In three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "with activated B cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0004561:B-cell [Cell]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "blasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337026:Blast [Natural Phenomenon or Process]
  1000   C0368761:Blasts [Cell]
  1000   C0523113:Blasts [Laboratory Procedure]

Phrase: "a 5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "to 10-fold suppression in IgM production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "observed in doxycycline-treated cells."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.100: The detection limit in these experiments was 20 ng/ml (dotted line).  

Phrase: "The detection limit in these experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2718050:Detection Limit [Quantitative Concept]
   753   C0439801:limit [Functional Concept]
   753   C1549649:Limit [Idea or Concept]
   753   C2349209:Limit [Conceptual Entity]

Phrase: "was"

Phrase: "20 ng/ml (dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0205132:Line [Spatial Concept]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.101: Doxycycline has only marginal effects on expression of activation markers and cell proliferation Because both terminal B cell differentiation and, especially, class switching have been correlated with cell division in vitro, we assessed the ability of doxycycline to suppress cell proliferation of LPS-stimulated B cells. 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "has"

Phrase: "only marginal effects on expression of activation markers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Because"

Phrase: "both terminal B cell differentiation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1511002:B-Cell Differentiation [Cell Function]
   902   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "especially,"

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "correlated with cell division"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0007590:Cell division [Cell Function]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C1704653:Cell [Medical Device]
   770   C1707520:Correlated [Qualitative Concept]
   770   C1948049:Cell [Spatial Concept]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the ability of doxycycline to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "cell proliferation of LPS-stimulated B cells."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   788   C1155008:B Cell Proliferation [Cell Function]
   778   C0596290:Cell Proliferation [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0334094:Proliferation [Pathologic Function]
   748   C1269647:Cell [Cell]
   748   C1514485:Proliferation [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.102: Both [3H]thymidine incorporation assays at day 2 of culture and direct measurement of cell division using vital CFSE staining indicated a small, variable decrease in proliferation of doxycycline-treated cells. 

Phrase: "Both"

Phrase: "[3H]thymidine incorporation assays at day 2 of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0243126:incorporation [Functional Concept]
   708   C0005507:Assay [Laboratory Procedure]
   708   C0243073:assay [Qualitative Concept]
   708   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "direct measurement of cell division"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "vital CFSE staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0523243:Vital staining [Laboratory Procedure]
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a small, variable decrease in proliferation of doxycycline-treated cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392756:Decrease [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.103: Specifically, doxycycline suppressed thymidine incorporation in LPS cultures to 87  23% of controls in seven independent experiments (Fig. 4A). 

Phrase: "Specifically,"

Phrase: "doxycycline suppressed thymidine incorporation in LPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0243126:incorporation [Functional Concept]

Phrase: "cultures to 87  23% of controls"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0450348:23 [Quantitative Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "in seven independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.104: Treated cells also generally displayed higher day 5 CFSE staining levels than controls, suggesting that they underwent a lower number of cell divisions (Fig. 4B). 

Phrase: "Treated cells also generally"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   812   C0007634:Cells [Cell]
   812   C0332293:treated [Therapeutic or Preventive Procedure]
   812   C1522326:Treated [Functional Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1292734:TREAT [Functional Concept]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "higher day 5 CFSE staining levels than controls,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0456951:Level 5 [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "underwent"

Phrase: "a lower number of cell divisions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: However, in several sets of experiments no significant decrease in proliferative capacity was observed. 

Phrase: "However,"

Phrase: "in several sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "of experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "no significant decrease in proliferative capacity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.106: Most importantly, there is no correlation between the degree of cell proliferation and class switch inhibition. 

Phrase: "Most importantly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205393:Most [Quantitative Concept]

Phrase: "there"

Phrase: "is"

Phrase: "no correlation between the degree of cell proliferation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "class switch inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.107: In fact, double CFSE/IgG3 staining reveals a deficiency in secondary isotype expression even in the fraction of doxycycline-treated cells that have undergone the highest number of cell divisions (Fig. 4C). 

Phrase: "In fact,"

Phrase: "double CFSE/IgG3 staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a deficiency in secondary isotype expression even"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C1623416:deficiency [Qualitative Concept]

Phrase: "in the fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "of doxycycline-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "have"

Phrase: "undergone"

Phrase: "the highest number of cell divisions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Thus, while doxycycline can partially inhibit cell proliferation in vitro, this is not the cause of class switch suppression. 

Phrase: "Thus,"

Phrase: "while"

Phrase: "doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "can"

Phrase: "partially"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "this"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the cause of class switch suppression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.109: View larger version (29K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.110: 4. 

Phrase: "4."
Processing 00000000.tx.111: Proliferation in doxycycline-treated cultures. 

Phrase: "Proliferation in doxycycline-treated cultures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0334094:Proliferation [Pathologic Function]
   760   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.112: (A) [3H]Thymidine incorporation in representative LPS and anti-CD40/IL-4 cultures without (open bars) or with (closed bars) 5 g/ml doxycycline. 

Phrase: "(A) [3H]Thymidine incorporation in representative LPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0243126:incorporation [Functional Concept]

Phrase: "and"

Phrase: "anti-CD40/IL-4 cultures without"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0010453:Cultures [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "(open bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "or with"

Phrase: "(closed bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "5 g/ml doxycycline."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   756 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.113: Average and standard deviation of triplicate or quadruplicate wells are shown; 

Phrase: "Average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "standard deviation of triplicate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0871420:Standard deviation [Quantitative Concept]
   770   C0012727:Deviation [Spatial Concept]
   770   C0205419:Deviation [Qualitative Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C1705236:Deviation [Finding]
   770   C2828392:Standard [Intellectual Product]

Phrase: "or"

Phrase: "quadruplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205175:Quadruplicate [Quantitative Concept]

Phrase: "wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.114: each set of bars represents an independent experiment. 

Phrase: "each"

Phrase: "set of bars"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   790   C1707156:BARS [Gene or Genome]
   790   C3274014:BARS [Intellectual Product]
   790   C3541345:BARS [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an independent experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.115: Note the partial decrease in incorporation in some of the cultures. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the partial decrease in incorporation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "in some"

Phrase: "of the cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.116: (B) CFSE-stained cells from day 5 LPS cultures without (thick line) or with doxycycline (thin line) were analyzed by FACS as described in Fig. 

Phrase: "(B) CFSE-stained cells from day 5 LPS"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0004561:B-Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "cultures without"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0010453:Culture [Idea or Concept]
   833   C0220814:culture [Functional Concept]
   833   C0430400:Culture [Laboratory Procedure]
   833   C2242979:Culture [Laboratory Procedure]

Phrase: "(thick line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "or with doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   734 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "(thin line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed by FACS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.117: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.118: Slightly higher levels of CFSE staining in doxycycline-treated cells reflect lower proliferative capacity. 

Phrase: "Slightly higher levels of CFSE staining"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in doxycycline-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "proliferative capacity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.119: However, counterstain for surface IgG3 expression using a biotin-conjugated anti-IgG3 antibody (clone R40-82) and streptavidinPE as a second-step reagent (C) shows that in doxycycline-treated cells, even among the cells that have undergone a higher number of cell divisions (which are partially reduced compared to controls), IgG3 switching is still inhibited by over 10-fold.  

Phrase: "However,"

Phrase: "counterstain for surface IgG3 expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2754966:surface IgG3 [Cell Component]
   760   C0020859:IgG3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0205148:Surface [Spatial Concept]
   760   C2828356:IgG3 [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a biotin-conjugated anti-IgG3 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C2754949:IgG3 antibody [Cell Component]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone R40-82"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "streptavidinPE as a second-step reagent"

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in doxycycline-treated cells,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "even among the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "have"

Phrase: "undergone"

Phrase: "a higher number of cell divisions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "("

Phrase: "which"

Phrase: "are"

Phrase: "partially"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "compared to controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "IgG3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020859:IgG3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2828356:IgG3 [Cell Component]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "is"

Phrase: "still"

Phrase: "inhibited by over 10-fold."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0311403:Inhibited [Qualitative Concept]
   760   C0332462:Fold [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]
Processing 00000000.tx.120: Non-specific effects on cell viability could also be ruled out, as the number of dead cells (by forward/side scatter, Trypan blue exclusion and propidium iodide staining) was not increased in doxycycline-treated cells (not shown). 

Phrase: "Non-specific effects on cell viability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "the number of dead cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007584:Cell Number [Laboratory Procedure]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "("

Phrase: "by forward/side scatter,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439742:scatter [Spatial Concept]
   827   C0441987:Side [Spatial Concept]

Phrase: "Trypan blue exclusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0680251:EXCLUSION [Functional Concept]
   827   C2828389:Exclusion [Activity]
   734   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "propidium iodide staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increased in doxycycline-treated cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   760   C0205217:Increased [Quantitative Concept]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0442805:Increased [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.121: Normal cell function is also indicated by the observation that early activation markers are similarly up-regulated in both doxycycline-treated cells and controls (Fig. 5 and not shown); 

Phrase: "Normal cell function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0007613:Cell Function [Cell Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0007634:Normal cell [Cell]
   734   C1268443:Normal cell [Cell]

Phrase: "is"

Phrase: "also"

Phrase: "indicated by the observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1444656:Indicated [Finding]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that early activation markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: "are"

Phrase: "similarly"

Phrase: "up-regulated in both doxycycline-treated cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   748   C0007634:Cells [Cell]
   748   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   748   C0332293:treated [Therapeutic or Preventive Procedure]
   748   C0547043:Up [Spatial Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1282911:Up [Spatial Concept]
   748   C1522326:Treated [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "and"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.122: however, the fraction of cells expressing the Syndecan-1/CD138 plasma cell marker was decreased by ~3-fold (over five experiments) (Fig. 5). 

Phrase: "however,"

Phrase: "the fraction of cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1264633:Fraction of [Quantitative Concept]
           Fraction
   802   C0805525:Cell Fraction [Cell Component]
   770   C1554103:Fraction [Idea or Concept]

Phrase: "expressing"

Phrase: "the Syndecan-1/CD138 plasma cell marker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0005516:Marker [Clinical Attribute]

Phrase: "was"

Phrase: "decreased by ~3-fold"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "(over five experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: ")"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: View larger version (53K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(53K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.124: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.125: Expression of activation and terminal differentiation markers in doxycycline-treated LPS cultures. 

Phrase: "Expression of activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "terminal differentiation markers in doxycycline-treated LPS cultures."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003324:Differentiation Markers [Immunologic Factor]
   770   C2752630:terminal differentiation [Cell Function]
   744   C0007589:Differentiation [Cell Function]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C2945687:Differentiation [Functional Concept]
   711   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.126: Cells from day 5 control and doxycycline-treated LPS (top and center panels) and LPS/IL-4 (bottom panel) were harvested and stained with antibodies to B220 (same as in Fig. 1), and to the activation antigens Syndecan-1/CD138 (clone 281-2, PE), B7-2/CD86 (clone GL1, PE) and CD23 (clone B3B4, FITC). 

Phrase: "Cells from day 5 control"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "doxycycline-treated LPS (top"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "center panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "LPS/IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0020898:IL [Geographic Area]
   827   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0022271:IL [Geographic Area]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "stained with antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to B220"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335285:B220 [Gene or Genome]
  1000   C1706240:B220 [Gene or Genome]

Phrase: "(same"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]

Phrase: "as in Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "and to the activation antigens Syndecan-1/CD138"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C1419891:SYNDECAN 1 [Gene or Genome]
       E   CD138 ANTIGEN
           SYNDECAN
   770   C1609943:Syndecan-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           CD138 Antigens
   744   C0003320:Antigens [Immunologic Factor]
   744   C0075691:syndecan [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1515981:And [Idea or Concept]
   744   C1879547:Activation [Activity]
   744   C3273112:CD138 [Gene or Genome]

Phrase: "(clone 281-2,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "PE"

Phrase: ")"

Phrase: ","

Phrase: "B7-2/CD86"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1413243:B7-2 [Gene or Genome]
   734   C2698599:B7-2 [Gene or Genome]

Phrase: "(clone GL1,"

Phrase: "PE)"

Phrase: "and"

Phrase: "CD23"

Phrase: "(clone B3B4,"

Phrase: "FITC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.127: Flow cytometry was performed as in Fig. 

Phrase: "Flow cytometry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.128: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.129: Note the reduction in the B220low, Syndecan-1+, more terminally differentiated B cells following doxycycline treatment (top). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the reduction in the B220low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "Syndecan-1+,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419891:SYNDECAN 1 [Gene or Genome]
           SYNDECAN
  1000   C1609943:Syndecan-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0075691:syndecan [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "more terminally differentiated B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0004561:B-Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "doxycycline treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "(top)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.130: B7-2 (center) and CD23 (bottom) are up-regulated normally in doxycycline-treated cells. 

Phrase: "B7-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1413243:B7-2 [Gene or Genome]
  1000   C2698599:B7-2 [Gene or Genome]

Phrase: "(center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "CD23"

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "are"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "normally in doxycycline-treated cells."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   704 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.131: The decrease in the B220low, B7-2low population in doxycycline-treated cultures is also likely due to lower numbers of plasmacytoid cells expressing this phenotype. 

Phrase: "The decrease in the B220low,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "B7-2low population in doxycycline-treated cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032659:Population [Quantitative Concept]
   748   C1257890:Population [Population Group]

Phrase: "is"

Phrase: "also likely due to lower numbers of plasmacytoid cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   764   C0678226:Due to [Functional Concept]
           due
   748   C0333825:Plasmacytoid cell [Cell]
   745   C0007584:Cell Number [Laboratory Procedure]
   742   C0007634:Cells [Cell]
   742   C0237753:*Number [Quantitative Concept]
   742   C0332148:Likely [Qualitative Concept]
   742   C0441994:Lower [Spatial Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0750492:Likely [Idea or Concept]
   742   C1548802:Lower [Body Location or Region]
   742   C2003888:Lower [Activity]
   742   C3146286:Due [Idea or Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "this phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.132: Uniformly higher levels of CD23 staining (87% higher on average over five experiments) were reproducibly observed, consistent with published data on the block of shedding of this receptor from the cell surface by MP inhibitors (43,46).  

Phrase: "Uniformly higher levels of CD23 staining"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(87% higher on average"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "over five experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "reproducibly"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "consistent with published data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "of shedding"

Phrase: "of this receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "from the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "by MP inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(43,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.133: Doxycycline inhibits class switch recombination Class switch recombination is blocked by mutation of the activation-induced deaminase (AID) gene, either in human autosomal hyper-IgM syndrome patients or in gene-targeted mutant mice (32,33). 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "class switch recombination Class switch recombination"

Phrase: "is"

Phrase: "blocked by mutation of the activation-induced deaminase (AID) gene,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   781   C1516890:Induced Gene Mutation [Genetic Function]
   762   C0017255:Gene Activation [Genetic Function]
   762   C0596611:Gene Mutation [Genetic Function]
   762   C1512710:Induced Mutation [Genetic Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0026882:Mutation [Genetic Function]
   742   C0028778:Blocked [Pathologic Function]
   742   C0205263:Induced [Functional Concept]
   742   C0332206:Blocked [Functional Concept]
   742   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
   742   C1879547:Activation [Activity]
   742   C2983591:BLOCKED [Research Activity]
   708 E C1533157:Block [Substance]
   708 E C1706084:Block [Geographic Area]
   708 E C2828370:Block [Quantitative Concept]

Phrase: "either in human autosomal hyper-IgM syndrome patients"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0272236:Hyper-IgM Syndrome [Disease or Syndrome]
   800   C0398689:HYPER-IgM SYNDROME [Disease or Syndrome]
   800   C1539082:hyper-IgM syndrome [Gene or Genome]
   767   C2825348:Human IgM [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0039082:Syndrome [Disease or Syndrome]
   744   C0086418:Human [Human]
   744   C0424295:HYPER [Finding]
   744   C0596142:autosomal [Cell Component]

Phrase: "or in gene-targeted mutant mice"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C0678941:Gene Mutant [Gene or Genome]
   783   C1417166:MICE gene [Gene or Genome]
   767   C1332838:Target Gene [Gene or Genome]
   753   C0017337:Gene [Gene or Genome]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1521840:Targeted [Functional Concept]
   719 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.134: Using Northern blot analysis, we found no significant differences in AID mRNA levels between treated and control RNA samples (Fig. 6A), ruling out an effect of doxycycline on AID gene transcription. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Northern blot analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant differences in AID mRNA levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1705241:*Difference [Quantitative Concept]
   708   C1705242:Difference [Qualitative Concept]

Phrase: "between treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "control RNA samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "ruling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruling [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "an effect of doxycycline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on AID gene transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.135: View larger version (46K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 6. 

Phrase: "6."
Processing 00000000.tx.137: Analysis of gene expression in doxycycline-treated LPS cultures. 

Phrase: "Analysis of gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in doxycycline-treated LPS cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.138: Total RNAs from day 2 and 5 control and doxycycline-treated lymphoblasts were analyzed by Northern blotting for expression of class switch-related (A) and terminal differentiation-related (B) transcripts. 

Phrase: "Total RNAs from day 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5 control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "doxycycline-treated lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0229613:Lymphoblasts [Cell]
   827   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "were"

Phrase: "analyzed by Northern blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005861:Northern Blotting [Molecular Biology Research Technique]
   816 E C1621557:Northern Blot [Research Device]
   770   C0936012:Analyzed [Research Activity]
   770   C1709269:Northern [Spatial Concept]

Phrase: "for expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of class switch-related"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   877   C0680416:class relations [Social Behavior]
   827   C0439849:Related [Qualitative Concept]
   827   C0445223:Related [Finding]
   755 E C0080103:Relation [Family Group]
   755 E C0869014:Relations [Social Behavior]

Phrase: "(A)"

Phrase: "and"

Phrase: "terminal differentiation-related"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0439849:Related [Qualitative Concept]
   827   C0445223:Related [Finding]
   755 E C0080103:Relation [Family Group]
   755 E C0869014:Relations [Social Behavior]
   734   C2752630:terminal differentiation [Cell Function]

Phrase: "(B) transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.139: The blots shown are representative of three independent experiments (two for J chain hybridization). 

Phrase: "The blots"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "(two for J chain hybridization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.140: (A) The Northern blot was sequentially hybridized with probes (indicated on the left) for the AID gene (0.7 kb cDNA fragment with the entire coding sequence), the I2b germline transcript exon (0.5 kb HindIIIXhoI fragment), the C2b gene (0.5 kb SacI fragment) and the 28S ribosomal RNA component (human 1.3 kb BamHI fragment). 

Phrase: "(A)"

Phrase: "The Northern blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005861:Northern Blot [Molecular Biology Research Technique]
  1000   C1621557:Northern Blot [Research Device]
   861   C1709269:Northern [Spatial Concept]

Phrase: "was"

Phrase: "sequentially"

Phrase: "hybridized with probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0182400:Probes [Medical Device]
   756 E C1704681:Probe [Gene or Genome]
   756 E C2347609:Probe [Chemical Viewed Functionally]
   756 E C3536729:Probe [Manufactured Object]

Phrase: "("

Phrase: "indicated on the left"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1444656:Indicated [Finding]
   770   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "for the AID gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "(0.7 kb cDNA fragment with the entire coding sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0332255:fragment [Functional Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the I2b germline transcript exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(0.5 kb HindIIIXhoI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the C2b gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(0.5 kb SacI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the 28S ribosomal RNA component"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0449432:Component [Manufactured Object]
   812   C1705248:Component [Conceptual Entity]
   756   C0035705:RNA, Ribosomal, 28S [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           28S RNA

Phrase: "(human 1.3 kb BamHI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.141: Intensity of the bands was quantified by analysis of Phosphorimager scans. 

Phrase: "Intensity of the bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "quantified by analysis of Phosphorimager scans."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0034606:Scan [Diagnostic Procedure]
   753   C0441633:Scan [Diagnostic Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C2826292:SCAN [Finding]
   719   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.142: Relative intensity values shown at the bottom represent the ratios of the intensity of individual bands versus the 28S loading control band, normalized to the day 2 LPS alone control RNA (set to 1). 

Phrase: "Relative intensity values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   896   C0205345:Relative Value [Qualitative Concept]
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "shown at the bottom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511276:Bottom [Spatial Concept]
   770   C1552825:bottom [Idea or Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the ratios of the intensity of individual bands"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0456603:Ratios [Quantitative Concept]
   744   C1610540:*Ratios [Quantitative Concept]
   711 E C1547037:Ratio [Intellectual Product]

Phrase: "versus"

Phrase: "the 28S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552142:28s [Body Part, Organ, or Organ Component]

Phrase: "loading"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loading [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "control band,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0175723:Band [Medical Device]
   861   C0439645:Band [Spatial Concept]
   861   C1521913:band [Cell Component]

Phrase: "normalized to the day 2 LPS alone control RNA (set"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   739   C0023810:LPS [Lipid]
   739   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0036849:Set [Mental Process]
   739   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   739   C0205171:Alone [Quantitative Concept]
   739   C0243148:control [Qualitative Concept]
   739   C0332173:/day [Temporal Concept]
   739   C0439044:alone [Finding]
   739   C0439228:day [Temporal Concept]
   739   C0439505:/day [Temporal Concept]
   739   C0679994:alone [Group Attribute]
   739   C1442518:Set [Functional Concept]
   739   C1550141:Control [Substance]
   739   C1705195:Set [Conceptual Entity]
   739   C1882115:Normalized [Research Activity]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C2697656:LPS [Gene or Genome]
   739   C3274648:Control [Qualitative Concept]

Phrase: "to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.143: Levels of AID and I2b transcripts are essentially unchanged by doxycycline treatment, while C2b levels are decreased by~2- to 5-fold, depending on the experiment (mem- and sec- denote transcripts bearing the alternatively spliced membrane or secretory mRNA poly-A tail). 

Phrase: "Levels of AID"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "I2b transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "essentially unchanged by doxycycline treatment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442739:Unchanged [Finding]
   760   C2346711:Unchanged [Qualitative Concept]

Phrase: "while"

Phrase: "C2b levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "decreased by~2-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "to 5-fold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "depending on the experiment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]
   737   C0725813:depend [Medical Device]

Phrase: "(mem-"

Phrase: "and"

Phrase: "sec-"

Phrase: "denote"

Phrase: "transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the alternatively spliced membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025255:Membrane [Tissue]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "secretory mRNA poly-A tail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0242494:POLY A TAIL [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.144: Note that the bands for the I2bC2b and VDJC2b transcripts detected by the C2b probe are partially overlapping (see the clear doublet for the secretory form of both bands, sec-C2b/sec-I2b), so the difference between samples may be somewhat under-estimated. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the bands for the I2bC2b"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0175723:Bands [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "and"

Phrase: "VDJC2b transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "detected by the C2b probe"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0182400:Probe [Medical Device]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704681:Probe [Gene or Genome]
   760   C2347609:Probe [Chemical Viewed Functionally]
   760   C3469680:C2B [Gene or Genome]
   760   C3536729:Probe [Manufactured Object]

Phrase: "are"

Phrase: "partially"

Phrase: "overlapping"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:Overlapping [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlapping [Conceptual Entity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the clear doublet for the secretory form of both bands,"

Phrase: "sec-C2b/sec-I2b"

Phrase: ")"

Phrase: ","

Phrase: "so"

Phrase: "the difference between samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "somewhat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2984079:Somewhat [Intellectual Product]

Phrase: "under-estimated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0542339:Under [Spatial Concept]
   861   C0750572:Estimated [Quantitative Concept]
Processing 00000000.tx.145: (B) A Northern blot with the same samples as in (A) was hybridized with probes for the C gene (0.8 kb XbaIBamHI genomic fragment), Blimp-1 (5.6 kb XhoI fragment, complete cDNA), c-myc (0.46 kb PstI fragment), J chain (1.3 kb XbaI fragment) and 28S. 

Phrase: "(B) A Northern blot with the same samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005861:Northern Blot [Molecular Biology Research Technique]
   770   C1621557:Northern Blot [Research Device]
   744   C1709269:Northern [Spatial Concept]

Phrase: "as"

Phrase: "in (A)"

Phrase: "was"

Phrase: "hybridized with probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0182400:Probes [Medical Device]
   756 E C1704681:Probe [Gene or Genome]
   756 E C2347609:Probe [Chemical Viewed Functionally]
   756 E C3536729:Probe [Manufactured Object]

Phrase: "for the C gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "(0.8 kb XbaIBamHI genomic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Blimp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0254341:BLIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(5.6 kb XhoI fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "complete cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "c-myc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "(0.46 kb PstI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "J chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416161:J CHAIN [Gene or Genome]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "(1.3 kb XbaI fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "28S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552142:28s [Body Part, Organ, or Organ Component]
Processing 00000000.tx.146: Relative hybridization signals were quantified as in (A). 

Phrase: "Relative hybridization signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "quantified"

Phrase: "as"

Phrase: "in (A"

Phrase: ")."
Processing 00000000.tx.147: Note the lack of up-regulation of Blimp-1 and J chain mRNA expression in doxycycline cultures, and the relatively unchanged levels of  transcripts (6080% of normal over four experiments). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the lack of up-regulation of Blimp-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "and"

Phrase: "J chain mRNA expression in doxycycline cultures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1515670:mRNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the relatively unchanged levels of  transcripts"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(6080% of normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: "over four experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.148: c-myc levels, which are decreased by ~2-fold between day 2 and day 5 of normal culture, were slightly increased by doxycycline treatment. 

Phrase: "c-myc levels,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0086661:c myc [Gene or Genome]

Phrase: "which"

Phrase: "are"

Phrase: "decreased by ~2-fold"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "between day 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "day 5 of normal culture,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0010453:Culture [Idea or Concept]
   760   C0205307:Normal [Qualitative Concept]
   760   C0220814:culture [Functional Concept]
   760   C0332173:/day [Temporal Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439166:% normal [Quantitative Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2347086:% Normal [Quantitative Concept]

Phrase: "were"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "increased by doxycycline treatment."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.149: (C) RNase protection assay of total RNAs from day 2 and 5 control and doxycycline-treated lymphoblasts. 

Phrase: "(C) RNase protection assay of total RNAs"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0597416:RNase protection assay [Molecular Biology Research Technique]
   774   C0073236:RNase C [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1545588:Protection [Finding]

Phrase: "from day 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "and"

Phrase: "5 control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "doxycycline-treated lymphoblasts."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0229613:Lymphoblasts [Cell]
   827   C1167770:Lymphoblasts [Laboratory Procedure]
Processing 00000000.tx.150: The PharMingen Mmyc template set, which generates probes for several mouse myc-related genes, was used. 

Phrase: "The PharMingen Mmyc template set,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036849:Set [Mental Process]
   812   C1442518:Set [Functional Concept]
   812   C1705195:Set [Conceptual Entity]

Phrase: "which"

Phrase: "generates"

Phrase: "probes for several mouse myc-related genes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0182400:Probes [Medical Device]
   741   C0441088:Gene probe [Medical Device]
   714 E C1704681:Probe [Gene or Genome]
   714 E C2347609:Probe [Chemical Viewed Functionally]
   714 E C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.151: Only some indicative bands are shown: note the slight increase in c-myc mRNA levels (as already shown by Northern in A) and the lower levels of mad-4 in doxycycline-treated cells. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "some indicative bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ":"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the slight increase in c-myc mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "already"

Phrase: "shown by Northern"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709269:Northern [Spatial Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "in A)"

Phrase: "and"

Phrase: "the lower levels of mad-4"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456950:Level 4 [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in doxycycline-treated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.152: Levels of other myc-related genes (sin-3, max and mad) are relatively unchanged.  

Phrase: "Levels of other myc-related genes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(sin-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0815304:sin [Idea or Concept]

Phrase: "max"

Phrase: "and"

Phrase: "mad)"

Phrase: "are"

Phrase: "relatively unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442739:Unchanged [Finding]
   861   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.153: Also required for class switching is the induction of germline transcripts from the heavy chain constant region genes targeted for recombination (reviewed in 34). 

Phrase: "Also"

Phrase: "required for class"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456387:Class [Intellectual Product]
   790   C1514873:Required [Functional Concept]
   790   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "is"

Phrase: "the induction of germline transcripts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "from the heavy chain constant region genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0598659:constant region gene [Gene or Genome]
   804   C0017337:Genes [Gene or Genome]

Phrase: "targeted for recombination"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0034865:Recombination [Genetic Function]
   790   C1521840:Targeted [Functional Concept]
   756 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "("

Phrase: "reviewed in 34"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.154: Northern blot analysis showed, however, similar levels of steady-state levels of germline transcripts in doxycycline-treated and control cultures (Fig. 6A), suggesting that doxycycline inhibits a later stage in the class switch process. 

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "however,"

Phrase: "similar levels of steady-state levels of germline transcripts"

Phrase: "in doxycycline-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "control cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "a later"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205087:Late [Temporal Concept]

Phrase: "stage in the class switch process."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205390:Stage [Temporal Concept]
   753   C0456387:Class [Intellectual Product]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]
   753   C1522240:Process [Phenomenon or Process]
   753   C1705943:Class [Classification]
   753   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.155: We therefore used a DC-PCR assay to establish whether actual switch recombination takes place in doxycycline-treated B lymphocytes. 

Phrase: "We therefore"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a DC-PCR assay to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0243073:assay [Qualitative Concept]
   812   C0677874:pCR [Finding]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "whether"

Phrase: "actual switch recombination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1512667:Switch Recombination [Genetic Function]
   827   C0034865:Recombination [Genetic Function]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in doxycycline-treated B lymphocytes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0442504:Place [Spatial Concept]
   753   C1704765:Place [Functional Concept]
   753   C1882509:Place [Activity]
   753   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.156: In this assay, genomic DNA fragments spanning rearranged switch regions are generated by restriction enzyme digestion and recircularized by ligation in diluted conditions. 

Phrase: "In this assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "genomic DNA fragments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0684192:DNA fragments [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "rearranged switch regions"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C1707719:Switch [Manufactured Object]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "are"

Phrase: "generated by restriction enzyme digestion"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0012238:Digestion [Organism Function]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443288:Restriction [Functional Concept]
   760   C2349986:Digestion [Research Activity]
   760   C3146294:Generated [Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "and"

Phrase: "recircularized by ligation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0023690:Ligation [Therapeutic or Preventive Procedure]

Phrase: "in diluted conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.157: The junction of the circularized fragments can be amplified by PCR using primers mapping 5' of the S region and 3' of the target S region (31); 

Phrase: "The junction of the circularized fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205144:Junction [Spatial Concept]
   753   C1706311:Junction [Medical Device]

Phrase: "can"

Phrase: "be"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "mapping"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1283195:Mapping [Activity]
   966 E C0024779:Map [Manufactured Object]
   966 E C1706473:Map [Conceptual Entity]

Phrase: "5'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "of the S region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "3'"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "of the target S region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.158: because these primers would map on different circularized fragments on unrearranged DNA, the amplification is specific to switched cells. 

Phrase: "because"

Phrase: "these primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "would"

Phrase: "map on different circularized fragments"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0024779:Map [Manufactured Object]
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C1705242:Different [Qualitative Concept]
   760   C1706473:Map [Conceptual Entity]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "on unrearranged DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "specific to switched cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
Processing 00000000.tx.159: DC-PCR analysis shows a >20-fold decrease in the amount of SS3 rearranged fragments in doxycycline-treated cells (Fig. 7). 

Phrase: "DC-PCR analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0200931:PCR analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a >20-fold decrease in the amount of SS3 rearranged fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "in doxycycline-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.160: Similar results were obtained for SS DC-PCR assays (not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for SS DC-PCR assays"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C1301820:Obtained [Functional Concept]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]
   719 E C1706701:Obtain [Activity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.161: Together with the germline transcript expression data, these findings strongly suggest that the switch block in doxycycline-treated cells occurs at, or immediately before, the recombination stage. 

Phrase: "Together with the germline transcript expression data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "these findings strongly"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the switch block in doxycycline-treated cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0028778:Block [Pathologic Function]
   748   C0332206:Block [Functional Concept]
   748   C1533157:Block [Substance]
   748   C1706084:Block [Geographic Area]
   748   C2828370:Block [Quantitative Concept]

Phrase: "occurs at,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1709305:Occur [Activity]
   833   C2745955:OCCUR [Temporal Concept]

Phrase: "or"

Phrase: "immediately before,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205548:Immediately [Temporal Concept]

Phrase: "the recombination stage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]
Processing 00000000.tx.162: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 7. 

Phrase: "7."
Processing 00000000.tx.164: Doxycycline inhibits class switching at the recombination stage. 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching at the recombination stage."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C1512667:Switch Recombination [Genetic Function]
   760   C0034865:Recombination [Genetic Function]
   760   C0205390:Stage [Temporal Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   726   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.165: Genomic DNAs from control or doxycycline-treated day 4 LPS activated B cell blasts were digested with XbaI and recircularized. 

Phrase: "Genomic DNAs from control"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0017428:Genomic [Gene or Genome]
   770   C0887950:genomic [Biomedical Occupation or Discipline]
   737   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "doxycycline-treated day 4 LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0023810:LPS [Lipid]
   804   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   804   C2697656:LPS [Gene or Genome]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "B cell blasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0337026:blasts [Natural Phenomenon or Process]
   827   C0368761:Blasts [Cell]
   827   C0523113:Blasts [Laboratory Procedure]
   734   C0004561:B-cell [Cell]

Phrase: "were"

Phrase: "digested with XbaI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0868946:digested [Physiologic Function]

Phrase: "and"

Phrase: "recircularized."
Processing 00000000.tx.166: DC-PCR reactions for the SS3 rearranged fragments (top panel) were performed on serial dilutions of religated product. 

Phrase: "DC-PCR reactions for the SS3 rearranged fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0443286:Reaction [Functional Concept]
   711   C1114821:Reaction [Clinical Attribute]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "performed on serial dilutions of religated product."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0031082:serial [Intellectual Product,Manufactured Object]
   748   C0079240:dilutions [Laboratory Procedure]
   748   C0884358:Performed [Functional Concept]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]
   714 E C1948037:Dilution [Functional Concept]
   714 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.167: The amount of substrate DNA was normalized with parallel DC-PCR amplification of the non-rearranging Delta-like ligand 3 (Dll3) gene (bottom panel). 

Phrase: "The amount of substrate DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "normalized with parallel DC-PCR amplification of the non-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0677874:pCR [Finding]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1518422:Non [Functional Concept]
   742   C1521871:Amplification [Phenomenon or Process]
   742   C1705759:Amplification [Cell or Molecular Dysfunction]
   742   C1882115:Normalized [Research Activity]
   742   C2348042:Parallel [Qualitative Concept]
   742   C2826345:PARALLEL [Research Activity]

Phrase: "rearranging"

Phrase: "Delta-like ligand 3 (Dll3) gene"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   888   C1414071:DELTA-LIKE 3 [Gene or Genome]
   875   C3542919:Delta 3 [Amino Acid, Peptide, or Protein]
   804   C0439097:Delta [Intellectual Product]
   804   C1705241:Delta [Quantitative Concept]
   804   C3146239:Delta [Eukaryote]
   804   C3538806:DELTA [Spatial Concept]
   804   C3540585:DELTA [Gene or Genome]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.168: The size of the products is indicated on the right. 

Phrase: "The size of the products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "indicated on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.169: The amount of detectable SS3 rearranged products is >20-fold lower in reactions from doxycycline-treated cells.  

Phrase: "The amount of detectable SS3 rearranged products is >20-fold lower"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1265611:Amount [Quantitative Concept]

Phrase: "in reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "from doxycycline-treated cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.170: Doxycycline inhibits expression of genes associated with terminal B cell differentiation Terminal B cell differentiation to Ig-secreting cells is accompanied by the induction of expression of the Blimp-1 gene, which is able to promote the differentiation of surface Ig+ cell lines into Ig secretors (35). 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "expression of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0017262:Gene Expression [Genetic Function]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "associated with terminal B cell differentiation Terminal B cell differentiation"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   782   C1511002:B-Cell Differentiation [Cell Function]
   760   C0004561:B-cell [Cell]
   760   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   760   C0332281:Associated with [Qualitative Concept]
           Associated
   757   C0699040:cell associated [Cell Component]
   757   C2752630:terminal differentiation [Cell Function]
   739   C0007634:Cell [Cell]
   739   C0205088:Terminal [Temporal Concept]
   739   C1269647:Cell [Cell]
   739   C1511938:Differentiation [Clinical Attribute]
   739   C1704653:Cell [Medical Device]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1948049:Cell [Spatial Concept]
   739   C2945687:Differentiation [Functional Concept]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to Ig-secreting cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   827   C0007634:Cells [Cell]
   827   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1327616:Secreting [Cell Function]
   827   C3282337:Cells [Cell]
   827   C3541296:IG [Idea or Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "accompanied by the induction of expression of the Blimp-1 gene,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0254341:BLIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0017262:Gene Expression [Genetic Function]
   754   C0920532:gene induction [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205263:Induction [Functional Concept]
   738   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the differentiation of surface Ig+ cell lines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   748   C1511938:Differentiation [Clinical Attribute]
   748   C2945687:Differentiation [Functional Concept]

Phrase: "into Ig secretors"

Phrase: "(35"

Phrase: ")."
Processing 00000000.tx.171: During late B cell activation, Blimp-1 up-regulation directly represses c-myc transcription, while expression of the myc antagonist mad-4 and of the secretory component of polymeric Ig, J chain are induced (3537). 

Phrase: "During late B cell activation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1155003:B-Cell Activation [Cell Function]
   923   C1332420:B-cell activation [Gene or Genome]
   861   C1326120:cell activation [Cell Function]
   812   C1879547:Activation [Activity]

Phrase: "Blimp-1 up-regulation directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]

Phrase: "represses"

Phrase: "c-myc transcription,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040649:Transcription [Genetic Function]
   734   C0086661:c myc [Gene or Genome]

Phrase: "while"

Phrase: "expression of the myc antagonist mad-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and of the secretory component of polymeric Ig,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0036538:Secretory Component [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   744   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0032521:Polymeric [Biomedical or Dental Material,Chemical Viewed Structurally]
   744   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0449432:Component [Manufactured Object]
   744   C1327616:Secretory [Cell Function]
   744   C1515981:And [Idea or Concept]
   744   C1705248:Component [Conceptual Entity]
   744   C3541296:IG [Idea or Concept]

Phrase: "J chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416161:J CHAIN [Gene or Genome]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "are"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "(3537"

Phrase: ")."
Processing 00000000.tx.172: We therefore analyzed the expression of these genes using Northern blot analysis and RNase protection. 

Phrase: "We therefore"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the expression of these genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Northern blot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0005861:Northern blot analysis [Molecular Biology Research Technique]
           Northern Blot
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C1621557:Northern Blot [Research Device]

Phrase: "and"

Phrase: "RNase protection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]
Processing 00000000.tx.173: In agreement with the decrease in Ig secretion, doxycycline-treated in vitro-activated B cell blasts expressed 3- to 5-fold less Blimp-1 transcripts and >10-fold less J chain transcripts compared to controls (Fig. 6B), and failed to up-regulate mad-4 transcription (Fig. 6C). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "in Ig secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "doxycycline-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "in vitro-activated B cell blasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0337026:blasts [Natural Phenomenon or Process]
   799   C0368761:Blasts [Cell]
   799   C0523113:Blasts [Laboratory Procedure]

Phrase: "expressed"

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "to 5-fold less Blimp-1 transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and >"

Phrase: "10-fold less J chain transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "compared to controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "mad-4 transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040649:Transcription [Genetic Function]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.174: A small but reproducible increase in c-myc mRNA levels (~50%) was also observed (Fig. 6B and C). 

Phrase: "A small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "reproducible increase in c-myc mRNA levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(~50%"

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 6B"

Phrase: "and"

Phrase: "C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.175: C transcript expression is also only marginally affected by doxycycline treatment in LPS cultures (6080% of normal) (Fig. 6B), ruling out a major modulation of IgH locus transcription by doxycycline. 

Phrase: "C transcript expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also only marginally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "affected by doxycycline treatment"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   737 E C0001721:Affect [Mental Process]
   715 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "in LPS cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "(6080% of normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205307:Normal [Qualitative Concept]
   790   C0439166:% normal [Quantitative Concept]
   790   C2347086:% Normal [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: ","

Phrase: "ruling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruling [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "a major modulation of IgH locus transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "by doxycycline."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.176: Our data suggest therefore that doxycycline may inhibit the entire terminal differentiation program, resulting in coordinate alterations of an entire set of genes and markers (Blimp-1, mad-4, J chain and Syndecan-1) characteristic of the later stages of B cell activation. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "therefore"

Phrase: "that doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the entire terminal differentiation program,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1709697:Program [Conceptual Entity]
   812   C2728259:Program [Pharmacologic Substance]
   812   C3484370:Program [Functional Concept]

Phrase: "resulting in coordinate alterations of an entire set of genes"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   760   C0332294:Resulting in [Functional Concept]
   741   C1366517:SET gene [Gene or Genome]
   739   C0017337:Genes [Gene or Genome]
   739   C0036849:Set [Mental Process]
   739   C0427184:coordinate [Finding]
   739   C0439751:Entire [Quantitative Concept]
   739   C0444667:Entire [Quantitative Concept]
   739   C0678226:resulting [Functional Concept]
   739   C0700114:coordinate [Functional Concept]
   739   C1442518:Set [Functional Concept]
   739   C1705195:Set [Conceptual Entity]
   739   C1707511:Coordinate [Spatial Concept]
   724   C0596611:Gene Alteration [Genetic Function]
   706 E C1274040:Result [Functional Concept]
   706   C1515926:Alteration [Idea or Concept]
   706 E C1546471:Result [Idea or Concept]
   706 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "(Blimp-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0254341:BLIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mad-4,"

Phrase: "J chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416161:J CHAIN [Gene or Genome]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "Syndecan-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419891:SYNDECAN 1 [Gene or Genome]
           SYNDECAN
  1000   C1609943:Syndecan-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0075691:syndecan [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "characteristic of the later stages of B cell activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.177: Other MP inhibitors suppress class switching in activated B cells As discussed above, tetracyclines display several pleiotropic effects on mammalian cells, only a handful of which have been thoroughly characterized. 

Phrase: "Other MP inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1152589:metalloproteinase inhibitor [Molecular Function]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching in activated B cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0004561:B-Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1879547:Activated [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1515877:Activate [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726   C1707719:Switch [Manufactured Object]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "As discussed above, tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0039651:Tetracyclines [Organic Chemical]
   827   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   793 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   755 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   755 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "several pleiotropic effects on mammalian cells,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a handful of which"

Phrase: "have"

Phrase: "been"

Phrase: "thoroughly"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.178: A significant property of tetracyclines is their ability to inhibit matrix MP, by reducing mRNA expression and directly blocking MP activity (6,8). 

Phrase: "A significant property of tetracyclines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0871161:Property [Qualitative Concept]
   760   C1882134:Property [Conceptual Entity]
   760   C2347695:Property [Entity]

Phrase: "is"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "matrix MP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "by reducing mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515670:mRNA Expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "directly blocking MP activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1150224:metalloproteinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(6,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.179: MP are ubiquitously expressed and are known to play important roles in lymphocyte development and function; 

Phrase: "MP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "ubiquitously"

Phrase: "expressed"

Phrase: "and"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "important roles in lymphocyte development"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.180: therefore, we tested other known inhibitors for their activity on B cells. 

Phrase: "therefore,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "other known inhibitors for their activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "on B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.181: First, we analyzed the effect of three tetracycline analogs lacking antibiotic activity: CMT3 and CMT8, which retain MP inhibitory activity, and CMT5, which does not (reviewed in 10). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the effect of three tetracycline analogs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "antibiotic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: ":"

Phrase: "CMT3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011195:CMT3 [Disease or Syndrome]

Phrase: "and"

Phrase: "CMT8,"

Phrase: "which"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "MP inhibitory activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C1150224:metalloproteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "CMT5,"

Phrase: "which"

Phrase: "does"

Phrase: "not ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reviewed in 10"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.182: Of the three reagents, CMT3 and CMT8 were able to inhibit class switching in vitro, at concentrations even lower than doxycycline (1.25 and 2.5 g/ml respectively); 

Phrase: "Of the three reagents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "CMT3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011195:CMT3 [Disease or Syndrome]

Phrase: "and"

Phrase: "CMT8"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "even lower than doxycycline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "(1.25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "and"

Phrase: "2.5 g/ml respectively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1300565:g/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.183: CMT5, on the other hand, did not display any effect at concentrations up to 7.5 g/ml (Fig. 8A). 

Phrase: "CMT5,"

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "any effect at concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "up to 7.5 g/ml (Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.184: View larger version (35K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.185: 8. 

Phrase: "8."
Processing 00000000.tx.186: Effects of other MP inhibitors on Ig class switching. 

Phrase: "Effects of other MP inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on Ig class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "switching."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.187: Day 5 lymphoblasts from LPS/dextran cultures were stained with antibodies to B220 (vertical axis) IgM and IgG3 (horizontal axis, as indicated) and analyzed by flow cytometry as described in Fig. 

Phrase: "Day 5 lymphoblasts from LPS/dextran cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0229613:Lymphoblasts [Cell]
   748   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "were"

Phrase: "stained with antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to B220"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1335285:B220 [Gene or Genome]
  1000   C1706240:B220 [Gene or Genome]

Phrase: "(vertical axis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1704553:Vertical Axis [Spatial Concept]
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "IgM"

Phrase: "and"

Phrase: "IgG3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020859:IgG3 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2828356:IgG3 [Cell Component]

Phrase: "(horizontal axis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "as"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by flow cytometry"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.188: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.189: Results are representative of three to five experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three to five experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882932:Representative [Activity]
Processing 00000000.tx.190: (A) Top, control culture; 

Phrase: "(A) Top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704458:Top [Spatial Concept]

Phrase: "control culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.191: bottom, cultures treated with non-antibiotic chemically modified tetracyclines CMT3 (1.25 g/ml), CMT5 (7.5 g/ml) and CMT8 (2.5 g/ml). 

Phrase: "bottom,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "treated with non-antibiotic chemically modified tetracyclines CMT3"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   744   C0003232:Antibiotic [Antibiotic]
   744   C0011195:CMT3 [Disease or Syndrome]
   744   C0039651:Tetracyclines [Organic Chemical]
   744   C0220806:Chemically [Chemical]
   744   C0392747:Modified [Functional Concept]
   744   C1518422:Non [Functional Concept]
   744   C1522326:Treated [Functional Concept]
   744   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   711 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "(1.25 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "CMT5"

Phrase: "(7.5 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "CMT8"

Phrase: "(2.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.192: CMT3 and CMT8, which retain MP inhibitory activity, are able to suppress class switching (lower numbers of IgG3+ and IgMlow cells), while CMT5, which has lost this activity, has no effect. 

Phrase: "CMT3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011195:CMT3 [Disease or Syndrome]

Phrase: "and"

Phrase: "CMT8,"

Phrase: "which"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "MP inhibitory activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C1150224:metalloproteinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "(lower numbers of IgG3+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "IgMlow cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "CMT5,"

Phrase: "which"

Phrase: "has"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "this activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.193: (B) Top, control culture; 

Phrase: "(B) Top,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704458:Top [Spatial Concept]

Phrase: "control culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.194: center, doxycycline-treated culture; 

Phrase: "center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "doxycycline-treated culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.195: bottom, KB8301-treated culture. 

Phrase: "bottom,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: "KB8301-treated culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.196: The hydroxamate KB8301 inhibits class switching to an extent comparable to that of doxycycline.  

Phrase: "The hydroxamate KB8301"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1175466:KB8301 [Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching to an extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439792:Extent [Spatial Concept]
   737   C1707719:Switch [Manufactured Object]

Phrase: "comparable to that of doxycycline."
Processing 00000000.tx.197: We then analyzed some tetracycline-unrelated MP inhibitors: TIMP-1 and -2, and the hydroxamate KB8301. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "some tetracycline-unrelated MP inhibitors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1152589:metalloproteinase inhibitor [Molecular Function]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "TIMP-1"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C1522552:Tissue Inhibitor of Metalloproteinases 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Tissue Inhibitor of Metalloproteinases
           Metalloproteinase Inhibitor 1
   991 E C0145947:Tissue-Inhibitor of Metalloproteinase-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-1 Tissue Inhibitor
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   797   C1418824:INHIBITOR 1 [Gene or Genome]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and -"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "the hydroxamate KB8301."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1175466:KB8301 [Organic Chemical]
Processing 00000000.tx.198: Note that TIMP are rather selective inhibitors, each acting on a restricted subset of MP, while both tetracyclines and hydroxamates have a wider spectrum of activity. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that TIMP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   926   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   926   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C1152589:metalloproteinase inhibitor [Molecular Function]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "are"

Phrase: "rather selective inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "each"

Phrase: "acting on a restricted subset of MP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0443288:Restricted [Functional Concept]
   748   C1515021:Subset [Classification]
   714   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "while"

Phrase: "both tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "hydroxamates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178696:hydroxamate [Organic Chemical]

Phrase: "have"

Phrase: "a wider spectrum of activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883073:Spectrum [Quantitative Concept]
   760   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.199: Normal expression of secondary isotypes was observed in cultures treated with the endogenous inhibitors TIMP-1 and -2 (not shown), but KB8301 at a concentration of 20 M inhibited class switching to an extent comparable to 5 g/ml doxycycline (Fig. 8B). 

Phrase: "Normal expression of secondary isotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed in cultures"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0010453:Cultures [Idea or Concept]
   790   C1441672:Observed [Functional Concept]
   756 E C0220814:culture [Functional Concept]
   756 E C0430400:Culture [Laboratory Procedure]
   756 E C2242979:Culture [Laboratory Procedure]

Phrase: "treated with the endogenous inhibitors TIMP-1"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   833   C1522552:Tissue Inhibitor of Metalloproteinases 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Tissue Inhibitor of Metalloproteinases
           Metalloproteinase Inhibitor 1
   825 E C0145947:Tissue-Inhibitor of Metalloproteinase-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-1 Tissue Inhibitor
   806   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   760   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   741   C1418824:INHIBITOR 1 [Gene or Genome]
   739   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0040300:Tissue [Tissue]
   739   C0205227:Endogenous [Functional Concept]
   739   C0243077:inhibitors [Chemical Viewed Functionally]
   739   C1522326:Treated [Functional Concept]
   739   C1547928:Tissue [Intellectual Product]
   724   C1152589:metalloproteinase inhibitor [Molecular Function]
   706 E C1292734:TREAT [Functional Concept]
   706 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and -"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "KB8301 at a concentration of 20 M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1175466:KB8301 [Organic Chemical]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching to an extent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439792:Extent [Spatial Concept]
   737   C1707719:Switch [Manufactured Object]

Phrase: "comparable to 5 g/ml doxycycline"

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.200: However, at this concentration no decrease in Ig secretion was observed in KB8301-treated cells (not shown). 

Phrase: "However,"

Phrase: "at this concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "no decrease in Ig secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed in KB8301-treated cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1175466:KB8301 [Organic Chemical]
   760   C1441672:Observed [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.201: Because tetracyclines (excluding, notably, CMT5) and hydroxamates can chelate divalent cations, including Zn2+ and Ca2+, the block in class switching could potentially be due to non-specific interference with calcium-mediated signaling. 

Phrase: "Because"

Phrase: "tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "(excluding,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0332196:Exclude [Functional Concept]
   966   C2828389:Exclude [Activity]

Phrase: "notably,"

Phrase: "CMT5"

Phrase: ")"

Phrase: "and"

Phrase: "hydroxamates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178696:hydroxamate [Organic Chemical]

Phrase: "can"

Phrase: "chelate"

Phrase: "divalent cations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   861   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Zn2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "and"

Phrase: "Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "the block in class"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0028778:Block [Pathologic Function]
   770   C0332206:Block [Functional Concept]
   770   C1533157:Block [Substance]
   770   C1706084:Block [Geographic Area]
   770   C2828370:Block [Quantitative Concept]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "could"

Phrase: "potentially"

Phrase: "be due to non-specific interference"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0205370:Non-specific [Qualitative Concept]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0205369:Specific [Qualitative Concept]
   753   C0521102:Interference [Qualitative Concept]
   753   C1518422:Non [Functional Concept]
   753   C1552740:specific [Intellectual Product]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "with calcium-mediated signaling."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600431:calcium-mediated signaling [Cell Function]
           Calcium Signaling
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
Processing 00000000.tx.202: To rule out this possibility, we supplemented LPS cultures with specific calcium chelators (0.5 mM EGTA or 2.5 M BAPTA-AM, both the highest possible non-cytotoxic concentrations in these cultures); 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "we"

Phrase: "supplemented"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0242295:Supplement [Food]
   966   C1947943:Supplement [Intellectual Product]
   966   C2348609:Supplement [Functional Concept]

Phrase: "LPS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023810:LPS [Lipid]
  1000   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
  1000   C2697656:LPS [Gene or Genome]

Phrase: "cultures with specific calcium chelators"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   824   C0054484:calcium specific chelator [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0010453:Culture [Idea or Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1552740:specific [Intellectual Product]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C1664784:Chelator [Eukaryote]

Phrase: "(0.5 mM EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "2.5 M BAPTA-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0043775:BAPTA [Organic Chemical,Pharmacologic Substance]

Phrase: "AM"

Phrase: ","

Phrase: "both"

Phrase: "the highest possible non-cytotoxic concentrations in these cultures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0086045:Concentrations [Mental Process]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.203: no effect on class switching was observed (not shown). 

Phrase: "no effect on class"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.204: Thus, the class switch inhibitory effect of doxycycline is common to other tetracyclines MP inhibitory activity and to at least one chemically unrelated MP inhibitor, the hydroxamate KB8301.  

Phrase: "Thus,"

Phrase: "the class switch inhibitory effect of doxycycline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "common to other tetracyclines MP inhibitory activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205214:Common [Quantitative Concept]
   748   C1522138:Common [Functional Concept]
   748   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "to at least one chemically unrelated MP inhibitor,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C1152589:metalloproteinase inhibitor [Molecular Function]
   744   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205447:One [Quantitative Concept]
   744   C0220806:Chemically [Chemical]
   744   C0445356:Unrelated [Finding]
   744   C1704623:Unrelated [Qualitative Concept]
   744   C1883351:To [Qualitative Concept]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "the hydroxamate KB8301."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1175466:KB8301 [Organic Chemical]
Processing 00000000.tx.205: Discussion Top Abstract Introduction Methods Results Discussion References  Following the discovery of a striking variety of non-antibiotic properties of tetracyclines, the therapeutic indications for these drugs have been successfully extended in the past 15 years to rheumatoid arthritis and periodontal disease, and potential new applications are being explored for conditions as diverse as stroke, aortic aneurysm, endotoxic shock and metastatic cancer (reviewed in 7,9,10). 

Phrase: "Discussion Top Abstract Introduction Methods Results Discussion References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the discovery of a striking variety of non-antibiotic properties of tetracyclines,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1880355:Discovery [Activity]

Phrase: "the therapeutic indications for these drugs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0392360:Indications [Idea or Concept]
   719 E C3146298:Indication [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "successfully"

Phrase: "extended in the past 15 years"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0231448:Extended [Functional Concept]
   753   C0231449:Extended [Spatial Concept]
   753   C0439234:years [Temporal Concept]
   753   C0439792:extended [Spatial Concept]
   753   C1444637:Past [Temporal Concept]
   719 E C0439508:/year [Temporal Concept]

Phrase: "to rheumatoid arthritis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
  1000   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   861   C0003864:Arthritis [Disease or Syndrome]
   768 E C0018099:Gout [Disease or Syndrome]

Phrase: "and"

Phrase: "periodontal disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0031090:Periodontal disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C2960678:Periodontal [Functional Concept]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "potential new applications"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0185125:applications [Health Care Activity]
   793 E C1947919:Application [Intellectual Product]
   793 E C2347934:Application [Intellectual Product]
   793 E C3539080:APPLICATION [Quantitative Concept]

Phrase: "are"

Phrase: "being"

Phrase: "explored for conditions"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "as diverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diverse [Qualitative Concept]

Phrase: "as stroke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038454:Stroke [Disease or Syndrome]

Phrase: "aortic aneurysm,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0003486:Aortic Aneurysm [Disease or Syndrome]
  1000   C0340629:Aortic Aneurysm [Disease or Syndrome]
   861   C0002940:Aneurysm [Disease or Syndrome]
   861   C0003483:Aortic [Body Part, Organ, or Organ Component]
   789 E C0439651:Aneurysmal [Spatial Concept]

Phrase: "endotoxic shock"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036981:Endotoxic shock [Pathologic Function]
   861   C0036974:Shock [Pathologic Function]

Phrase: "and"

Phrase: "metastatic cancer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027627:metastatic cancer [Neoplastic Process]
  1000   C0346957:metastatic cancer [Neoplastic Process]
  1000   C2939419:Metastatic cancer [Neoplastic Process]
  1000   C2939420:metastatic cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "("

Phrase: "reviewed in 7,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.206: This is certainly in large part due to the tetracyclines' ability to inhibit the release of pro-inflammatory mediators, including NO, TNF- and IL-1 as well as the production and activity of enzymes directly involved in tissue destruction, such as the matrix MP collagenase and stromelysin (reviewed in 7,9,10). 

Phrase: "This"

Phrase: "is"

Phrase: "certainly in large part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449719:Part [Spatial Concept]
   770   C0549177:Large [Quantitative Concept]
   770   C1709471:Part [Quantitative Concept]

Phrase: "due to the tetracyclines' ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0085732:Ability [Organism Attribute]
   755 E C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the release of pro-inflammatory mediators,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "NO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1298908:no [Idea or Concept]
  1000   C1549444:No [Idea or Concept]

Phrase: "TNF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "as well as"

Phrase: "the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "activity of enzymes directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0243102:enzyme activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "involved in tissue destruction,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0040300:Tissue [Tissue]
   770   C1261381:Destruction [Therapeutic or Preventive Procedure]
   770   C1314939:Involved [Functional Concept]
   770   C1547928:Tissue [Intellectual Product]
   770   C1948029:Destruction [Activity]

Phrase: "such as the matrix MP collagenase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   734   C0623362:Matrix Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "stromelysin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0164371:Stromelysin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "reviewed in 7,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.207: Evidence of more subtle but significant effects of tetracyclines on immune function is also well established, although less clearly characterized. 

Phrase: "Evidence of more subtle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "but"

Phrase: "significant effects of tetracyclines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on immune function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1817756:Immune Function [Organ or Tissue Function]
   861   C0031843:function [Physiologic Function]
   861   C0439662:Immune [Functional Concept]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "also well established,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205170:Well [Qualitative Concept]
   827   C0443211:Established [Qualitative Concept]
   827   C1272684:Established [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "although"

Phrase: "less clearly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.208: In this report, we show that doxycycline can have specific, direct effects on B lymphocytes, selectively blocking some of the activities characteristic of activated lymphoblasts and terminally differentiated B cells. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "can"

Phrase: "have"

Phrase: "specific, direct effects on B lymphocytes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "selectively"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "some of the activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0205392:Some [Quantitative Concept]
   770   C0441655:Activities [Activity]
   770   C3540770:Some [Intellectual Product]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "characteristic of activated lymphoblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "and"

Phrase: "terminally differentiated B cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.209: This novel finding provides a key for interpretation of some of the activities of tetracyclines on the immune system. 

Phrase: "This novel finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a key for interpretation of some of the activities of tetracyclines"

Phrase: "on the immune system."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0020962:Immune system [Body System]
  1000   C1291764:IMMUNE SYSTEM [Finding]
   861   C0439662:Immune [Functional Concept]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.210: While doxycycline-treated B cells have on average slightly lower proliferative capacity than controls, they are able to up-regulate specific activation markers, and to express AID and heavy chain germline transcripts. 

Phrase: "While"

Phrase: "doxycycline-treated B cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "have on average slightly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0750482:Slightly [Idea or Concept]
   770   C1510992:Average [Quantitative Concept]
   770   C2825518:AVERAGE [Quantitative Concept]
   770   C3154893:Have [Idea or Concept]
   770   C3539897:Have [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "proliferative capacity than controls,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516240:Capacity [Quantitative Concept]

Phrase: "they"

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "specific activation markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "AID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "heavy chain germline transcripts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.211: These observations indicate that early activation events are largely unaffected by doxycycline treatment. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that early activation events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441471:Events [Event]
   827   C3541888:Events [Classification]

Phrase: "are"

Phrase: "largely unaffected by doxycycline treatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.212: Unlike the events occurring during early B cell activation, terminal B cell differentiation is strikingly affected by doxycycline, with significant decreases in Ig secretion, J chain mRNA levels and Syndecan-1 expression (three key plasma cell markers). 

Phrase: "Unlike the events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "occurring during early B cell activation,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1155003:B-Cell Activation [Cell Function]
   833   C1332420:B-cell activation [Gene or Genome]
   790   C0004561:B-cell [Cell]
   790   C1326120:cell activation [Cell Function]
   753   C0007634:Cell [Cell]
   753   C1269647:Cell [Cell]
   753   C1279919:Early [Temporal Concept]
   753   C1704653:Cell [Medical Device]
   753   C1879547:Activation [Activity]
   753   C1948049:Cell [Spatial Concept]
   719   C1709305:Occur [Activity]
   719   C2745955:OCCUR [Temporal Concept]

Phrase: "terminal B cell differentiation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1511002:B-Cell Differentiation [Cell Function]
   902   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "is"

Phrase: "strikingly"

Phrase: "affected by doxycycline,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
   734 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "with significant decreases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0547047:decreases [Quantitative Concept]
   827 E C0392756:Decrease [Qualitative Concept]

Phrase: "in Ig secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "J chain mRNA levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "Syndecan-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1419891:SYNDECAN 1 [Gene or Genome]
   734   C1609943:Syndecan-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(three key plasma cell markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0005516:Marker [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.213: The entire differentiation program appears to be targeted, since doxycycline treatment also decreases expression of the Blimp-1 gene, considered a master transcription factor for terminal B cell differentiation (35), and of mad-4, also induced upon terminal differentiation (37). 

Phrase: "The entire differentiation program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: ","

Phrase: "since"

Phrase: "doxycycline treatment also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "expression of the Blimp-1 gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "a master transcription factor for terminal B cell differentiation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   810   C0021760:Differentiation Factor, B-Cell [Amino Acid, Peptide, or Protein,Immunologic Factor]
   810   C1334122:B-CELL DIFFERENTIATION FACTOR [Gene or Genome]
   764   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0033453:Factor B [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   762   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   762   C0960756:factor A [Organic Chemical]
   762   C1824728:FACTOR B [Gene or Genome]
   742   C0040649:Transcription [Genetic Function]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "and of mad-4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "also"

Phrase: "induced upon terminal differentiation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C2752630:terminal differentiation [Cell Function]
   770   C0007589:Differentiation [Cell Function]
   770   C0205088:Terminal [Temporal Concept]
   770   C0205263:Induced [Functional Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C1705314:Terminal [Manufactured Object]
   770   C1705315:Terminal [Spatial Concept]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.214: Consistently, c-myc expression levels, which are normally down-regulated in terminally differentiated B cells by direct Blimp-1-mediated repression (36), are slightly (51  11% over three experiments) but reproducibly higher in the presence of doxycycline. 

Phrase: "Consistently,"

Phrase: "c-myc expression levels,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C3244092:expression level [Idea or Concept]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "are"

Phrase: "normally"

Phrase: "down-regulated in terminally differentiated B cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0004561:B-Cells [Cell]
   769   C1511002:b cells differentiation [Cell Function]
   748   C0007589:Differentiated [Cell Function]
           cells differentiation
   748   C0007634:Cells [Cell]
   748   C0205615:Differentiated [Qualitative Concept]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "by direct Blimp-1-mediated repression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0035143:Repression [Mental Process]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "are"

Phrase: "slightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750482:Slightly [Idea or Concept]

Phrase: "(51  11% over three experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205449:Three [Quantitative Concept]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: ")"

Phrase: "but"

Phrase: "reproducibly higher in the presence of doxycycline."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.215: In contrast to terminal B cell differentiation, inhibition of class switching appears to be affected at the recombination stage and is not accompanied by inhibition of expression of either germline transcripts or the AID gene. 

Phrase: "In contrast to terminal B cell differentiation,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1511002:B-Cell Differentiation [Cell Function]
   902   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "inhibition of class"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "affected at the recombination stage"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0034865:Recombination [Genetic Function]
   760   C0205390:Stage [Temporal Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accompanied by inhibition of expression of either germline transcripts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0017473:Germ Line [Cell]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C3463820:Inhibition [Activity]

Phrase: "or"

Phrase: "the AID gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.216: Whether this is a direct effect on the recombination mechanism or indirectly mediated through some unknown intermediate factor remains to be investigated. 

Phrase: "Whether"

Phrase: "this"

Phrase: "is"

Phrase: "a direct effect on the recombination mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "indirectly"

Phrase: "mediated through some unknown intermediate factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205103:Intermediate [Spatial Concept]
   753   C0439673:Unknown [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.217: Both in vitro class switching and terminal B cell differentiation are known to be correlated with the number of cell divisions (28,29,38), suggesting perhaps that, although largely independent phenomena, they may share some early common induction pathway. 

Phrase: "Both in vitro class"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0456387:Class [Intellectual Product]
   827   C1705943:Class [Classification]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "and"

Phrase: "terminal B cell differentiation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C1511002:B-Cell Differentiation [Cell Function]
   902   C2752630:terminal differentiation [Cell Function]
   861   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   812   C1511938:Differentiation [Clinical Attribute]
   812   C2945687:Differentiation [Functional Concept]
   741 E C0205615:Differentiated [Qualitative Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "correlated with the number of cell divisions"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0007590:Cell Divisions [Cell Function]
   774   C0007584:Cell Number [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1293097:Division [Therapeutic or Preventive Procedure]
   748   C1704653:Cell [Medical Device]
   748   C1707520:Correlated [Qualitative Concept]
   748   C1948049:Cell [Spatial Concept]
   748   C2919030:Division [Organization]
   748   C2919031:Division [Activity]

Phrase: "(28,"

Phrase: "29,"

Phrase: "38"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "perhaps"

Phrase: "that,"

Phrase: "although"

Phrase: "largely independent phenomena,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882365:Phenomena [Phenomenon or Process]

Phrase: "they"

Phrase: "may"

Phrase: "share"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "some early common induction pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.218: In any case, our data show that the small, variable effect of doxycycline on proliferation is most likely not responsible for the observed effects. 

Phrase: "In any case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the small, variable effect of doxycycline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "is"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "not responsible for the observed effects."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]
Processing 00000000.tx.219: The ability of other MP inhibitors to mimic doxycycline's effect on class switching is particularly interesting and may suggest a previously unrecognized role of these enzymes in B cell activation. 

Phrase: "The ability of other MP inhibitors to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "mimic"

Phrase: "doxycycline's effect on class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "is"

Phrase: "particularly"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "and"

Phrase: "may"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a previously unrecognized role of these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in B cell activation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155003:B-Cell Activation [Cell Function]
  1000   C1332420:B-cell activation [Gene or Genome]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0004561:B-cell [Cell]
Processing 00000000.tx.220: MP have already been implicated in many aspects of lymphocyte development and function: among their substrates are several members of the TNF/TNF receptor family, CD43, CD23, L-selectin (12,3947, reviewed in 48). 

Phrase: "MP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "already"

Phrase: "been"

Phrase: "implicated in many aspects of lymphocyte development"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C3158359:lymphocyte development [Cell Function]
   774   C0243107:development aspects [Physiologic Function]
           development
   748   C0024264:Lymphocyte [Cell]
   748   C0678723:Development [Organism Function]
   748   C1527148:Development [Functional Concept]
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "among their substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710236:Substrate [Manufactured Object]

Phrase: "are"

Phrase: "several members of the TNF/TNF receptor family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   751   C0086282:Family Members [Family Group]
   736   C0680022:members [Population Group]
   734 E C1611821:Family Member [Intellectual Product]
   703 E C2698041:Member [Professional or Occupational Group]

Phrase: "CD43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538777:CD43 [Gene or Genome]

Phrase: "CD23,"

Phrase: "L-selectin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0125090:L-Selectin [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
  1000   C1335808:L-SELECTIN [Gene or Genome]
   861   C0282651:Selectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325391:selectin [Molecular Function]

Phrase: "(12,"

Phrase: "3947,"

Phrase: "reviewed in 48"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.221: MP are also involved in the processing of Notch family receptors and their ligands (review in 49), and are generally expressed in a specific and regulated fashion in B and T cells (5052). 

Phrase: "MP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "also"

Phrase: "involved in the processing of Notch family receptors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1155453:Notch receptor processing [Molecular Function]
   767   C0083792:Receptors, Notch [Amino Acid, Peptide, or Protein,Receptor]
   744   C0015576:Family [Family Group]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C1235660:Notch [Body Space or Junction]
   744   C1314939:Involved [Functional Concept]
   744   C1704727:Family [Conceptual Entity]
   744   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "their ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "(review in 49"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0282443:Review [Intellectual Product]
   790   C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "are"

Phrase: "generally"

Phrase: "expressed in a specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "regulated fashion in B"

Phrase: "and"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(5052"

Phrase: ")."
Processing 00000000.tx.222: Indeed, it has already been reported that batimastat, another hydroxamate, is able to inhibit IgE, but not IgG, production in activated human and mouse B cells (43,46). 

Phrase: "Indeed,"

Phrase: "it"

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that batimastat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215791:batimastat [Organic Chemical,Pharmacologic Substance]

Phrase: "another hydroxamate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178696:hydroxamate [Organic Chemical]

Phrase: "is"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "IgE,"

Phrase: "but"

Phrase: "not IgG,"

Phrase: "production in activated human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "mouse B cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   983   C1522109:Mouse B Cell [Cell]
   901   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(43,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.223: In that case, the effect was correlated with the ability of this compound to inhibit the shedding of CD23, thereby amplifying a well-characterized negative feed-back loop on IgE secretion (53). 

Phrase: "In"

Phrase: "that case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "correlated with the ability of this compound to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0085732:Ability [Organism Attribute]
   744   C0205198:Compound [Qualitative Concept]
   744   C1706082:Compound [Chemical]
   744   C1707520:Correlated [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the shedding of CD23,"

Phrase: "thereby"

Phrase: "amplifying"

Phrase: "a well-characterized negative feed-back loop on IgE secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0419518:Loop [Medical Device]
   739   C0445022:Loop [Spatial Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.224: Although we observe a similar effect of doxycycline on CD23 expression in LPS/IL-4-activated B cells, this mechanism cannot fully explain our observations, since in our hands other isotypes besides IgE are affected, and because we showed that doxycycline can directly act at the class switch recombination level. 

Phrase: "Although"

Phrase: "we"

Phrase: "observe"

Phrase: "a similar effect of doxycycline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on CD23 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in LPS/IL-4-activated B cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0004561:B-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "cannot"

Phrase: "fully"

Phrase: "explain"

Phrase: "our observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "since in our hands"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0018563:Hands [Body Part, Organ, or Organ Component]
   770   C1711239:Since [Temporal Concept]
   737 E C1281583:Hand [Body Part, Organ, or Organ Component]
   737 E C1552914:hand [Quantitative Concept]

Phrase: "other isotypes besides IgE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021017:isotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "are"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "and"

Phrase: "because"

Phrase: "we"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "act at the class switch recombination level."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0206071:class switch recombination [Genetic Function]
   778   C1512667:Switch Recombination [Genetic Function]
   748   C0034865:Recombination [Genetic Function]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0456387:Class [Intellectual Product]
   748   C1547707:Level [Geographic Area]
   748   C1705943:Class [Classification]
   748   C1707719:Switch [Manufactured Object]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.225: It is possible that differences in the specificity of batimastat, KB8301 and tetracyclines for individual MP, or in their bioavailability (unlike doxycycline, hydroxamates are highly insoluble), may be responsible for the variability in their effect on different aspects of B cell activation. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that differences in the specificity of batimastat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "KB8301"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1175466:KB8301 [Organic Chemical]

Phrase: "and"

Phrase: "tetracyclines for individual MP,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0039651:Tetracyclines [Organic Chemical]
   770   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   737 E C0039644:Tetracycline [Antibiotic,Organic Chemical]

Phrase: "or in their bioavailability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005508:Bioavailability [Quantitative Concept]
   770   C1706947:BIO-AVAILABILITY [Research Activity]

Phrase: "("

Phrase: "unlike doxycycline,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "hydroxamates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178696:hydroxamate [Organic Chemical]

Phrase: "are"

Phrase: "highly insoluble"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the variability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "in their effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "on different aspects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547011:Aspect [Quantitative Concept]
   827   C1879746:Aspect [Qualitative Concept]

Phrase: "of B cell activation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155003:B-Cell Activation [Cell Function]
  1000   C1332420:B-cell activation [Gene or Genome]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0004561:B-cell [Cell]
Processing 00000000.tx.226: Further investigation of these discrepancies may reveal whether a single or multiple pathways are involved in the inhibition of class switching and Ig secretion by these compounds. 

Phrase: "Further investigation of these discrepancies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Investigation [Health Care Activity]
   760   C1552578:investigation [Idea or Concept]

Phrase: "may"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "whether"

Phrase: "a single"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037179:Single [Population Group]
  1000   C0087136:single [Finding]
  1000   C0205171:Single [Quantitative Concept]

Phrase: "or"

Phrase: "multiple pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "are"

Phrase: "involved in the inhibition of class"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0456387:Class [Intellectual Product]
   753   C1314939:Involved [Functional Concept]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1705943:Class [Classification]
   753   C3463820:Inhibition [Activity]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "and"

Phrase: "Ig secretion by these compounds."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
Processing 00000000.tx.227: Among the most appealing candidates for our observations are members of the TNF/TNF receptor family, including TNF- itself, Blys/BAFF/zTNF4/Tall-1/THANK and its receptors TACI and BCMA, as well as CD30CD30 ligand, which have all been shown to profoundly affect B cell function in vivo and in vitro (47,5460, reviewed in 61,62). 

Phrase: "Among the most appealing candidates"

Phrase: "for our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "are"

Phrase: "members of the TNF/TNF receptor family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   754   C0086282:Family Members [Family Group]
   738   C0680022:members [Population Group]
   737 E C1611821:Family Member [Intellectual Product]
   704 E C2698041:Member [Professional or Occupational Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TNF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "itself,"

Phrase: "Blys/BAFF/zTNF4/Tall-1/"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   840   C0767393:TALL-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
           BAFF
           BLyS
   840   C1420816:TALL-1 [Gene or Genome]
           BAFF
           BLYS
   840   C2986676:TALL-1 [Gene or Genome]
           BAFF
           BLYS
           ZTNF4
   804   C0023493:t-all [Neoplastic Process]
   804   C1961099:T-ALL [Neoplastic Process]

Phrase: "THANK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "and"

Phrase: "its receptors TACI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425349:TACI [Gene or Genome]

Phrase: "and"

Phrase: "BCMA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626649:BCMA [Organic Chemical,Pharmacologic Substance]
  1000   C1420809:BCMA [Gene or Genome]
  1000   C3273658:BCMA [Gene or Genome]

Phrase: "as well as"

Phrase: "CD30CD30 ligand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "which"

Phrase: "have"

Phrase: "all"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to profoundly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "B cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004561:B-cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(47,"

Phrase: "5460,"

Phrase: "reviewed in 61,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "62"

Phrase: ")."
Processing 00000000.tx.228: However, while these ligandreceptor pairs are generally thought to act in trans, either by secretion or cellcell contact, our results suggest a B cell-intrinsic mechanism for the activity of MP inhibitors. 

Phrase: "However,"

Phrase: "while"

Phrase: "these ligandreceptor pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709450:Pair [Qualitative Concept]

Phrase: "are"

Phrase: "generally"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "in trans, either by secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0150312:In [Quantitative Concept]
   760   C0332285:In [Spatial Concept]
   760   C2826298:TRANS [Idea or Concept]

Phrase: "or"

Phrase: "cellcell contact,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332158:contact [Functional Concept]
   861   C0337611:Contact [Population Group]
   861   C1705415:Contact [Idea or Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a B cell-intrinsic mechanism for the activity of MP inhibitors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.229: Specific experiments will be required to establish whether homotypic interactions between activated B cells or autocrine stimulation through any of these pathways plays a role in the effect of MP inhibitors on class switching. 

Phrase: "Specific experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "will"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "whether"

Phrase: "homotypic interactions between activated B cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0007582:Interactions, Cell [Cell Function]
   719   C1704675:Interaction [Functional Concept]

Phrase: "or"

Phrase: "autocrine stimulation through any of these pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   748   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the effect of MP inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "on class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.230: The MP-inhibitory activity of tetracyclines and hydroxamates depends at least in part on their ability to interfere with the Zn2+ ion in the MP active site (reviewed in 10,63). 

Phrase: "The MP-inhibitory activity of tetracyclines"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1150224:metalloproteinase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "hydroxamates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178696:hydroxamate [Organic Chemical]

Phrase: "depends at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0725813:depend [Medical Device]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "on their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "interfere with the Zn2+ ion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0022023:Ion [Element, Ion, or Isotope]
   760   C0521102:Interfere [Qualitative Concept]
   760   C1700702:ION [Functional Concept]
   760   C2346521:Zn2+ [Element, Ion, or Isotope,Inorganic Chemical]

Phrase: "in the MP active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0205681:Active Site [Functional Concept]
   827   C0205145:Site [Spatial Concept]
   827   C0205177:Active [Functional Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: "reviewed in 10,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0282443:reviewed [Intellectual Product]
   790   C1709940:Reviewed [Qualitative Concept]
   756 E C1552617:Review [Idea or Concept]

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.231: Indeed, loss of the ability to chelate divalent cations, such as in CMT-5, abrogates the tetracyclines MP-inhibitory activity (10,63). 

Phrase: "Indeed,"

Phrase: "loss of the ability to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "chelate"

Phrase: "divalent cations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007448:Cations, Divalent [Chemical Viewed Structurally]
   861   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "such as"

Phrase: "in CMT-5,"

Phrase: "abrogates"

Phrase: "the tetracyclines MP-inhibitory activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C1150224:metalloproteinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(10,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.232: Because neither EGTA nor BAPTA-AM have any effect on class switching in LPS cultures, non-specific effects on Ca2+-mediated signals can be ruled out. 

Phrase: "Because"

Phrase: "neither EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "nor"

Phrase: "BAPTA-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043775:BAPTA [Organic Chemical,Pharmacologic Substance]

Phrase: "AM"

Phrase: "have"

Phrase: "any effect on class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "switching in LPS cultures,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0010453:Cultures [Idea or Concept]
   770   C0023810:LPS [Lipid]
   770   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   770   C2697656:LPS [Gene or Genome]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737   C1707719:Switch [Manufactured Object]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "non-specific effects on Ca2+-mediated signals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.233: It is possible, however, that tetracyclines and hydroxamates may also interfere with the activity of other metalloproteins, such as zinc-finger transcription factors, DNA repair enzymes or histone deacetylase (64). 

Phrase: "It"

Phrase: "is"

Phrase: "possible, however,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "hydroxamates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178696:hydroxamate [Organic Chemical]

Phrase: "may"

Phrase: "also"

Phrase: "interfere with the activity of other metalloproteins,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0025544:Metalloproteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0521102:Interfere [Qualitative Concept]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "such as zinc-finger transcription factors,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "DNA repair enzymes"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C1258083:DNA Repair Enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C0208356:DNA repair enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325315:DNA repair enzyme [Molecular Function]
   966 E C1442799:DNA Repair Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0012899:DNA Repair [Genetic Function]
   884   C0599123:repair enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]
   827   C0043240:Repair, NOS [Organism Function]
   827   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "histone deacetylase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019643:Histone Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0019652:Histone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1333261:Deacetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(64"

Phrase: ")."
Processing 00000000.tx.234: Interestingly, the cytidine deaminase activity of AID also has been shown to be Zn2+ dependent (65). 

Phrase: "Interestingly,"

Phrase: "the cytidine deaminase activity of AID also"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1149736:cytidine deaminase activity [Molecular Function]
   764   C1149731:deaminase activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "Zn2+ dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.235: Although the exact role of AID and cytidine deamination in class switching is still unknown, the possibility of inhibition of AID function by doxycycline is particularly intriguing. 

Phrase: "Although"

Phrase: "the exact role of AID"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "cytidine deamination in class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1327164:cytidine deamination [Molecular Function]
   770   C0011061:Deamination [Natural Phenomenon or Process]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "is"

Phrase: "still unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]

Phrase: "the possibility of inhibition of AID function"

Phrase: "by doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "is"

Phrase: "particularly intriguing."
Processing 00000000.tx.236: Taken together, our observations suggest that the immunosuppressive effects of tetracyclines on humoral immune function in vivo, as judged by both reduction of basal total Ig and rheumatoid factor levels in rheumatoid arthritis patients as well as decreased responses in immunized mice, are at least in part due to a direct effect on B lymphocytes. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the immunosuppressive effects of tetracyclines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0021080:Immunosuppressive Effect [Organism Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on humoral immune function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1817756:Immune Function [Organ or Tissue Function]
   827   C0031843:function [Physiologic Function]
   827   C0439662:Immune [Functional Concept]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "as"

Phrase: "judged by both reduction of basal total Ig"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0205112:Basal [Spatial Concept]
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0439175:% total [Quantitative Concept]
   744   C0439810:Total [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]
   744   C3541296:IG [Idea or Concept]
   711   C0221191:Judge [Professional or Occupational Group]

Phrase: "and"

Phrase: "rheumatoid factor levels in rheumatoid arthritis patients"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   780   C0427389:Rheumatoid factor level [Laboratory or Test Result]
   778   C0035448:Rheumatoid Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0201660:Rheumatoid factor NOS [Laboratory Procedure]
   774   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   774   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]
   748   C0441889:Levels [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "as well as"

Phrase: "decreased responses in immunized mice,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "are at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1551058:Are [Quantitative Concept]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "due to a direct effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "on B lymphocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004561:B-Lymphocytes [Cell]
   861   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.237: Another important implication of these studies concerns the use of doxycycline-inducible transcription systems for in vitro and in vivo transgenic studies. 

Phrase: "Another important implication of these studies"

Phrase: "concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concern [Idea or Concept]

Phrase: "the use of doxycycline-inducible transcription systems"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1524063:Use of [Functional Concept]
   748   C0042153:use [Functional Concept]
   748   C0457083:Use [Functional Concept]
   748   C1947944:Use [Intellectual Product]

Phrase: "for in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo transgenic studies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   906   C0681829:in vivo study [Research Activity]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]
Processing 00000000.tx.238: In general, it is assumed (and advertised) that doxycycline is devoid of pleiotropic effects. 

Phrase: "In general,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "("

Phrase: "and"

Phrase: "advertised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001690:advertised [Occupational Activity]

Phrase: ")"

Phrase: "that doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "is"

Phrase: "devoid of pleiotropic effects."
Processing 00000000.tx.239: Yet, in vitro systems using the tetracycline-dependent activator rtTA require doxycycline concentrations up to 1 g/ml (26), very close to the effective dose observed in our experiments. 

Phrase: "Yet,"

Phrase: "in vitro systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the tetracycline-dependent activator rtTA"

Phrase: "require"

Phrase: "doxycycline concentrations up to 1 g/ml (26"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "very"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442824:Very [Qualitative Concept]

Phrase: "close to the effective dose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0178602:Dose [Quantitative Concept]
   760   C0587267:Close [Functional Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "observed in our experiments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1441672:Observed [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.240: In addition, in vivo transgenic experiments are performed feeding the mice water supplemented with as much as 200 g/ml doxycycline (27). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "in vivo transgenic experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "are"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "the mice water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "supplemented with"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0242295:Supplement [Food]
   799   C1947943:Supplement [Intellectual Product]
   799   C2348609:Supplement [Functional Concept]

Phrase: "as"

Phrase: "much as 200 g/ml doxycycline"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   753   C0439267:g% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.241: Assuming a similar pharmacokinetics of doxycycline in mice and humans, this dose is actually higher than what normally given to patients, whose serum doxycycline concentration can rise to >8 g/ml during treatment (66). 

Phrase: "Assuming"

Phrase: "a similar pharmacokinetics of doxycycline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031327:Pharmacokinetics [Physiologic Function]
   760   C0031328:pharmacokinetics [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "humans,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "this dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "is"

Phrase: "actually higher than what normally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "given to patients,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1442162:GIVEN [Conceptual Entity]
   790   C1550718:given [Idea or Concept]
   790   C3244317:given [Intellectual Product]
   756 E C1947971:Give [Functional Concept]

Phrase: "whose serum doxycycline concentration"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0683149:serum concentration [Quantitative Concept]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "can"

Phrase: "rise"

Phrase: "to >8 g/ml during treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1300565:g/mL [Quantitative Concept]
   783 E C1637390:mL/g [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(66"

Phrase: ")."
Processing 00000000.tx.242: The possibility of experimental artifacts in such systems is further amplified by the potential synergism between the multiple activities of doxycycline (even at sub-optimal concentrations) and other experimental variables. 

Phrase: "The possibility of experimental artifacts"

Phrase: "in such systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0449913:System [Functional Concept]
   966   C1553451:System [Manufactured Object]
   966   C1704459:System [Medical Device]
   916 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "amplified by the potential synergism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0599739:synergism [Molecular Function]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "between the multiple activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "of doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "(even at sub-optimal concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0542339:Sub- [Spatial Concept]
   760   C1264637:SUB [Quantitative Concept]
   760   C2698651:Optimal [Qualitative Concept]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "other experimental variables."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]
Processing 00000000.tx.243: The extensive published data on the pleiotropic effects of doxycycline, exemplified by the present report, should certainly serve as a cautionary note regarding the application of these assays to complex experimental systems and the interpretation of their results. 

Phrase: "The extensive published data on the pleiotropic effects of doxycycline,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1511726:Data [Idea or Concept]
   739   C3245479:data [Medical Device]

Phrase: "exemplified by the present report,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C3273238:Report [Intellectual Product]

Phrase: "should"

Phrase: "certainly"

Phrase: "serve as a cautionary note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1316572:Note [Clinical Attribute]
   760   C1317574:Note [Intellectual Product]
   760   C1369612:Note [Clinical Attribute]

Phrase: "regarding"

Phrase: "the application of these assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185125:Application [Health Care Activity]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "to complex experimental systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "the interpretation of their results."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0459471:Interpretation [Intellectual Product]
   760   C3173575:Interpretation [Clinical Attribute]
Processing 00000000.tx.244: In summary, we have described new and significant effects of doxycycline and other MP inhibitors on in vitro B cell activation. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "new"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205314:New [Temporal Concept]

Phrase: "and"

Phrase: "significant effects of doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "other MP inhibitors on in vitro B cell activation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0243077:inhibitors [Chemical Viewed Functionally]
   731   C1152589:metalloproteinase inhibitor [Molecular Function]
   708 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.245: These findings provide a likely explanation for some of the observed effects of tetracyclines on humoral responses and autoimmune parameters in vivo. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a likely explanation for some of the observed effects of tetracyclines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0681841:Explanation [Intellectual Product]

Phrase: "on humoral responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "autoimmune parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.246: Detailed biochemical and molecular analyses of the activity of these compounds and of the potential role of MP in B cell activation will contribute new insights into the mechanisms of Ig secretion and class switching, and may lead to the development of new therapeutic strategies for autoimmune and allergic diseases.  

Phrase: "Detailed biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "molecular analyses of the activity of these compounds"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   750   C0556570:Activity analysis [Therapeutic or Preventive Procedure]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "and of the potential role of MP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035820:Role [Social Behavior]
   748   C1515981:And [Idea or Concept]
   748   C1705810:Role [Conceptual Entity]
   748   C3245505:Potential [Qualitative Concept]

Phrase: "in B cell activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155003:B-Cell Activation [Cell Function]
  1000   C1332420:B-cell activation [Gene or Genome]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0004561:B-cell [Cell]

Phrase: "will"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "new insights into the mechanisms of Ig secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:insights [Mental Process]

Phrase: "and"

Phrase: "class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456387:Class [Intellectual Product]
  1000   C1705943:Class [Classification]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: ","

Phrase: "and"

Phrase: "may"

Phrase: "lead to the development of new therapeutic strategies"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0039796:Therapeutic [Therapeutic or Preventive Procedure]
   744   C0205314:New [Temporal Concept]
   744   C0243107:development [Physiologic Function]
   744   C0302350:Therapeutic [Functional Concept]
   744   C0678723:Development [Organism Function]
   744   C0679199:strategies [Mental Process]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522538:Lead [Functional Concept]
   744   C1527148:Development [Functional Concept]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "for autoimmune"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443146:Autoimmune [Pathologic Function]

Phrase: "and"

Phrase: "allergic diseases."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.247: Acknowledgments  We wish to thank Chris Ritchlin and Sally Haas-Smith (Immunology Unit, URMC) for useful discussion of our data, sharing of reagents and technical help, and Collagenex Inc. for providing us with CMT samples. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Chris Ritchlin"

Phrase: "and"

Phrase: "Sally Haas-Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0554249:Smith [Professional or Occupational Group]

Phrase: "(Immunology Unit,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439148:Unit [Quantitative Concept]
   861   C1519795:Unit [Quantitative Concept]
   861   C1704753:Unit [Manufactured Object]
   861   C1880519:Unit [Quantitative Concept]

Phrase: "URMC"

Phrase: ")"

Phrase: "for useful discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "of our data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "sharing of reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   790   C0237876:Sharing [Social Behavior]

Phrase: "and"

Phrase: "technical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449851:Technical [Functional Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: ","

Phrase: "and"

Phrase: "Collagenex Inc."

Phrase: "for providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "us with CMT samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.248: We are also grateful for the encouragement and suggestions of Bob Greenwald (Long Island Jewish Medical Center), Brad Zerler (Collagenex Inc.) and several other participants to the 1999 Gordon Conference on `Non-antibiotic Properties of Tetracyclines', and to Bortolo Nardini for inspiration. 

Phrase: "We"

Phrase: "are"

Phrase: "also grateful for the encouragement"

Phrase: "and"

Phrase: "suggestions of Bob Greenwald"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0038659:Suggestions [Idea or Concept]
   737 E C1705535:suggestion [Idea or Concept]

Phrase: "(Long Island Jewish Medical Center"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   840   C1555260:Long Island [Population Group]
   804   C0022130:Island [Geographic Area]
   804   C0022422:Jewish [Idea or Concept]
   804   C0178443:Jewish [Population Group]
   804   C0205099:Center [Spatial Concept]
   804   C0205166:Long [Qualitative Concept]
   804   C0205476:Medical [Functional Concept]
   804   C1706317:Long [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Brad Zerler"

Phrase: "(Collagenex"

Phrase: "Inc.)"

Phrase: "and"

Phrase: "several"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439064:Several [Quantitative Concept]
  1000   C0443302:Several [Quantitative Concept]

Phrase: "other participants to the 1999 Gordon Conference on `Non-antibiotic Properties"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0679646:participants [Population Group]
   704 E C2698741:Participant [Classification]

Phrase: "of Tetracyclines',"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "and to Bortolo Nardini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "for inspiration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004048:Inspiration [Organism Function]
Processing 00000000.tx.249: This work was funded in part by NIH grants RO1AI45012 to A .B., RO1AI37123 and RO1HD36293 to R. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "funded in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016820:funded [Quantitative Concept]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by NIH grants RO1AI45012"

Phrase: "to A .B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: "RO1AI37123"

Phrase: "and"

Phrase: "RO1HD36293 to R."
Processing 00000000.tx.250: A. 

Phrase: "A."
Processing 00000000.tx.251: I., and R29CA73696 to F. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "R29CA73696 to F."
Processing 00000000.tx.252: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.253: Y.; 

Phrase: "Y."

Phrase: ";"
Processing 00000000.tx.254: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.255: K. was supported by training grant AI07169 and S. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "was"

Phrase: "supported by training grant AI07169"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0555633:Training grant [Intellectual Product]
   781   C0040608:Training Support [Educational Activity]
   760   C0018173:Grant [Quantitative Concept]
   760   C0040607:Training [Educational Activity]
   760   C0220931:Training [Educational Activity]
   760   C1521721:Supported [Conceptual Entity]
   760   C1548284:Grant [Idea or Concept]
   760   C2673163:training [Qualitative Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: L. by training grant AI07285. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "by training grant AI07285."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0555633:Training grant [Intellectual Product]
Processing 00000000.tx.257: This paper is dedicated to Dongming's memory.  

Phrase: "This paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "is"

Phrase: "dedicated"

Phrase: "to Dongming's memory."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025260:Memory [Mental Process]
   827   C0700327:memory [Finding]
   827   C1706377:Memory [Manufactured Object]
   771 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.258: Abbreviations  CFSE 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester CMT chemically modified tetracycline DC-PCR digestion-circularization PCR LPS lipopolysaccharide MP metalloproteinase RPA RNase protection assay TIMP tissue inhibitor of metalloproteinases TNF tumor necrosis factor  Notes  Transmitting editor: C. 

Phrase: "Abbreviations  CFSE 5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0000723:Abbreviations [Intellectual Product]
   827   C0254579:CFSE [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "("

Phrase: "and"

Phrase: "6-"

Phrase: ")"

Phrase: "carboxyfluorescein diacetate succinimidyl ester CMT chemically modified tetracycline DC-PCR digestion-circularization PCR LPS lipopolysaccharide MP metalloproteinase RPA RNase protection assay TIMP tissue inhibitor"
Meta Candidates (Total=35; Excluded=3; Pruned=0; Remaining=32)
   816   C0145988:Metalloproteinases Tissue Inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C1152589:metalloproteinase inhibitor [Molecular Function]
   795   C0254579:carboxyfluorescein diacetate succinimidyl ester [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   785   C0054736:carboxyfluoresceindiacetate [Organic Chemical]
   781   C0012238:Digestion [Organism Function]
   781   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   781   C0014898:Ester [Organic Chemical]
   781   C0023810:LPS [Lipid]
           Lipopolysaccharide
   781   C0025543:Metalloproteinases [Amino Acid, Peptide, or Protein,Enzyme]
   781   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   781   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   781   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   781   C0039644:Tetracycline [Antibiotic,Organic Chemical]
   781   C0039651:tetracycline [Organic Chemical]
   781   C0040300:Tissue [Tissue]
   781   C0108453:carboxyfluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   781   C0175697:LPS [Congenital Abnormality,Disease or Syndrome]
   781   C0220806:Chemically [Chemical]
   781   C0369114:Diacetate [Organic Chemical]
   781   C0392747:Modified [Functional Concept]
   781   C0677874:pCR [Finding]
   781   C1545588:Protection [Finding]
   781   C1547928:Tissue [Intellectual Product]
   781   C1744619:tetracycline [Antibiotic,Organic Chemical]
   781   C1999216:Inhibitor [Qualitative Concept]
   781   C2349986:Digestion [Research Activity]
   781   C2697656:LPS [Gene or Genome]
   757   C0597416:RNase protection assay [Molecular Biology Research Technique]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   726 E C0443277:Peptic [Functional Concept]
   726 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   726 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "of metalloproteinases TNF tumor necrosis factor"

Phrase: "Notes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "Transmitting editor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707883:Editor [Occupation or Discipline]

Phrase: ":"

Phrase: "C."
Processing 00000000.tx.259: J. 

Phrase: "J."
Processing 00000000.tx.260: Paige Received 8 December 2000, accepted 6 April 2001.  

Phrase: "Paige"

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "8 December 2000,"

Phrase: "accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "6 April 2001."
Processing 00000000.tx.261: References Top Abstract Introduction Methods Results Discussion References  Amin, A. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Amin,"

Phrase: "A."
Processing 00000000.tx.262: R., Attur, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Attur,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.263: G., Thakker, G. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thakker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.264: D., Patel, P. 

Phrase: "D."

Phrase: ","

Phrase: "Patel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.265: D., Vyas, P. 

Phrase: "D."

Phrase: ","

Phrase: "Vyas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.266: R., Patel, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Patel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.267: N., Patel, I. 

Phrase: "N., Patel,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.268: R. and Abramson, S. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Abramson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.269: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.270: 1996. 

Phrase: "1996."
Processing 00000000.tx.271: A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. 

Phrase: "A novel mechanism of action of tetracyclines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C0031327:mechanism of action [Physiologic Function]
   814   C1524059:mechanism of action [Functional Concept]
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "effects on nitric oxide synthases."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.272: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.273: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.274: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.275: USA 93:14014.[Abstract/Free FullText] Amin, A. 

Phrase: "USA 93"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "14014."

Phrase: "[Abstract/Free FullText"

Phrase: "] Amin,"

Phrase: "A."
Processing 00000000.tx.276: R., Patel, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Patel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.277: N., Thakker, G. 

Phrase: "N., Thakker,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.278: D., Lowenstein, C. 

Phrase: "D."

Phrase: ","

Phrase: "Lowenstein,"

Phrase: "C."
Processing 00000000.tx.279: J., Attur, M. 

Phrase: "J.,"

Phrase: "Attur,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.280: G. and Abramson, S. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Abramson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.281: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.282: 1997. 

Phrase: "1997."
Processing 00000000.tx.283: Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. 

Phrase: "Post-transcriptional regulation of inducible nitric oxide synthase mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1514248:Post-Transcriptional Regulation [Genetic Function]
   764   C1158770:Transcriptional Regulation [Genetic Function]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1327622:Regulation [Biologic Function]

Phrase: "in murine macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024432:Macrophages [Cell]
   861   C1546706:Macrophages [Intellectual Product]
   861   C1550652:Macrophages [Body Substance]

Phrase: "by doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "chemically modified tetracyclines."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0039651:Tetracyclines [Organic Chemical]
   827   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   793 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   755 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   755 E C0740484:Achromycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.284: FEBS Lett. 

Phrase: "FEBS Lett."
Processing 00000000.tx.285: 410:259.[ISI][Medline] Pruzanski, W., Greenwald, R. 

Phrase: "410"

Phrase: ":"

Phrase: "259."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pruzanski,"

Phrase: "W.,"

Phrase: "Greenwald,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.286: A., Street, I. 

Phrase: "A.,"

Phrase: "Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442658:Street [Manufactured Object]
  1000   C1301826:Street [Finding]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.287: P., Laliberte, F., Stefanski, E. and Vadas, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Laliberte,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Stefanski,"

Phrase: "E."

Phrase: "and"

Phrase: "Vadas,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.288: 1992. 

Phrase: "1992."
Processing 00000000.tx.289: Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. 

Phrase: "Inhibition of enzymatic activity of phospholipases A2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C3269629:inhibition of phospholipase A2 activity [Molecular Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by minocycline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026187:Minocycline [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "doxycycline."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]
Processing 00000000.tx.290: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.291: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.292: 44:1165.[ISI][Medline] Patel, R. 

Phrase: "44"

Phrase: ":"

Phrase: "1165."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Patel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.293: N., Attur, M. 

Phrase: "N., Attur,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.294: G., Dave, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Dave,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.295: N., Patel, I. 

Phrase: "N., Patel,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.296: V., Stuchin, S. 

Phrase: "V., Stuchin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.297: A., Abramson, S. 

Phrase: "A.,"

Phrase: "Abramson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.298: B. and Amin, A. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Amin,"

Phrase: "A."
Processing 00000000.tx.299: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.300: 1999. 

Phrase: "1999."
Processing 00000000.tx.301: A novel mechanism of action of chemically modified tetracyclines: inhibition of COX-2-mediated prostaglandin E2 production. 

Phrase: "A novel mechanism of action of chemically modified tetracyclines"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031327:mechanism of action [Physiologic Function]
   790   C1524059:mechanism of action [Functional Concept]
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "inhibition of COX-2-mediated prostaglandin E2 production."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0279497:prostaglandin inhibition [Therapeutic or Preventive Procedure]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]
Processing 00000000.tx.302: J. 

Phrase: "J."
Processing 00000000.tx.303: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.304: 163:3459.[Abstract/Free FullText] Attur, M. 

Phrase: "163"

Phrase: ":"

Phrase: "3459."

Phrase: "[Abstract/Free FullText"

Phrase: "] Attur,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.305: G., Patel, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Patel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.306: N., Patel, P. 

Phrase: "N., Patel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.307: D., Abramson, S. 

Phrase: "D."

Phrase: ","

Phrase: "Abramson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.308: B. and Amin, A. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Amin,"

Phrase: "A."
Processing 00000000.tx.309: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.310: 1999. 

Phrase: "1999."
Processing 00000000.tx.311: Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. 

Phrase: "Tetracycline"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0039644:Tetracycline [Antibiotic,Organic Chemical]
  1000   C0039651:tetracycline [Organic Chemical]
  1000   C1744619:tetracycline [Antibiotic,Organic Chemical]
   944 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   944 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "COX-2 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1565860:COX-2 [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1705323:COX-2 [Gene or Genome]

Phrase: "and"

Phrase: "prostaglandin E2 production independent of its effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514503:Prostaglandin Production [Physiologic Function]
   748   C0033268:production [Occupational Activity]

Phrase: "on nitric oxide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.312: J. 

Phrase: "J."
Processing 00000000.tx.313: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.314: 162:3160.[Abstract/Free FullText] Greenwald, R. 

Phrase: "162"

Phrase: ":"

Phrase: "3160."

Phrase: "[Abstract/Free FullText"

Phrase: "] Greenwald,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.315: A., Golub, L. 

Phrase: "A.,"

Phrase: "Golub,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.316: M., Lavietes, B., Ramamurthy, N. 

Phrase: "M."

Phrase: ","

Phrase: "Lavietes,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ramamurthy,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.317: S., Gruber, B., Laskin, R. 

Phrase: "S."

Phrase: ","

Phrase: "Gruber,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Laskin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.318: S. and McNamara, T. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "McNamara,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.319: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.320: 1987. 

Phrase: "1987."
Processing 00000000.tx.321: Tetracyclines inhibit human synovial collagenase in vivo and in vitro. 

Phrase: "Tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "human synovial collagenase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.322: J. 

Phrase: "J."
Processing 00000000.tx.323: Rheumatol. 

Phrase: "Rheumatol."
Processing 00000000.tx.324: 14:28.[ISI][Medline] Golub, L. 

Phrase: "14"

Phrase: ":"

Phrase: "28."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Golub,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.325: M., Ramamurthy, N. 

Phrase: "M."

Phrase: ","

Phrase: "Ramamurthy,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.326: S., McNamara, T. 

Phrase: "S."

Phrase: ","

Phrase: "McNamara,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.327: F., Greenwald, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Greenwald,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.328: A. and Rifkin, B. 

Phrase: "A."

Phrase: "and"

Phrase: "Rifkin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.329: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.330: 1991. 

Phrase: "1991."
Processing 00000000.tx.331: Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. 

Phrase: "Tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "connective tissue breakdown"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1883344:Tissue Breakdown [Injury or Poisoning]
   827   C0443161:break down [Qualitative Concept]
   827   C0699900:breakdown [Organism Function]
   827   C1265875:breakdown [Acquired Abnormality]
   734   C0009780:Connective Tissue [Tissue]

Phrase: ":"

Phrase: "new therapeutic implications for an old family of drugs."
Processing 00000000.tx.332: Crit. 

Phrase: "Crit."
Processing 00000000.tx.333: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.334: Oral Biol. 

Phrase: "Oral Biol."
Processing 00000000.tx.335: Med. 

Phrase: "Med."
Processing 00000000.tx.336: 2:297.[Abstract] Hanemaaijer, R., Visser, H., Koolwijk, P., Sorsa, T., Salo, T., Golub, L. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "297."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hanemaaijer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Visser,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Koolwijk,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorsa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Salo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Golub,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.337: M. and van Hinsbergh, V. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "van Hinsbergh,"

Phrase: "V."
Processing 00000000.tx.338: W. 

Phrase: "W."
Processing 00000000.tx.339: 1998. 

Phrase: "1998."
Processing 00000000.tx.340: Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. 

Phrase: "Inhibition of MMP synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "chemically modified tetracyclines (CMTs) in human endothelial cells."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0039651:Tetracyclines [Organic Chemical]
   748   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   714 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
Processing 00000000.tx.341: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.342: Dental Res. 

Phrase: "Dental Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.343: 12:114.[Medline] Vernillo, A. 

Phrase: "12"

Phrase: ":"

Phrase: "114."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vernillo,"

Phrase: "A."
Processing 00000000.tx.344: T. and Rifkin, B. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Rifkin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.345: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.346: 1998. 

Phrase: "1998."
Processing 00000000.tx.347: Effects of tetracyclines on bone metabolism. 

Phrase: "Effects of tetracyclines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on bone metabolism."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0596204:bone metabolism [Organ or Tissue Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   789 E C0443157:Bony [Functional Concept]
Processing 00000000.tx.348: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.349: Dental Res. 

Phrase: "Dental Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.350: 12:56.[Medline] Golub, L. 

Phrase: "12"

Phrase: ":"

Phrase: "56."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Golub,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.351: M., Lee, H. 

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.352: M., Ryan, M. 

Phrase: "M."

Phrase: ","

Phrase: "Ryan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.353: E., Giannobile, W. 

Phrase: "E.,"

Phrase: "Giannobile,"

Phrase: "W."
Processing 00000000.tx.354: V., Payne, J. and Sorsa, T. 

Phrase: "V., Payne,"

Phrase: "J."

Phrase: "and"

Phrase: "Sorsa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.355: 1998. 

Phrase: "1998."
Processing 00000000.tx.356: Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. 

Phrase: "Tetracyclines"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039651:Tetracyclines [Organic Chemical]
  1000   C1744619:Tetracyclines [Antibiotic,Organic Chemical]
   966 E C0039644:Tetracycline [Antibiotic,Organic Chemical]
   928 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   928 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "connective tissue breakdown by multiple non-antimicrobial mechanisms."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1883344:Tissue Breakdown [Injury or Poisoning]
   744   C0443161:break down [Qualitative Concept]
   744   C0699900:breakdown [Organism Function]
   744   C1265875:breakdown [Acquired Abnormality]
Processing 00000000.tx.357: Adv. 

Phrase: "Adv."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001483:ADV [Virus]
Processing 00000000.tx.358: Dental Res. 

Phrase: "Dental Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.359: 12:12.[Medline] Shapira, L., Soskolne, W. 

Phrase: "12"

Phrase: ":"

Phrase: "12."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shapira,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Soskolne,"

Phrase: "W."
Processing 00000000.tx.360: A., Houri, Y., Barak, V., Halabi, A. and Stabholz, A. 

Phrase: "A.,"

Phrase: "Houri,"

Phrase: "Y.,"

Phrase: "Barak,"

Phrase: "V.,"

Phrase: "Halabi,"

Phrase: "A."

Phrase: "and"

Phrase: "Stabholz,"

Phrase: "A."
Processing 00000000.tx.361: 1996. 

Phrase: "1996."
Processing 00000000.tx.362: Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. 

Phrase: "Protection against endotoxic shock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1545588:Protection [Finding]

Phrase: "and"

Phrase: "lipopolysaccharide-induced local inflammation by tetracycline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0021368:Inflammation [Pathologic Function]

Phrase: ":"

Phrase: "correlation with inhibition of cytokine secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1707520:Correlation [Qualitative Concept]
   716   C2255854:inhibition of cytokine secretion [Cell Function]
Processing 00000000.tx.363: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.364: Immun. 

Phrase: "Immun."
Processing 00000000.tx.365: 64:825.[Abstract] Liu, J., Kuszynski, C. 

Phrase: "64"

Phrase: ":"

Phrase: "825."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Liu,"

Phrase: "J.,"

Phrase: "Kuszynski,"

Phrase: "C."
Processing 00000000.tx.366: A. and Baxter, B. 

Phrase: "A."

Phrase: "and"

Phrase: "Baxter,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.367: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.368: 1999. 

Phrase: "1999."
Processing 00000000.tx.369: Doxycycline induces Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes. 

Phrase: "Doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013090:Doxycycline [Antibiotic,Organic Chemical]
   944 E C0699957:Vibramycin [Antibiotic,Organic Chemical]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Fas/Fas ligand-mediated apoptosis in Jurkat T lymphocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C2610891:T-lymphocyte apoptosis [Cell Function]
   745   C1518060:lymphocyte apoptosis [Cell Function]
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.370: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.371: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.372: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.373: Commun. 

Phrase: "Commun."
Processing 00000000.tx.374: 260:562.[ISI][Medline] Tilley, B. 

Phrase: "260"

Phrase: ":"

Phrase: "562."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Tilley,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.375: C., Alarcon, G. 

Phrase: "C., Alarcon,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.376: S., Heyse, S. 

Phrase: "S."

Phrase: ","

Phrase: "Heyse,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.377: P., Trentham, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trentham,"

Phrase: "D."
Processing 00000000.tx.378: E., Neuner, R., Kaplan, D. 

Phrase: "E.,"

Phrase: "Neuner,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kaplan,"

Phrase: "D."
Processing 00000000.tx.379: A., Clegg, D. 

Phrase: "A.,"

Phrase: "Clegg,"

Phrase: "D."
Processing 00000000.tx.380: O., Leisen, J. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Leisen,"

Phrase: "J."
Processing 00000000.tx.381: C., Buckley, L., Cooper, S. 

Phrase: "C., Buckley,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.382: M., et al. 

Phrase: "M."

Phrase: ","

Phrase: "et al."
Processing 00000000.tx.383: 1995. 

Phrase: "1995."
Processing 00000000.tx.384: Minocycline in rheumatoid arthritis. 

Phrase: "Minocycline in rheumatoid arthritis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026187:Minocycline [Antibiotic,Organic Chemical]
Processing 00000000.tx.385: A 48-week, double-blind, placebo-controlled trial. 

Phrase: "A 48-week,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: "double-blind,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0013072:DOUBLE BLIND [Research Activity]
   861   C0150108:Blind [Research Activity]
   861   C0205173:Double [Functional Concept]
   861   C0456909:Blind [Disease or Syndrome]
   861   C0525065:blind [Patient or Disabled Group]
   861   C1705764:Double [Activity]
   861   C1705765:Double [Qualitative Concept]

Phrase: "placebo-controlled trial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008976:Trial [Research Activity]
   734   C1706408:placebo-controlled [Research Activity]
Processing 00000000.tx.386: MIRA Trial Group. 

Phrase: "MIRA Trial Group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.387: Ann. 

Phrase: "Ann."
Processing 00000000.tx.388: Intern. 

Phrase: "Intern."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1144859:INTERN [Professional or Occupational Group]
Processing 00000000.tx.389: Med. 

Phrase: "Med."
Processing 00000000.tx.390: 122:81.[Abstract/Free FullText] Kloppenburg, M., Dijkmans, B. 

Phrase: "122"

Phrase: ":"

Phrase: "81."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kloppenburg,"

Phrase: "M."

Phrase: ","

Phrase: "Dijkmans,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.391: A., Verweij, C. 

Phrase: "A.,"

Phrase: "Verweij,"

Phrase: "C."
Processing 00000000.tx.392: L. and Breedveld, F. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Breedveld,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.393: C. 

Phrase: "C."
Processing 00000000.tx.394: 1996. 

Phrase: "1996."
Processing 00000000.tx.395: Inflammatory and immunological parameters of disease activity in rheumatoid arthritis patients treated with minocycline. 

Phrase: "Inflammatory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333348:Inflammatory [Functional Concept]

Phrase: "and"

Phrase: "immunological parameters of disease activity"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "in rheumatoid arthritis patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0003873:Rheumatoid Arthritis [Disease or Syndrome]
   734   C2697391:RHEUMATOID ARTHRITIS [Gene or Genome]

Phrase: "treated with minocycline."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0026187:Minocycline [Antibiotic,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.396: Immunopharmacology 31:163.[ISI][Medline] Van den Bogert, C. and Kroon, A. 

Phrase: "Immunopharmacology 31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450355:31 [Intellectual Product]
   861   C0681953:immunopharmacology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "163."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Van den Bogert,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "C."

Phrase: "and"

Phrase: "Kroon,"

Phrase: "A."
Processing 00000000.tx.397: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.398: 1982. 

Phrase: "1982."
Processing 00000000.tx.399: Effects of oxytetracycline on in vivo proliferation and differentiation of erythroid and lymphoid cells in the rat. 

Phrase: "Effects of oxytetracycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on in vivo proliferation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "differentiation of erythroid"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0007589:Differentiation [Cell Function]
   790   C1511938:Differentiation [Clinical Attribute]
   790   C2945687:Differentiation [Functional Concept]
   718 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "lymphoid cells in the rat."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0086574:Lymphoid Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1518071:Lymphoid [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.400: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.401: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.402: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.403: 50:327.[ISI][Medline] Bellahsene, A. and Forsgren, A. 

Phrase: "50"

Phrase: ":"

Phrase: "327."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bellahsene,"

Phrase: "A."

Phrase: "and"

Phrase: "Forsgren,"

Phrase: "A."
Processing 00000000.tx.404: 1985. 

Phrase: "1985."
Processing 00000000.tx.405: Effect of doxycycline on immune response in mice. 

Phrase: "Effect of doxycycline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.406: Infect. 

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.407: Immun. 

Phrase: "Immun."
Processing 00000000.tx.408: 48:556.[ISI][Medline] Woo, P. 

Phrase: "48"

Phrase: ":"

Phrase: "556."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Woo,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.409: C., Tsoi, H. 

Phrase: "C., Tsoi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.410: W., Wong, L. 

Phrase: "W., Wong,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.411: P., Leung, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Leung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.412: C. and Yuen, K. 

Phrase: "C."

Phrase: "and"

Phrase: "Yuen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.413: Y. 

Phrase: "Y."
Processing 00000000.tx.414: 1999. 

Phrase: "1999."
Processing 00000000.tx.415: Antibiotics modulate vaccine-induced humoral immune response. 

Phrase: "Antibiotics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "vaccine-induced humoral immune response."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0020967:Humoral Immune Response [Organism Function]
   884   C1155229:Humoral immune response [Cell Function]
   840   C0301872:Immune response [Organ or Tissue Function]
   804   C0439662:Immune [Functional Concept]
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]
Processing 00000000.tx.416: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.417: Diagn. 

Phrase: "Diagn."
Processing 00000000.tx.418: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.419: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.420: 6:832.[Abstract/Free FullText] Thong, Y. 

Phrase: "6"

Phrase: ":"

Phrase: "832."

Phrase: "[Abstract/Free FullText"

Phrase: "] Thong,"

Phrase: "Y."
Processing 00000000.tx.421: H. and Ferrante, A. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ferrante,"

Phrase: "A."
Processing 00000000.tx.422: 1979. 

Phrase: "1979."
Processing 00000000.tx.423: Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. 

Phrase: "Inhibition of mitogen-induced human lymphocyte proliferative responses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   750   C1510574:Response Inhibition [Mental Process]
   750   C3463820:Response Inhibition [Activity]
           Inhibition
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]

Phrase: "by tetracycline analogues."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243071:Analogue [Chemical Viewed Structurally]
Processing 00000000.tx.424: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.425: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.426: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.427: 35:443.[ISI][Medline] Potts, R. 

Phrase: "35"

Phrase: ":"

Phrase: "443."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Potts,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.428: C., Hassan, H. 

Phrase: "C., Hassan,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.429: A., Brown, R. 

Phrase: "A.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.430: A., MacConnachie, A., Gibbs, J. 

Phrase: "A.,"

Phrase: "MacConnachie,"

Phrase: "A.,"

Phrase: "Gibbs,"

Phrase: "J."
Processing 00000000.tx.431: H., Robertson, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Robertson,"

Phrase: "A."
Processing 00000000.tx.432: J. and Beck, J. 

Phrase: "J."

Phrase: "and"

Phrase: "Beck,"

Phrase: "J."
Processing 00000000.tx.433: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.434: 1983. 

Phrase: "1983."
Processing 00000000.tx.435: In vitro effects of doxycycline and tetracycline on mitogen stimulated lymphocyte growth. 

Phrase: "In vitro effects of doxycycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "tetracycline on mitogen"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0039644:Tetracycline [Antibiotic,Organic Chemical]
   790   C0039651:tetracycline [Organic Chemical]
   790   C1744619:tetracycline [Antibiotic,Organic Chemical]
   734 E C0699124:Panmycin [Antibiotic,Organic Chemical]
   734 E C0740484:Achromycin [Antibiotic,Organic Chemical]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "lymphocyte growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
Processing 00000000.tx.436: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.437: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.438: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.439: 53:458.[ISI][Medline] Ibrahim, M. 

Phrase: "53"

Phrase: ":"

Phrase: "458."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ibrahim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: S., Maged, Z. 

Phrase: "S."

Phrase: ","

Phrase: "Maged,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1424211:MAGED [Gene or Genome]

Phrase: "Z."
Processing 00000000.tx.441: A., Haron, A., Khalil, R. 

Phrase: "A.,"

Phrase: "Haron,"

Phrase: "A.,"

Phrase: "Khalil,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: Y. and Attallah, A. 

Phrase: "Y."

Phrase: "and"

Phrase: "Attallah,"

Phrase: "A."
Processing 00000000.tx.443: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.444: 1988. 

Phrase: "1988."
Processing 00000000.tx.445: Antibiotics and immunity: effects of antibiotics on mitogen responsiveness of lymphocytes and interleukin-2 production. 

Phrase: "Antibiotics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "and"

Phrase: "immunity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020964:Immunity [Physiologic Function]
   928 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "effects of antibiotics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on mitogen responsiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0205342:Responsive [Functional Concept]
   761 E C2371924:Responsivity [Mental Process]

Phrase: "of lymphocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]

Phrase: "and"

Phrase: "interleukin-2 production."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1819447:interleukin-2 production [Organism Function]
   913   C3159141:interleukin production [Organism Function]
   827   C0033268:production [Occupational Activity]
   734   C0021756:Interleukin-2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C0879590:INTERLEUKIN 2 [Gene or Genome]
   734   C1522405:Interleukin-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.446: Chemioterapia 7:369.[ISI][Medline] Kloppenburg, M., Verweij, C. 

Phrase: "Chemioterapia 7"

Phrase: ":"

Phrase: "369."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kloppenburg,"

Phrase: "M."

Phrase: ","

Phrase: "Verweij,"

Phrase: "C."
Processing 00000000.tx.447: L., Miltenburg, A. 

Phrase: "L., Miltenburg,"

Phrase: "A."
Processing 00000000.tx.448: M., Verhoeven, A. 

Phrase: "M."

Phrase: ","

Phrase: "Verhoeven,"

Phrase: "A."
Processing 00000000.tx.449: J., Daha, M. 

Phrase: "J.,"

Phrase: "Daha,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.450: R., Dijkmans, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dijkmans,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.451: A. and Breedveld, F. 

Phrase: "A."

Phrase: "and"

Phrase: "Breedveld,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.452: C. 

Phrase: "C."
Processing 00000000.tx.453: 1995. 

Phrase: "1995."
Processing 00000000.tx.454: The influence of tetracyclines on T cell activation. 

Phrase: "The influence of tetracyclines"

Phrase: "on T cell activation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1155065:T-Cell Activation [Cell Function]
   901   C1326120:cell activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C0039194:T-cell [Cell]
Processing 00000000.tx.455: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.456: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.457: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.458: 102:635.[ISI][Medline] Preus, H., Tollefsen, T. and Morland, B. 

Phrase: "102"

Phrase: ":"

Phrase: "635."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Preus,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tollefsen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Morland,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.459: 1987. 

Phrase: "1987."
Processing 00000000.tx.460: Effects of tetracycline on human monocyte phagocytosis and lymphocyte proliferation. 

Phrase: "Effects of tetracycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "on human monocyte phagocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031308:Phagocytosis [Cell Function]

Phrase: "and"

Phrase: "lymphocyte proliferation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0596873:lymphocyte proliferation [Cell Function]
   861   C0024264:Lymphocyte [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]
Processing 00000000.tx.461: Acta Odontol. 

Phrase: "Acta Odontol."
Processing 00000000.tx.462: Scand. 

Phrase: "Scand."
Processing 00000000.tx.463: 45:297.[ISI][Medline] Ingham, E., Turnbull, L. and Kearney, J. 

Phrase: "45"

Phrase: ":"

Phrase: "297."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ingham,"

Phrase: "E.,"

Phrase: "Turnbull,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Kearney,"

Phrase: "J."
Processing 00000000.tx.464: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.465: 1991. 

Phrase: "1991."
Processing 00000000.tx.466: The effects of minocycline and tetracycline on the mitotic response of human peripheral blood-lymphocytes. 

Phrase: "The effects of minocycline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "tetracycline on the mitotic response of human peripheral blood-lymphocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0039644:Tetracycline [Antibiotic,Organic Chemical]
   739   C0039651:tetracycline [Organic Chemical]
   739   C1744619:tetracycline [Antibiotic,Organic Chemical]
Processing 00000000.tx.467: J. 

Phrase: "J."
Processing 00000000.tx.468: Antimicrob. 

Phrase: "Antimicrob."
Processing 00000000.tx.469: Chemother. 

Phrase: "Chemother."
Processing 00000000.tx.470: 27:607.[Abstract] Myers, M. 

Phrase: "27"

Phrase: ":"

Phrase: "607."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Myers,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: J., Farrell, D. 

Phrase: "J.,"

Phrase: "Farrell,"

Phrase: "D."
Processing 00000000.tx.472: E. and Henderson, M. 

Phrase: "E."

Phrase: "and"

Phrase: "Henderson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.473: 1995. 

Phrase: "1995."
Processing 00000000.tx.474: Oxy- tetracycline-mediated alteration of murine immunocompetence. 

Phrase: "Oxy- tetracycline-mediated alteration of murine immunocompetence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.475: Pathobiology 63:270.[ISI][Medline] Gossen, M. and Bujard, H. 

Phrase: "Pathobiology 63"

Phrase: ":"

Phrase: "270."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gossen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Bujard,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.476: 1992. 

Phrase: "1992."
Processing 00000000.tx.477: Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. 

Phrase: "Tight control of gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "in mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by tetracycline-responsive promoters."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.478: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.479: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.480: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.481: USA 89:5547.[Abstract] Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W. and Bujard, H. 

Phrase: "USA 89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "5547."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gossen,"

Phrase: "M."

Phrase: ","

Phrase: "Freundlieb,"

Phrase: "S."

Phrase: ","

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Muller,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hillen,"

Phrase: "W."

Phrase: "and"

Phrase: "Bujard,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.482: 1995. 

Phrase: "1995."
Processing 00000000.tx.483: Transcriptional activation by tetracyclines in mammalian cells. 

Phrase: "Transcriptional activation by tetracyclines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0162493:Transcriptional Activation [Genetic Function]
   770   C1879547:Activation [Activity]

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.484: Science 268:1766.[ISI][Medline] Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lubbert, H. and Bujard, H. 

Phrase: "Science 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1766."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kistner,"

Phrase: "A.,"

Phrase: "Gossen,"

Phrase: "M."

Phrase: ","

Phrase: "Zimmermann,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Jerecic,"

Phrase: "J.,"

Phrase: "Ullmer,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lubbert,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Bujard,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.485: 1996. 

Phrase: "1996."
Processing 00000000.tx.486: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. 

Phrase: "Doxycycline-mediated quantitative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0392762:Quantitative [Quantitative Concept]

Phrase: "and"

Phrase: "tissue-specific control of gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.487: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.488: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.489: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.490: USA 93:10933.[Abstract/Free FullText] Hodgkin, P. 

Phrase: "USA 93"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "10933."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hodgkin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.491: D., Lee, J. 

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.492: H. and Lyons, A. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lyons,"

Phrase: "A."
Processing 00000000.tx.493: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.494: 1996. 

Phrase: "1996."
Processing 00000000.tx.495: B cell differentiation and isotype switching is related to division cycle number. 

Phrase: "B cell differentiation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1511002:B-Cell Differentiation [Cell Function]
   901   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "isotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021017:Isotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "switching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]

Phrase: "is"

Phrase: "related to division cycle number."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0449788:Number [Quantitative Concept]
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C1511572:Cycle [Temporal Concept]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.496: J. 

Phrase: "J."
Processing 00000000.tx.497: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.498: Med. 

Phrase: "Med."
Processing 00000000.tx.499: 184:277.[Abstract] Hasbold, J., Lyons, A. 

Phrase: "184"

Phrase: ":"

Phrase: "277."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hasbold,"

Phrase: "J.,"

Phrase: "Lyons,"

Phrase: "A."
Processing 00000000.tx.500: B., Kehry, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kehry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.501: R. and Hodgkin, P. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Hodgkin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.502: D. 

Phrase: "D."
Processing 00000000.tx.503: 1998. 

Phrase: "1998."
Processing 00000000.tx.504: Cell division number regulates IgG1 and IgE switching of B cells following stimulation by CD40 ligand and IL-4. 

Phrase: "Cell division number"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0007584:Cell Number [Laboratory Procedure]
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]
   734   C0007590:Cell division [Cell Function]

Phrase: "regulates"

Phrase: "IgG1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020855:IgG1 [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "IgE"

Phrase: "switching of B cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0004561:B-Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737   C1707719:Switch [Manufactured Object]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "stimulation by CD40 ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "IL-4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.505: Eur. 

Phrase: "Eur."
Processing 00000000.tx.506: J. 

Phrase: "J."
Processing 00000000.tx.507: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.508: 28:1040.[ISI][Medline] Xu, L. and Rothman, P. 

Phrase: "28"

Phrase: ":"

Phrase: "1040."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Xu,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Rothman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.509: 1994. 

Phrase: "1994."
Processing 00000000.tx.510: IFN- represses germline transcription and subsequently down-regulates switch recombination to . Int. 

Phrase: "IFN-"

Phrase: "represses"

Phrase: "germline transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040649:Transcription [Genetic Function]

Phrase: "and"

Phrase: "subsequently"

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "switch recombination to . Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1512667:Switch Recombination [Genetic Function]
   770   C0034865:Recombination [Genetic Function]
Processing 00000000.tx.511: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.512: 6:515.[Abstract] Chu, C. 

Phrase: "6"

Phrase: ":"

Phrase: "515."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chu,"

Phrase: "C."
Processing 00000000.tx.513: C., Paul, W. 

Phrase: "C., Paul,"

Phrase: "W."
Processing 00000000.tx.514: E. and Max, E. 

Phrase: "E."

Phrase: "and"

Phrase: "Max,"

Phrase: "E."
Processing 00000000.tx.515: E. 

Phrase: "E."
Processing 00000000.tx.516: 1992. 

Phrase: "1992."
Processing 00000000.tx.517: Quantitation of immunoglobulin m-1 heavy chain switch region recombination by a digestion-circularization polymerase chain reaction method. 

Phrase: "Quantitation of immunoglobulin m-1 heavy chain switch region recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709793:Quantitation [Quantitative Concept]

Phrase: "by a digestion-circularization polymerase chain reaction method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0025663:Method [Intellectual Product]
   799   C0449851:Method [Functional Concept]
   799   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.518: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.519: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.520: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.521: USA 89:6978.[Abstract] Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. and Honjo, T. 

Phrase: "USA 89"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "6978."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Muramatsu,"

Phrase: "M."

Phrase: ","

Phrase: "Kinoshita,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fagarasan,"

Phrase: "S."

Phrase: ","

Phrase: "Yamada,"

Phrase: "S."

Phrase: ","

Phrase: "Shinkai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3339677:Shinkai [Eukaryote]

Phrase: "Y."

Phrase: "and"

Phrase: "Honjo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.522: 2000. 

Phrase: "2000."
Processing 00000000.tx.523: Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. 

Phrase: "Class switch recombination"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206071:class switch recombination [Genetic Function]
   901   C1512667:Switch Recombination [Genetic Function]
   827   C0034865:Recombination [Genetic Function]

Phrase: "and"

Phrase: "hypermutation"

Phrase: "require"

Phrase: "activation-induced cytidine deaminase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1421876:ACTIVATION-INDUCED CYTIDINE DEAMINASE [Gene or Genome]
  1000   C3538973:Activation-Induced Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010723:Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1413247:CYTIDINE DEAMINASE [Gene or Genome]
   812   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(AID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "a potential RNA editing enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.524: Cell 102:553.[ISI][Medline] Revy, P., Muto, T., Levy, Y., Geissmann, F., Plebani, A., Sanal, O., Catalan, N., Forveille, M., Dufourcq-Labelouse, R., Gennery, A., Tezcan, I., Ersoy, F., Kayserili, H., Ugazio, A. 

Phrase: "Cell 102"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "553."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Revy,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Muto,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Levy,"

Phrase: "Y.,"

Phrase: "Geissmann,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Plebani,"

Phrase: "A.,"

Phrase: "Sanal,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Catalan,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Forveille,"

Phrase: "M."

Phrase: ","

Phrase: "Dufourcq-Labelouse,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gennery,"

Phrase: "A.,"

Phrase: "Tezcan,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ersoy,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kayserili,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ugazio,"

Phrase: "A."
Processing 00000000.tx.525: G., Brousse, N., Muramatsu, M., Notarangelo, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brousse,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Muramatsu,"

Phrase: "M."

Phrase: ","

Phrase: "Notarangelo,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.526: D., Kinoshita, K., Honjo, T., Fischer, A. and Durandy, A. 

Phrase: "D."

Phrase: ","

Phrase: "Kinoshita,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Honjo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Fischer,"

Phrase: "A."

Phrase: "and"

Phrase: "Durandy,"

Phrase: "A."
Processing 00000000.tx.527: 2000. 

Phrase: "2000."
Processing 00000000.tx.528: Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome. 

Phrase: "Activation-induced cytidine deaminase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1421876:ACTIVATION-INDUCED CYTIDINE DEAMINASE [Gene or Genome]
  1000   C3538973:Activation-Induced Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010723:Cytidine Deaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1413247:CYTIDINE DEAMINASE [Gene or Genome]
   812   C0010715:Cytidine [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(AID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011155:Deficiency [Functional Concept]
  1000   C0162429:Deficiency [Disease or Syndrome]
  1000   C1623416:deficiency [Qualitative Concept]
   928 E C1636779:% deficient [Quantitative Concept]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the autosomal recessive form of the Hyper-IgM syndrome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]
Processing 00000000.tx.529: Cell 102:565.[ISI][Medline] Stavnezer, J. 

Phrase: "Cell 102"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "565."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stavnezer,"

Phrase: "J."
Processing 00000000.tx.530: 1996. 

Phrase: "1996."
Processing 00000000.tx.531: Immunoglobulin class switching. 

Phrase: "Immunoglobulin class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456387:Class [Intellectual Product]
   861   C1705943:Class [Classification]

Phrase: "switching."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707719:Switch [Manufactured Object]
Processing 00000000.tx.532: Curr. 

Phrase: "Curr."
Processing 00000000.tx.533: Opin. 

Phrase: "Opin."
Processing 00000000.tx.534: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.535: 8:199.[ISI][Medline] Turner, C. 

Phrase: "8"

Phrase: ":"

Phrase: "199."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Turner,"

Phrase: "C."
Processing 00000000.tx.536: A., Jr, Mack, D. 

Phrase: "A.,"

Phrase: "Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Mack,"

Phrase: "D."
Processing 00000000.tx.537: H. and Davis, M. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Davis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.538: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.539: 1994. 

Phrase: "1994."
Processing 00000000.tx.540: Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. 

Phrase: "Blimp-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0254341:BLIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a novel zinc finger-containing protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "can"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the maturation of B lymphocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]

Phrase: "into immunoglobulin-secreting cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0085820:Immunoglobulin-Secreting Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1327616:Secreting [Cell Function]
   827   C1621846:immunoglobulin [Molecular Function]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.541: Cell 77:297.[ISI][Medline] Lin, Y., Wong, K. and Calame, K. 

Phrase: "Cell 77"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "297."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y.,"

Phrase: "Wong,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Calame,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.542: 1997. 

Phrase: "1997."
Processing 00000000.tx.543: Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. 

Phrase: "Repression of c-myc transcription"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0920533:Transcription Repression [Genetic Function]
   760   C0035143:Repression [Mental Process]

Phrase: "by Blimp-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0254341:BLIMP-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an inducer of terminal B cell differentiation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0018894:Inducer cell [Cell]
   774   C1511939:Differentiation Inducer [Chemical Viewed Functionally]
Processing 00000000.tx.544: Science 276:596.[Abstract/Free FullText] Knodel, M., Kuss, A. 

Phrase: "Science 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "596."

Phrase: "[Abstract/Free FullText"

Phrase: "] Knodel,"

Phrase: "M."

Phrase: ","

Phrase: "Kuss,"

Phrase: "A."
Processing 00000000.tx.545: W., Lindemann, D., Berberich, I. and Schimpl, A. 

Phrase: "W., Lindemann,"

Phrase: "D."

Phrase: ","

Phrase: "Berberich,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schimpl,"

Phrase: "A."
Processing 00000000.tx.546: 1999. 

Phrase: "1999."
Processing 00000000.tx.547: Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family. 

Phrase: "Reversal of Blimp-1-mediated apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443290:Reversal [Functional Concept]

Phrase: "by A1,"

Phrase: "a member of the Bcl-2 family."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.548: Eur. 

Phrase: "Eur."
Processing 00000000.tx.549: J. 

Phrase: "J."
Processing 00000000.tx.550: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.551: 29:2988.[ISI][Medline] Hodgkin, P. 

Phrase: "29"

Phrase: ":"

Phrase: "2988."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hodgkin,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.552: D., Yamashita, L. 

Phrase: "D."

Phrase: ","

Phrase: "Yamashita,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.553: C., Coffman, R. 

Phrase: "C., Coffman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.554: L. and Kehry, M. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Kehry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.555: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.556: 1990. 

Phrase: "1990."
Processing 00000000.tx.557: Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. 

Phrase: "Separation of events"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036679:Separation [Pathologic Function]
   790   C0237868:Separation [Social Behavior]
   790   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "B cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155008:B Cell Proliferation [Cell Function]
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0004561:B-cell [Cell]

Phrase: "and"

Phrase: "Ig production by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "T cell membranes"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0007603:Cell membranes [Cell Component]
   867 E C3161472:Cell Membrane [Cell Component]
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C0039194:T-cell [Cell]

Phrase: "and"

Phrase: "lymphokines."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024297:Lymphokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1527201:Lymphokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.558: J. 

Phrase: "J."
Processing 00000000.tx.559: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.560: 145:2025.[Abstract/Free FullText] Bazil, V. and Strominger, J. 

Phrase: "145"

Phrase: ":"

Phrase: "2025."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bazil,"

Phrase: "V."

Phrase: "and"

Phrase: "Strominger,"

Phrase: "J."
Processing 00000000.tx.561: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.562: 1993. 

Phrase: "1993."
Processing 00000000.tx.563: CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes. 

Phrase: "CD43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538777:CD43 [Gene or Genome]

Phrase: "the major sialoglycoprotein of human leukocytes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0074479:Leukocyte Sialoglycoprotein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0037028:sialoglycoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "proteolytically"

Phrase: "cleaved from the surface of stimulated lymphocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0024264:Lymphocytes [Cell]
   748   C0205148:Surface [Spatial Concept]
   748   C0205242:Cleaved [Spatial Concept]
   748   C0333853:Cleaved [Cell]
   748   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "granulocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018183:Granulocytes [Cell]
  1000   C0857490:Granulocytes [Laboratory Procedure]
Processing 00000000.tx.564: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.565: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.566: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.567: USA 90:3792.[Abstract] Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K. and Yagita, H. 

Phrase: "USA 90"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0041703:USA [Geographic Area]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "3792."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kayagaki,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kawasaki,"

Phrase: "A.,"

Phrase: "Ebata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ohmoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "S."

Phrase: ","

Phrase: "Inoue,"

Phrase: "S."

Phrase: ","

Phrase: "Yoshino,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Okumura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yagita,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.568: 1995. 

Phrase: "1995."
Processing 00000000.tx.569: Metalloproteinase-mediated release of human Fas ligand. 

Phrase: "Metalloproteinase-mediated release of human Fas ligand."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.570: J. 

Phrase: "J."
Processing 00000000.tx.571: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.572: Med. 

Phrase: "Med."
Processing 00000000.tx.573: 182:1777.[Abstract] Feehan, C., Darlak, K., Kahn, J., Walcheck, B., Spatola, A. 

Phrase: "182"

Phrase: ":"

Phrase: "1777."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Feehan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Darlak,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kahn,"

Phrase: "J.,"

Phrase: "Walcheck,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Spatola,"

Phrase: "A."
Processing 00000000.tx.574: F. and Kishimoto, T. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Kishimoto,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.575: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.576: 1996. 

Phrase: "1996."
Processing 00000000.tx.577: Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor. 

Phrase: "Shedding of the lymphocyte L-selectin adhesion molecule"

Phrase: "is"

Phrase: "inhibited by a hydroxamic acid-based protease inhibitor."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0020314:Hydroxamic Acid [Organic Chemical]
   770   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   770   C3536890:Protease Inhibitor [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0311403:Inhibited [Qualitative Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C1947941:Protease [Enzyme]
   744   C1999216:Inhibitor [Qualitative Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.578: Identification with an L-selectin-alkaline phosphatase reporter. 

Phrase: "Identification with an L-selectin-alkaline phosphatase reporter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]
Processing 00000000.tx.579: J. 

Phrase: "J."
Processing 00000000.tx.580: Biol. 

Phrase: "Biol."
Processing 00000000.tx.581: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.582: 271:7019.[Abstract/Free FullText] Preece, G., Murphy, G. and Ager, A. 

Phrase: "271"

Phrase: ":"

Phrase: "7019."

Phrase: "[Abstract/Free FullText"

Phrase: "] Preece,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Ager,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412278:AGER [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.583: 1996. 

Phrase: "1996."
Processing 00000000.tx.584: Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. 

Phrase: "Metalloproteinase-mediated regulation of L-selectin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "on leucocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023516:leucocytes [Cell]
Processing 00000000.tx.585: J. 

Phrase: "J."
Processing 00000000.tx.586: Biol. 

Phrase: "Biol."
Processing 00000000.tx.587: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.588: 271:11634.[Abstract/Free FullText] Christie, G., Barton, A., Bolognese, B., Buckle, D. 

Phrase: "271"

Phrase: ":"

Phrase: "11634."

Phrase: "[Abstract/Free FullText"

Phrase: "] Christie,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Barton,"

Phrase: "A.,"

Phrase: "Bolognese,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Buckle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0347847:buckle [Spatial Concept]
  1000   C0542562:Buckle [Manufactured Object]

Phrase: "D."
Processing 00000000.tx.589: R., Cook, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.590: M., Hansbury, M. 

Phrase: "M."

Phrase: ","

Phrase: "Hansbury,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.591: J., Harper, G. 

Phrase: "J.,"

Phrase: "Harper,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.592: P., Marshall, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.593: A., McCord, M. 

Phrase: "A.,"

Phrase: "McCord,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.594: E., Moulder, K., Murdock, P. 

Phrase: "E.,"

Phrase: "Moulder"

Phrase: ","

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murdock,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.595: R., Seal, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Seal,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036492:Seal [Mammal]
  1000   C0325125:seal [Mammal]
  1000   C1704637:Seal [Manufactured Object]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.596: M., Spackman, V. 

Phrase: "M."

Phrase: ","

Phrase: "Spackman,"

Phrase: "V."
Processing 00000000.tx.597: M., Weston, B. 

Phrase: "M."

Phrase: ","

Phrase: "Weston,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.598: J. and Mayer, R. 

Phrase: "J."

Phrase: "and"

Phrase: "Mayer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.599: J. 

Phrase: "J."
Processing 00000000.tx.600: 1997. 

Phrase: "1997."
Processing 00000000.tx.601: IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FcRII). 

Phrase: "IgE secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "attenuated by an inhibitor of proteolytic processing of CD23"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C1514570:Proteolytic Processing [Molecular Function]
   742   C0332161:Attenuated [Qualitative Concept]
   742   C0597304:Proteolytic [Molecular Function]
   742   C0599946:Attenuated [Activity]
   742   C1709694:Processing [Activity]
   742   C1947941:proteolytic [Enzyme]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(FcRII"

Phrase: ")."
Processing 00000000.tx.602: Eur. 

Phrase: "Eur."
Processing 00000000.tx.603: J. 

Phrase: "J."
Processing 00000000.tx.604: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.605: 27:3228.[ISI][Medline] Black, R. 

Phrase: "27"

Phrase: ":"

Phrase: "3228."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Black,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.606: A., Rauch, C. 

Phrase: "A.,"

Phrase: "Rauch,"

Phrase: "C."
Processing 00000000.tx.607: T., Kozlosky, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kozlosky,"

Phrase: "C."
Processing 00000000.tx.608: J., Peschon, J. 

Phrase: "J.,"

Phrase: "Peschon,"

Phrase: "J."
Processing 00000000.tx.609: J., Slack, J. 

Phrase: "J.,"

Phrase: "Slack,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425836:SLACK [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.610: L., Wolfson, M. 

Phrase: "L., Wolfson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.611: F., Castner, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Castner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.612: J., Stocking, K. 

Phrase: "J.,"

Phrase: "Stocking,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0453908:Stocking [Manufactured Object]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.613: L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. 

Phrase: "L., Reddy,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Srinivasan,"

Phrase: "S."

Phrase: ","

Phrase: "Nelson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Boiani,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Schooley,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.614: A., Gerhart, M., Davis, R., Fitzner, J. 

Phrase: "A.,"

Phrase: "Gerhart,"

Phrase: "M."

Phrase: ","

Phrase: "Davis,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Fitzner,"

Phrase: "J."
Processing 00000000.tx.615: N., Johnson, R. 

Phrase: "N., Johnson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.616: S., Paxton, R. 

Phrase: "S."

Phrase: ","

Phrase: "Paxton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463948:Paxton [Fish]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.617: J., March, C. 

Phrase: "J.,"

Phrase: "March,"

Phrase: "C."
Processing 00000000.tx.618: J. and Cerretti, D. 

Phrase: "J."

Phrase: "and"

Phrase: "Cerretti,"

Phrase: "D."
Processing 00000000.tx.619: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.620: 1997. 

Phrase: "1997."
Processing 00000000.tx.621: A metalloproteinase disintegrin that releases tumour-necrosis factor- from cells. 

Phrase: "A metalloproteinase disintegrin"

Phrase: "that"

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "tumour-necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "from cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.622: Nature 385:729.[ISI][Medline] Moss, M. 

Phrase: "Nature 385"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "729."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282635:Moss [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.623: L., Jin, S. 

Phrase: "L., Jin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.624: L., Milla, M. 

Phrase: "L., Milla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1015991:Milla [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.625: E., Bickett, D. 

Phrase: "E.,"

Phrase: "Bickett,"

Phrase: "D."
Processing 00000000.tx.626: M., Burkhart, W., Carter, H. 

Phrase: "M."

Phrase: ","

Phrase: "Burkhart,"

Phrase: "W.,"

Phrase: "Carter,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.627: L., Chen, W. 

Phrase: "L., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "W."
Processing 00000000.tx.628: J., Clay, W. 

Phrase: "J.,"

Phrase: "Clay,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0055863:clay [Inorganic Chemical]

Phrase: "W."
Processing 00000000.tx.629: C., Didsbury, J. 

Phrase: "C., Didsbury,"

Phrase: "J."
Processing 00000000.tx.630: R., Hassler, D., Hoffman, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hassler,"

Phrase: "D."

Phrase: ","

Phrase: "Hoffman,"

Phrase: "C."
Processing 00000000.tx.631: R., Kost, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kost,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.632: A., Lambert, M. 

Phrase: "A.,"

Phrase: "Lambert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551092:Lambert [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.633: H., Leesnitzer, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leesnitzer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.634: A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. 

Phrase: "A.,"

Phrase: "McCauley,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McGeehan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mitchell,"

Phrase: "J.,"

Phrase: "Moyer,"

Phrase: "M."

Phrase: ","

Phrase: "Pahel,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rocque,"

Phrase: "W.,"

Phrase: "Overton,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.635: K., Schoenen, F., Seaton, T., Su, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Schoenen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Seaton,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "J."
Processing 00000000.tx.636: L., Becherer, J. 

Phrase: "L., Becherer,"

Phrase: "J."
Processing 00000000.tx.637: D., et al. 

Phrase: "D."

Phrase: ","

Phrase: "et al."
Processing 00000000.tx.638: 1997. 

Phrase: "1997."
Processing 00000000.tx.639: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. 

Phrase: "Cloning of a disintegrin metalloproteinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009015:Cloning [Research Activity]

Phrase: "that processes precursor tumour-necrosis factor-alpha."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   901   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
   901   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   901   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   861   C1323304:tumor necrosis factor [Molecular Function]
   827   C0333516:Tumor necrosis [Neoplastic Process]
   799   C0027540:Necrosis [Organ or Tissue Function]
   799   C0027651:Tumor [Neoplastic Process]
   799   C0439095:Alpha [Intellectual Product]
   799   C1334928:Necrosis [Finding]
   799   C1521761:Factor [Functional Concept]
   799   C1578706:Tumor [Intellectual Product]
   799   C2003941:Alpha [Intellectual Product]
   799   C2350010:Alpha [Qualitative Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C3273930:Tumor [Finding]
Processing 00000000.tx.640: Nature 385:733.[ISI][Medline] Marolewski, A. 

Phrase: "Nature 385"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "733."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marolewski,"

Phrase: "A."
Processing 00000000.tx.641: E., Buckle, D. 

Phrase: "E.,"

Phrase: "Buckle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0347847:buckle [Spatial Concept]
  1000   C0542562:Buckle [Manufactured Object]

Phrase: "D."
Processing 00000000.tx.642: R., Christie, G., Earnshaw, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Christie,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Earnshaw,"

Phrase: "D."
Processing 00000000.tx.643: L., Flamberg, P. 

Phrase: "L., Flamberg,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.644: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.645: Marshall, L. 

Phrase: "Marshall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551881:Marshall [Population Group]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.646: A., Smith, D. 

Phrase: "A.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.647: G. and Mayer, R. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Mayer,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.648: J. 

Phrase: "J."
Processing 00000000.tx.649: 1998. 

Phrase: "1998."
Processing 00000000.tx.650: CD23 (FcRII) release from cell membranes is mediated by a membrane-bound metalloprotease. 

Phrase: "CD23"

Phrase: "(FcRII"

Phrase: ")"

Phrase: "release from cell membranes"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   833   C0007603:Cell membranes [Cell Component]
   799 E C3161472:Cell Membrane [Cell Component]
   770   C0007634:Cell [Cell]
   770   C0025255:Membranes [Tissue]
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1269647:Cell [Cell]
   770   C1283071:Release [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "is"

Phrase: "mediated by a membrane-bound metalloprotease."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0025255:Membrane [Tissue]
   753   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0332297:bound [Spatial Concept]
           Bounded by
   753   C0596901:Membrane [Cell Component]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C1706182:Membrane [Manufactured Object]
   753   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.651: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.652: J. 

Phrase: "J."
Processing 00000000.tx.653: 333:573.[ISI][Medline] Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J. 

Phrase: "333"

Phrase: ":"

Phrase: "573."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schneider,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "MacKay,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Steiner,"

Phrase: "V.,"

Phrase: "Hofmann,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bodmer,"

Phrase: "J."
Processing 00000000.tx.654: L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., Valmori, D., Romero, P., Werner-Favre, C., Zubler, R. 

Phrase: "L., Holler,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ambrose,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lawton,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bixler,"

Phrase: "S."

Phrase: ","

Phrase: "Acha-Orbea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1190554:Orbea [Plant]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Valmori,"

Phrase: "D."

Phrase: ","

Phrase: "Romero,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Werner-Favre,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Zubler,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.655: H., Browning, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Browning,"

Phrase: "J."
Processing 00000000.tx.656: L. and Tschopp, J. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Tschopp,"

Phrase: "J."
Processing 00000000.tx.657: 1999. 

Phrase: "1999."
Processing 00000000.tx.658: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. 

Phrase: "BAFF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0767393:BAFF [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1420816:BAFF [Gene or Genome]
  1000   C2986676:BAFF [Gene or Genome]

Phrase: "a novel ligand of the tumor necrosis factor family,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0023688:Ligand [Chemical]

Phrase: "stimulates"

Phrase: "B cell growth."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   734   C0004561:B-cell [Cell]
Processing 00000000.tx.659: J. 

Phrase: "J."
Processing 00000000.tx.660: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.661: Med. 

Phrase: "Med."
Processing 00000000.tx.662: 189:1747.[Abstract/Free FullText] Yamamoto, S., Higuchi, Y., Yoshiyama, K., Shimizu, E., Kataoka, M., Hijiya, N. and Matsuura, K. 

Phrase: "189"

Phrase: ":"

Phrase: "1747."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "S."

Phrase: ","

Phrase: "Higuchi,"

Phrase: "Y.,"

Phrase: "Yoshiyama,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Shimizu,"

Phrase: "E.,"

Phrase: "Kataoka,"

Phrase: "M."

Phrase: ","

Phrase: "Hijiya,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Matsuura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.663: 1999. 

Phrase: "1999."
Processing 00000000.tx.664: ADAM family proteins in the immune system. 

Phrase: "ADAM family proteins in the immune system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1332023:ADAM Family Protein [Amino Acid, Peptide, or Protein,Enzyme]
   774   C1566416:ADAM Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.665: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.666: Today 20:278.[ISI][Medline] Osborne, B. and Miele, L. 

Phrase: "Today 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]

Phrase: ":"

Phrase: "278."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Osborne,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Miele,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.667: 1999. 

Phrase: "1999."
Processing 00000000.tx.668: Notch and the immune system. 

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "and"

Phrase: "the immune system."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0020962:Immune system [Body System]
  1000   C1291764:IMMUNE SYSTEM [Finding]
   861   C0439662:Immune [Functional Concept]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.669: Immunity 11:653.[ISI][Medline] Johnatty, R. 

Phrase: "Immunity 11"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "653."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnatty,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.670: N., Taub, D. 

Phrase: "N., Taub,"

Phrase: "D."
Processing 00000000.tx.671: D., Reeder, S. 

Phrase: "D."

Phrase: ","

Phrase: "Reeder,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.672: P., Turcovski-Corrales, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Turcovski-Corrales,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.673: M., Cottam, D. 

Phrase: "M."

Phrase: ","

Phrase: "Cottam,"

Phrase: "D."
Processing 00000000.tx.674: W., Stephenson, T. 

Phrase: "W., Stephenson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.675: J. and Rees, R. 

Phrase: "J."

Phrase: "and"

Phrase: "Rees,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555622:Ree [Language]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.676: C. 

Phrase: "C."
Processing 00000000.tx.677: 1997. 

Phrase: "1997."
Processing 00000000.tx.678: Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. 

Phrase: "Cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "chemokine regulation of proMMP-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "TIMP-1 production"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   938   C1522552:Tissue Inhibitor of Metalloproteinases 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Tissue Inhibitor of Metalloproteinases
           Metalloproteinase Inhibitor 1
   929 E C0145947:Tissue-Inhibitor of Metalloproteinase-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Metalloproteinase-1 Tissue Inhibitor
   882   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   783   C1418824:INHIBITOR 1 [Gene or Genome]
   767   C1152589:metalloproteinase inhibitor [Molecular Function]
   753   C0040300:Tissue [Tissue]
   753   C1547928:Tissue [Intellectual Product]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "by human peripheral blood lymphocytes."
Meta Candidates (Total=16; Excluded=8; Pruned=0; Remaining=8)
   890   C1518997:Peripheral Blood Lymphocyte [Cell]
   861   C0229664:peripheral blood [Body Substance]
           Blood
   844   C0024264:Blood lymphocyte [Cell]
           Lymphocytes
   819 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0205100:Peripheral [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.679: J. 

Phrase: "J."
Processing 00000000.tx.680: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.681: 158:2327.[Abstract] Stetler-Stevenson, M., Mansoor, A., Lim, M., Fukushima, P., Kehrl, J., Marti, G., Ptaszynski, K., Wang, J. and Stetler-Stevenson, W. 

Phrase: "158"

Phrase: ":"

Phrase: "2327."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Stetler-Stevenson,"

Phrase: "M."

Phrase: ","

Phrase: "Mansoor,"

Phrase: "A.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "M."

Phrase: ","

Phrase: "Fukushima,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kehrl,"

Phrase: "J.,"

Phrase: "Marti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ptaszynski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wang,"

Phrase: "J."

Phrase: "and"

Phrase: "Stetler-Stevenson,"

Phrase: "W."
Processing 00000000.tx.682: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.683: 1997. 

Phrase: "1997."
Processing 00000000.tx.684: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. 

Phrase: "Expression of matrix metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tissue inhibitors of metalloproteinases"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   991   C0145988:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Metalloproteinases Tissue Inhibitor
   991   C1522552:Tissue Inhibitor of Metalloproteinases [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C1152589:metalloproteinase inhibitor [Molecular Function]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "in reactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205332:Reactive [Qualitative Concept]

Phrase: "and"

Phrase: "neoplastic lymphoid cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0597032:Neoplastic cells [Cell]
   901   C0086574:Lymphoid Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C1518071:Lymphoid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.685: Blood 89:1708.[Abstract/Free FullText] Di Girolamo, N., Tedla, N., Lloyd, A. and Wakefield, D. 

Phrase: "Blood 89"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "1708."

Phrase: "[Abstract/Free FullText"

Phrase: "] Di Girolamo,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tedla,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lloyd,"

Phrase: "A."

Phrase: "and"

Phrase: "Wakefield,"

Phrase: "D."
Processing 00000000.tx.686: 1998. 

Phrase: "1998."
Processing 00000000.tx.687: Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. 

Phrase: "Expression of matrix metalloproteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by human plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C0427861:Human cells [Laboratory or Test Result]
   901   C0032112:Plasma Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0544357:Human plasma [Pharmacologic Substance]

Phrase: "and"

Phrase: "B lymphocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0004561:B-Lymphocytes [Cell]
   861   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.688: Eur. 

Phrase: "Eur."
Processing 00000000.tx.689: J. 

Phrase: "J."
Processing 00000000.tx.690: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.691: 28:1773.[ISI][Medline] Luo, H., Hofstetter, H., Banchereau, J. and Delespesse, G. 

Phrase: "28"

Phrase: ":"

Phrase: "1773."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hofstetter,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Banchereau,"

Phrase: "J."

Phrase: "and"

Phrase: "Delespesse,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.692: 1991. 

Phrase: "1991."
Processing 00000000.tx.693: Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. 

Phrase: "Cross-linking of CD23 antigen"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0123242:CD23 Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   806   C0332220:Cross-linking [Functional Concept]
   806   C3273109:CD23 Antigen [Amino Acid, Peptide, or Protein]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0003320:Antigen [Immunologic Factor]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "by its natural ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "(IgE)"

Phrase: "or by anti-CD23 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1327944:anti-CD23 Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "B lymphocyte proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155008:B-lymphocyte proliferation [Cell Function]
   901   C0596873:lymphocyte proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0004561:B lymphocyte [Cell]

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.694: J. 

Phrase: "J."
Processing 00000000.tx.695: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.696: 146:2122.[Abstract/Free FullText] Shanebeck, K. 

Phrase: "146"

Phrase: ":"

Phrase: "2122."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shanebeck,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.697: D., Maliszewski, C. 

Phrase: "D."

Phrase: ","

Phrase: "Maliszewski,"

Phrase: "C."
Processing 00000000.tx.698: R., Kennedy, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kennedy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.699: K., Picha, K. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Picha,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.700: S., Smith, C. 

Phrase: "S."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.701: A., Goodwin, R. 

Phrase: "A.,"

Phrase: "Goodwin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.702: G. and Grabstein, K. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Grabstein,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.703: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.704: 1995. 

Phrase: "1995."
Processing 00000000.tx.705: Regulation of murine B cell growth and differentiation by CD30 ligand. 

Phrase: "Regulation of murine B cell growth"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C0596286:regulation of cell growth [Cell Function]
           Cell Growth Regulation
   820   C1160191:regulation of growth [Organism Function]
           growth regulation
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "differentiation by CD30 ligand."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.706: Eur. 

Phrase: "Eur."
Processing 00000000.tx.707: J. 

Phrase: "J."
Processing 00000000.tx.708: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.709: 25:2147.[ISI][Medline] Cerutti, A., Schaffer, A., Shah, S., Zan, H., Liou, H. 

Phrase: "25"

Phrase: ":"

Phrase: "2147."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cerutti,"

Phrase: "A.,"

Phrase: "Schaffer,"

Phrase: "A.,"

Phrase: "Shah,"

Phrase: "S."

Phrase: ","

Phrase: "Zan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421566:ZAN [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Liou,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.710: C., Goodwin, R. 

Phrase: "C., Goodwin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.711: G. and Casali, P. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Casali,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.712: 1998. 

Phrase: "1998."
Processing 00000000.tx.713: CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells. 

Phrase: "CD30"

Phrase: "is"

Phrase: "a CD40-inducible molecule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0054959:CD40 molecule [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "that negatively"

Phrase: "regulates"

Phrase: "CD40-mediated immunoglobulin class"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456387:Class [Intellectual Product]
   812   C1705943:Class [Classification]

Phrase: "switching in non-antigen-selected human B cells."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   776   C0486379:B-cell Antigen [Immunologic Factor]
   770   C0004561:B-Cells [Cell]
   767   C0003318:Antigen Switching [Molecular Function]
   767   C0368721:antigen b [Immunologic Factor]
   767   C0427861:Human cells [Laboratory or Test Result]
   744   C0003320:Antigen [Immunologic Factor]
   744   C0007634:Cells [Cell]
   744   C0086418:Human [Human]
   744   C1518422:Non [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711   C1707391:Select [Activity]
   711   C1707719:Switch [Manufactured Object]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.714: Immunity 9:247.[ISI][Medline] Cerutti, A., Schaffer, A., Goodwin, R. 

Phrase: "Immunity 9"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: ":"

Phrase: "247."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cerutti,"

Phrase: "A.,"

Phrase: "Schaffer,"

Phrase: "A.,"

Phrase: "Goodwin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.715: G., Shah, S., Zan, H., Ely, S. and Casali, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Shah,"

Phrase: "S."

Phrase: ","

Phrase: "Zan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421566:ZAN [Gene or Genome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551591:Ely [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Casali,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.716: 2000. 

Phrase: "2000."
Processing 00000000.tx.717: Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. 

Phrase: "Engagement of CD153"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0425152:engagement [Finding]
   790   C2937292:engagement [Finding]

Phrase: "(CD30 ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0218093:CD30 Ligand [Amino Acid, Peptide, or Protein]
  1000   C1420820:CD30 LIGAND [Gene or Genome]
   861   C0023688:Ligand [Chemical]

Phrase: ")"

Phrase: "by CD30+ T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "class switch DNA recombination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0206071:class switch recombination [Genetic Function]
   875   C1512667:Switch Recombination [Genetic Function]
   861   C0034865:DNA Recombination [Genetic Function]
           Recombination

Phrase: "and"

Phrase: "antibody production in human IgD+ IgM+ B cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003261:Antibody Production [Biologic Function]
   744   C0033268:production [Occupational Activity]
Processing 00000000.tx.718: J. 

Phrase: "J."
Processing 00000000.tx.719: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.720: 165:786.[Abstract/Free FullText] Moore, P. 

Phrase: "165"

Phrase: ":"

Phrase: "786."

Phrase: "[Abstract/Free FullText"

Phrase: "] Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.721: A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D. 

Phrase: "A.,"

Phrase: "Belvedere,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Orr,"

Phrase: "A.,"

Phrase: "Pieri,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "LaFleur,"

Phrase: "D."
Processing 00000000.tx.722: W., Feng, P., Soppet, D., Charters, M., Gentz, R., Parmelee, D., Li, Y., Galperina, O., Giri, J., Roschke, V., Nardelli, B., Carrell, J., Sosnovtseva, S., Greenfield, W., Ruben, S. 

Phrase: "W., Feng,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Soppet,"

Phrase: "D."

Phrase: ","

Phrase: "Charters,"

Phrase: "M."

Phrase: ","

Phrase: "Gentz,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Parmelee,"

Phrase: "D."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.,"

Phrase: "Galperina,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Giri,"

Phrase: "J.,"

Phrase: "Roschke,"

Phrase: "V.,"

Phrase: "Nardelli,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Carrell,"

Phrase: "J.,"

Phrase: "Sosnovtseva,"

Phrase: "S."

Phrase: ","

Phrase: "Greenfield,"

Phrase: "W.,"

Phrase: "Ruben,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0766022:RuBen [Organic Chemical,Pharmacologic Substance]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.723: M., Olsen, H. 

Phrase: "M."

Phrase: ","

Phrase: "Olsen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.724: S., Fikes, J. and Hilbert, D. 

Phrase: "S."

Phrase: ","

Phrase: "Fikes,"

Phrase: "J."

Phrase: "and"

Phrase: "Hilbert,"

Phrase: "D."
Processing 00000000.tx.725: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.726: 1999. 

Phrase: "1999."
Processing 00000000.tx.727: BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. 

Phrase: "BLyS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0767393:BLyS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1420816:BLYS [Gene or Genome]
  1000   C2986676:BLYS [Gene or Genome]

Phrase: ":"

Phrase: "member of the tumor necrosis factor family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "B lymphocyte stimulator."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0767393:B Lymphocyte Stimulator [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1420816:B-LYMPHOCYTE STIMULATOR [Gene or Genome]
   901   C0004561:B lymphocyte [Cell]
   827   C0024264:Lymphocyte [Cell]
   827   C0175727:Stimulator [Medical Device]
Processing 00000000.tx.728: Science 285:260.[Abstract/Free FullText] Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G. 

Phrase: "Science 285"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "260."

Phrase: "[Abstract/Free FullText"

Phrase: "] Mukhopadhyay,"

Phrase: "A.,"

Phrase: "Ni,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Zhai,"

Phrase: "Y.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.729: L. and Aggarwal, B. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Aggarwal,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.730: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.731: 1999. 

Phrase: "1999."
Processing 00000000.tx.732: Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. 

Phrase: "Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of a novel cytokine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "THANK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: ","

Phrase: "a TNF homologue"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1334043:Homologue [Gene or Genome]
   756   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C1323304:tumor necrosis factor [Molecular Function]
   756   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "nuclear factor-kappaB,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0079904:Nuclear Factor kappa B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0521447:Nuclear [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "c-Jun NH2-terminal kinase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   937   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   708   C1707271:C-Terminal [Amino Acid Sequence]
Processing 00000000.tx.733: J. 

Phrase: "J."
Processing 00000000.tx.734: Biol. 

Phrase: "Biol."
Processing 00000000.tx.735: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.736: 274:15978.[Abstract/Free FullText] Shu, H. 

Phrase: "274"

Phrase: ":"

Phrase: "15978."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.737: B., Hu, W. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hu,"

Phrase: "W."
Processing 00000000.tx.738: H. and Johnson, H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Johnson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.739: 1999. 

Phrase: "1999."
Processing 00000000.tx.740: TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. 

Phrase: "TALL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0767393:TALL-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1420816:TALL-1 [Gene or Genome]
  1000   C2986676:TALL-1 [Gene or Genome]
   861   C0023493:t-all [Neoplastic Process]
   861   C1961099:T-ALL [Neoplastic Process]

Phrase: "is"

Phrase: "a novel member of the TNF family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "that"

Phrase: "is"

Phrase: "down-regulated by mitogens."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0026249:Mitogens [Pharmacologic Substance]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   737 E C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]
Processing 00000000.tx.741: J. 

Phrase: "J."
Processing 00000000.tx.742: Leuk. 

Phrase: "Leuk."
Processing 00000000.tx.743: Biol. 

Phrase: "Biol."
Processing 00000000.tx.744: 65:680.[Abstract] Gross, J. 

Phrase: "65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "680."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gross, J."
Processing 00000000.tx.745: A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. 

Phrase: "A.,"

Phrase: "Johnston,"

Phrase: "J.,"

Phrase: "Mudri,"

Phrase: "S."

Phrase: ","

Phrase: "Enselman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dillon,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.746: R., Madden, K., Xu, W., Parrish-Novak, J., Foster, D., Lofton-Day, C., Moore, M., Littau, A., Grossman, A., Haugen, H., Foley, K., Blumberg, H., Harrison, K., Kindsvogel, W. and Clegg, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Madden"

Phrase: ","

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Xu,"

Phrase: "W.,"

Phrase: "Parrish-Novak,"

Phrase: "J.,"

Phrase: "Foster,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242298:foster [Daily or Recreational Activity]
  1000   C0344349:foster [Family Group]

Phrase: "D."

Phrase: ","

Phrase: "Lofton-Day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "Littau,"

Phrase: "A.,"

Phrase: "Grossman,"

Phrase: "A.,"

Phrase: "Haugen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Foley,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Blumberg,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Harrison,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kindsvogel,"

Phrase: "W."

Phrase: "and"

Phrase: "Clegg,"

Phrase: "C."
Processing 00000000.tx.747: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.748: 2000. 

Phrase: "2000."
Processing 00000000.tx.749: TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. 

Phrase: "TACI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425349:TACI [Gene or Genome]

Phrase: "and"

Phrase: "BCMA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0626649:BCMA [Organic Chemical,Pharmacologic Substance]
  1000   C1420809:BCMA [Gene or Genome]
  1000   C3273658:BCMA [Gene or Genome]

Phrase: "are"

Phrase: "receptors for a TNF homologue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0077503:Receptors, Tumor Necrosis Factor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "implicated in B-cell autoimmune disease."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0004364:Autoimmune Disease [Disease or Syndrome]
   790   C0004561:B-cell [Cell]
   753   C0007634:Cell [Cell]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0443146:Autoimmune [Pathologic Function]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.750: Nature404:995.[ISI][Medline] Kwon, B., Youn, B. 

Phrase: "Nature404"

Phrase: ":"

Phrase: "995."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kwon,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Youn,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.751: S. and Kwon, B. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Kwon,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.752: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.753: 1999. 

Phrase: "1999."
Processing 00000000.tx.754: Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies in lymphocytes. 

Phrase: "Functions of newly identified members of the tumor necrosis factor receptor/ligand superfamilies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   735   C0542341:Functions [Functional Concept]
   732   C0920644:function receptor [Molecular Function]
   702 E C0031843:function [Physiologic Function]
   702 E C0700205:FUNCTION [Classification]
   702 E C1705273:Function [Intellectual Product]

Phrase: "in lymphocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.755: Curr. 

Phrase: "Curr."
Processing 00000000.tx.756: Opin. 

Phrase: "Opin."
Processing 00000000.tx.757: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.758: 11:340.[ISI][Medline] Gravestein, L. 

Phrase: "11"

Phrase: ":"

Phrase: "340."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gravestein,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.759: A. and Borst, J. 

Phrase: "A."

Phrase: "and"

Phrase: "Borst,"

Phrase: "J."
Processing 00000000.tx.760: 1998. 

Phrase: "1998."
Processing 00000000.tx.761: Tumor necrosis factor receptor family members in the immune system. 

Phrase: "Tumor necrosis factor receptor family members in the immune system."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C0077503:Tumor Necrosis Factor Receptor Family [Amino Acid, Peptide, or Protein,Receptor]
   760   C0086282:Family Members [Family Group]
   757   C0680024:family system [Family Group]
   739   C0015576:Family [Family Group]
   739   C0680022:members [Population Group]
   739   C1704727:Family [Conceptual Entity]
   726 E C1611821:Family Member [Intellectual Product]
   706 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.762: Semin. 

Phrase: "Semin."
Processing 00000000.tx.763: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.764: 10:423.[ISI][Medline] Kleiner, D. 

Phrase: "10"

Phrase: ":"

Phrase: "423."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kleiner,"

Phrase: "D."
Processing 00000000.tx.765: E. 

Phrase: "E."
Processing 00000000.tx.766: J. and Stetler-Stevenson, W. 

Phrase: "J."

Phrase: "and"

Phrase: "Stetler-Stevenson,"

Phrase: "W."
Processing 00000000.tx.767: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.768: 1993. 

Phrase: "1993."
Processing 00000000.tx.769: Structural biochemistry and activation of matrix metalloproteases. 

Phrase: "Structural biochemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514998:Structural Biochemistry [Occupation or Discipline]
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "activation of matrix metalloproteases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]
Processing 00000000.tx.770: Curr. 

Phrase: "Curr."
Processing 00000000.tx.771: Opin. 

Phrase: "Opin."
Processing 00000000.tx.772: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.773: 5:891.[Medline] Finnin, M. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "891."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Finnin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.774: S., Donigian, J. 

Phrase: "S."

Phrase: ","

Phrase: "Donigian,"

Phrase: "J."
Processing 00000000.tx.775: R., Cohen, A., Richon, V. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cohen,"

Phrase: "A.,"

Phrase: "Richon,"

Phrase: "V."
Processing 00000000.tx.776: M., Rifkind, R. 

Phrase: "M."

Phrase: ","

Phrase: "Rifkind,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.777: A., Marks, P. 

Phrase: "A.,"

Phrase: "Marks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:marks [Qualitative Concept]
   916 E C1706089:Marked [Qualitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.778: A. 

Phrase: "A."
Processing 00000000.tx.779: Breslow, R. and Pavletich, N. 

Phrase: "Breslow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511325:Breslow [Clinical Attribute]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Pavletich,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.780: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.781: 1999. 

Phrase: "1999."
Processing 00000000.tx.782: Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. 

Phrase: "Structures of a histone deacetylase homologue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "bound to the TSA"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1266025:TSA [Neoplastic Process]
   770   C1418880:TSA [Gene or Genome]
   770   C1689898:% bound [Quantitative Concept]
   770   C2247518:TSA [Molecular Function]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "SAHA inhibitors."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.783: Nature 401:188.[ISI][Medline] Muramatsu, M., Sankaranand, V. 

Phrase: "Nature 401"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "188."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Muramatsu,"

Phrase: "M."

Phrase: ","

Phrase: "Sankaranand,"

Phrase: "V."
Processing 00000000.tx.784: S., Anant, S., Sugai, M., Kinoshita, K., Davidson, N. 

Phrase: "S."

Phrase: ","

Phrase: "Anant,"

Phrase: "S."

Phrase: ","

Phrase: "Sugai,"

Phrase: "M."

Phrase: ","

Phrase: "Kinoshita,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Davidson,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.785: O. and Honjo, T. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Honjo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.786: 1999. 

Phrase: "1999."
Processing 00000000.tx.787: Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. 

Phrase: "Specific expression of activation-induced cytidine deaminase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(AID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582118:Deaminase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "a novel member of the RNA-editing deaminase family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0086282:Family member [Family Group]
   762   C1611821:Family Member [Intellectual Product]
   742   C0680022:member [Population Group]
   742   C2698041:Member [Professional or Occupational Group]

Phrase: "in germinal center B cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0004561:B-Cells [Cell]
   861   C0282491:Germinal Center [Tissue]
   812   C0007634:Cells [Cell]
   812   C0205099:Center [Spatial Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.788: J. 

Phrase: "J."
Processing 00000000.tx.789: Biol. 

Phrase: "Biol."
Processing 00000000.tx.790: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.791: 274:18470.[Abstract/Free FullText] Karlsson, M., Hammers, S., Nilsson-Ehle, I., Malmborg, A. 

Phrase: "274"

Phrase: ":"

Phrase: "18470."

Phrase: "[Abstract/Free FullText"

Phrase: "] Karlsson,"

Phrase: "M."

Phrase: ","

Phrase: "Hammers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0181107:Hammer [Manufactured Object]

Phrase: "S."

Phrase: ","

Phrase: "Nilsson-Ehle,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Malmborg,"

Phrase: "A."
Processing 00000000.tx.792: S. and Wretlind, B. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Wretlind,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.793: 1996. 

Phrase: "1996."
Processing 00000000.tx.794: Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. 

Phrase: "Concentrations of doxycycline"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0086045:Concentrations [Mental Process]
   756 E C1446561:Concentration [Quantitative Concept]
   706 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "penicillin G in sera"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   770   C0030842:Penicillin [Antibiotic,Organic Chemical]
   770   C0220892:Penicillin [Antibiotic,Organic Chemical]
   770   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "cerebrospinal fluid of patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0007806:Cerebrospinal Fluid [Body Substance]
   833   C0007807:cerebrospinal fluid [Functional Concept]
   770   C0005889:FLUID [Body Substance]
   770   C0302908:fluid [Substance]
   770   C0444611:Fluid [Qualitative Concept]
   770   C1704353:Fluid [Substance]

Phrase: "treated for neuroborreliosis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C0948264:neuroborreliosis [Disease or Syndrome]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.795: Antimicrob. 

Phrase: "Antimicrob."
Processing 00000000.tx.796: Agents Chemother. 

Phrase: "Agents Chemother."
Processing 00000000.tx.797: 40:1104.[Abstract]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "1104."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

